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The diagnosis of a patient presenting with an oral keratosis is the
first stage in the management of the patient. Diagnosis is based on a
combination of patient history, clinical examination and laboratory
investigations. The aim of this thesis was to identify factors which
may be helpful in the diagnosis of oral keratoses. It is based on a
prospective study of 159 patients being examined haematologically,
immunologically and histopathologically. Two main groups of keratoses
were identified by the presence or absence of an associated
inflammatory cell infiltrate. Infiltrated keratoses comprised
patients diagnosed as lichen planus, leukoplakia, discoid lupus
erythematosus, candidal leukoplakia and squamous cell carcinoma. Non
infiltrated keratoses also comprised patients diagnosed as leukoplakia
but also comprised frictional and smoking keratoses and hereditary
keratoses. A third category, intermediate infiltrated leukoplakia was
distinguished by changeable clinical and histopathological appearances
during the study period.
Individual patient diagnosis followed clinical examination and
immunological and histopathological investigations. Cross-tabulation
of the diagnostic categories with the clinical presentations of the
keratoses showed that the clinical appearances may be common to
different diagnostic categories. Non infiltrated leukoplakia was seen
frequently to involve the floor of mouth. All categories of keratoses
had a high proportion of patients currently taking medication: non
steroid anti-inflammatory drugs were more frequently taken by patients
with erosive lichen planus (29%) than those with non erosive lichen
x x i i i
planus (3%). Abnormal intestinal sugar permeability was detected in
65% and 60% of lichen planus and infiltrated leukoplakia patients
respectively but not in any patients with non infiltrated keratoses.
Haematological deficiencies were detected in 23 patients (14.4%) of
the whole study group and were related particularily to lichen planus
and non infiltrated leukoplakia, 22.5% and 19.2% respectively.
Tobacco habits were positively associated with categories of
leukoplakia and squamous cell carcinoma. Patients with lichen planus
had significantly lower tobacco and alcohol use than infiltrated ,non
infiltrated leukoplakia and the squamous cell carcinoma categories.
Histopathological assessment of the oral keratoses did not identify
any singular diagnostic characteristic. Epithelial dysplasia was seen
in lichen planus, leukoplakia and squamous cell carcinoma.
Inflammatory infiltrate phenotypes were identifiied using the
immunoperoxidase system and quantitative differences existed between
the diagnostic categories. The T4/T8 ratio was highest for the
frictional and smoking keratoses and lowest for intermediate
infiltrated leukoplakia. The intermediate infiltrated leukoplakia
category also showed significantly lower serum immunoglobulins (IgG,
IgA and IgM) than other diagnostic categories. No evidence of
macrophage induced suppression for lymphocyte transformation of
peripheral blood or lesional lymphocytes was found. Co-culture
experiments suggest lesional cells exert suppressor effects for
squamous cell carcinoma and not for the categories of leukoplakia.
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CHAPTER 1
REVIEW OF THE LITERATURE PERTAINING TO
ORAL KERATOSES
EARLY HISTORICAL REVIEW
White appearing lesions of the oral mucosa are not unusual and obtain
their appearance from the scattering of light through an altered
surface. Such changes may be the result of a thickened layer of
keratin or altered hydration of the keratin, and conditions presenting
in this way are generally regarded as oral keratoses.
Hipocrates (460-370 B.C.) used the term "aphthai" to describe
infantile thrush which presents as a white patch (1). Acute
pseudomembranous candidiasis (thrush) is characterised clinically by
white lesions of the oral mucosa which can be scraped off to leave a
raw, bleeding surface and is associated with altered keratinisation
(2,3).
The first description of white patches on the oral mucosa in recent
times is attributed to Sir James Paget (1851) who described a smoker's
patch of the tongue as leukoma (4), a term adopted later by Butlin
( 1 885) in his monograph "Diseases of the Tongue" (5). Morris (1 874)
later pronounced Hulke's report to the Royal Medical and Chirurgical
Society (1864) to be the first description of "ichthyosis glossae",
white patches of the tongue or cheek (6). It was then that the
association between "ichthyosis" and "epithelioma" was first raised by
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Sir James Paget (1364), who was to be the first of many to address the
concept of premalignancy, reporting an association of ichthyosis (a
white patch) preceeding epithelioma (neoplasia) in an elderly lady he
had treated (6). Further cases were then reported of the association
between an oral white patch and epithelioma, providing evidence of the
premalignant nature of some oral keratoses (6,7,8). In 1877 oral
"leucoplakia" was described and distinguished from psoriasis by
Schwimmer (9). Today the term leukoplakia persists and continues to
be used to describe a range of oral white lesions. Furthermore the
historical recognition of malignant change associated with leukoplakia
has been confirmed during the course of this century (10,11,12).
Descriptive terms for the oral keratoses are diverse (Table 1). The
suspected aetiologies of leukoplakia were diverse in the early
literature. Irritation from broken teeth, spicy food or drink,
infection and tobacco use were often considered important (13,14,15).
Syphilis was more commonly considered to be causative (13,16,17,18);
this association was endorsed especially during the first decade of
the 20th Century in France (16). Initially, dental filling materials
were reported to be important aetologically in oral keratoses
(11,13,14) but more recently doubt concerning this aspect has been
raised (19). Alcoholic beverages especially spirits, were considered
to exert an effect on the oral mucosa (20). This is now reported to
be an aetiological component of oral squamous cell carcinoma (21).
-2-
TABLE 1
Synonyms and Descriptions Used During the Last













Plaques de la bouche
Plaques opalines
Hyperkeratosis buccalis vel linguae
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Some observers considered the different forms of tobacco use to exert
a greater or lesser effect on the mucosa, while Bloodgood ( 1925)
stated that the quantity of tobacco used was the critical feature in
leukoplakia (22), Bettman (1931) stated that he had never "seen
leukoplakia in a patient who had not used tobacco" (23). Indeed
Hollander ( 1933) included tobacco as first in a list of local factors
important in understanding leukoplakia (24).
Other local factors have been associated with leukoplakia: galvanic
effects due to dissimilar metal restorations, corrosion products and
food allergies (25-29). Dental prostheses of poorly cured vulcanite
were thought to encourage chronic bacterial growth and cause
leukoplakia; the mercury sulphide of overcoloured vulcanite and
sulphur in undercured dentures were also thought to cause additional
mucosal irritation (25). Chronic oral sepsis and bacterial infections
of the gingivae were also reported to be important (27).
Leukoplakia was reported to involve other mucosal sites such as the
vagina, oesophagus and bladder (24). Although local low grade sepsis
was considered to be aetiological, investigators reported systemic
aspects associated with leukoplakia. Diabetes and Vitamin A
deficiency were suspected of encouraging leukoplakia, vitamin A
exerting its effect alone or in association with Indian betel nut
chewing (30-32).
Oral leukoplakia has been reported to be associated with ichthyosis,
lichen planus and psoriasis of the skin (26). Further cases were
quoted by Fitzwilliams (1927) of leukoplakia associated with lupus
-4-
vulgaris and oral tuberculosis (26). Indeed Fox ( 1925) stated that
opinions differed regarding features of leukoplakia and that "nobody
has yet defined leukoplakia satisfactorily and different observers
have no doubt described widely different lesions" (27). He went on to
indicate in his paper describing clinical and histological features of
leukoplakia, that the term leukoplakia may encompass different
entities (27).
Saison (1371) reported diagnostic problems in differentiating between
leukoplakia and lichen planus of the buccal mucosa: in one case, the
oral lesions of lichen planus were not accompanied by skin eruptions
(33). Later, in 1885, Thibierge discussed further diagnostic problems
in differentiating types of oral keratosis including leukoplakia,
smokers' patches, local trauma, buccal psoriasis, marginal exfoliative
glossitis ("la glossite exfoliatrice marginee"), oral syphilitic
lesions and lichen planus (34).
Mucosal involvement with lichen planus was described by an increasing
number of authors by the late nineteenth century (34). It was a
keratosis distinguishable by clinical presentation. However this was
not infallible as illustrated by the growing discussion on oral
keratotic diseases (6-8) .
-5-
Lichen planus is a chronic mucocutaneous dermatosis (12). Clinicians
were aware of cutaneous lichen planus by the early 18th century and a
wealth of descriptive terms arose during the next century to specify
variations of the disease (35-38). Oral involvement however was not
reported until the latter half of the 18th century (38,39). The
mucosal lesions had a similar appearance to the papular skin lesions
but were flat. It was during an address by Wilson in 1 866 to the 34th
annual meeting of the British Medical Association, that he attempted
to simplify the terminology for cutaneous lichen planus (38). The
variety of synonyms and descriptive terms in use then are shown in
Table 2.
Pospelow (1881) described to the Medical Society of Moscow the
manifestations of lichen planus on the tongue, palate, gingivae and
the associated cutaneous eruptions in a twenty three year old student
(40). In a later review of cutaneous and mucosal lichen planus,
Thibierge ( 1 885) commented that the lichen planus papules affecting
the mucosa had atrophic centres and were "un peu gros qu'un grain de
millet..." (34,40). An early French thesis by Lavergne ( 1 883) on
lichen planus detailed observations by Neumann (1881) and Crocker
(1882) of lichen planus involving the mouth (41-43). These authors
documented the clinical appearance and history of oral lichen planus
in its morphological forms. Indeed, Thibierge ( 1 885) illustrated a
case of cutaneous lichen planus that was preceeded by the development
of oral leukoplakia "cette plaque qui presente absolument les
characteres d'une plaque de leukoplakie de la joue" (34). This case
presented with unilateral leukoplakia of the commissure, buccal mucosa
and gingivae extending to the throat (34). These features were
-6-
TABLE 2
Historical Synonyms and Descriptive Terms










Lichen ruber of Hebra
Lichen accruminatus of Kaposi
Pityriasis rubra piloris of Devergie
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atypical for a patient with a history of only a few months pipe
smoking and the ensuing cutaneous lichen planus may suggest a
diagnosis of oral plaque type lichen planus (34). Lavergne ( 1 883) had
not identified oral lesions of lichen planus but recognised that other
investigators including Crocker ( 1 883) had reported oral involvement
of the condition (39,41). Wickham (1 895) described striae, a
pathognomonic sign of lichen planus (44) : VVickham referred to the
striae seen in cutaneous lichen planus and did not describe striae in
the oral forms of lichen planus.
The pharyngeal involvement of lichen planus was considered by Wilson
(1866) as a cause of marasmus, a wasting condition further described
by Hebra ( 1869) (36, 38). Later Crocker (1883) reported examples of
lingual, buccal and pharyngeal lichen planus (39).
Pathological features of cutaneous lichen planus were initially
described by Hebra and Kaposi (1 880) and were already becoming the
subject of communication (45,46). It was not until Dubreuilh's report
in 1 906 that the pathological features of cutaneous lichen planus and
oral lichen planus were compared (47). The microscopic features upon
which diagnosis of lichen planus was based, closely resemble those
currently in use today (48,49). Dubreuilh ( 1906) considered a biopsy
of the oral mucosa to be easier than that for skin as "la muqueuse est
moins sensible que la peau et I'on ne fait pas de cicatrice" (47).
This opinion was endorsed by Dubreuilh's observation that lichen
planus occurred more frequently on the buccal mucosa than on the skin
(47). Important pathological features recognised by Dubreuilh
included a subepithelial dense and uniform infiltrate of small
-8-
lymphocytes, oedema of the basal layer of epithelial cells and an
absence of plasma cells and mast cells (47).
The clinical presentation of oral lichen planus encompasses a variety
of morphological variations. Wilson (1 866) described the appearance
of "round white spots, having the normal size of the papules on the
skin, but without elevation" on the tongue, buccal mucosa and labial
mucosa of a 56 year old female patient (38). Pospelow (1831)
similarly described flat papules on the tongue of a 23 year old male
patient (40). Thibierge (1 885) also described a case of irregular
plaques and papules of oral lichen planus occurring on the buccal
mucosa adjacent to a grossly carious molar (34).
Crocker presented an encompassing appraisal of lichen planus to the
Dermatological Society of London in 1900 (50). In discussion, Dr
Pringle considered the commoner sites of oral lichen planus to be
palate and buccal mucosa, rather than the tongue. Dr T. E. Fox
recounted a French investigator who considered that "in two thirds of
the cases the eruption was seen in the mucous membrane". He disagreed
with the frequency but observed "that the eruption in the mouth does
not itch and, therefore, it very often passes unnoticed" (50).
Initial observations of malignant change in oral white patches were
made by Sir James Paget (1851), Morris (1874) and Clarke (1 874)
(4,6,7). In France Hallopeau (1910) recorded an association of
neoplasia v/ith gingival lichen planus and recommended that a biopsy
was valuable in such a case (51). Copinger (1883) described
ichthyosis of the tongue with malignant degeneration (52).
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Microscopic sections were shown to be a useful adjunct in determining
the malignant changes (52). Previously Fox (1874), adding to the
discussion concerning ichthyosis and keratosis linguae, recognised
microscopic features of altered epithelium of a keratotic tongue and
stated, in referring to ichthyosis linguae, "the latter, no one I
suppose now doubts, is an early stage of epithelioma..." (53).
Sturgis and Lund ( 1 934) reviewed aetiological aspects for leukoplakia
and while outlining local and systemic aspects, considered that the
persistent keratotic lesion remained an indicator of possible
malignant degeneration (54).
Current thinking is that the majority of white lesions of the oral
mucosa are the result of altered keratinization, with the remainder
due to secondary factors directly affecting the epithelial cells and
keratin (for example an aspirin burn). The former lesions are
commonly considered to comprise a group of "Keratoses" which include
conditions or lesions such as lichen planus, leukoplakia and discoid
lupus erythematosus. The present thesis is largely concerned with the
study of oral lichen planus and leukoplakia which are the two most
common types of oral keratoses. As this was a prospective study of
unrelated keratoses, a small number of less common keratoses were
included.
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CLASSIFICATION OF ORAL KERATOSES
Diseases may present with a great spectrum of features. Diagnosis
when defined as the "determination of the nature of a case of
disease", enables not only treatment appropriate to the disease but
also permits classification of disease (55). Diseases may be
recognised by changes in the function and structure of the tissues and
as discussed by Underwood (1981), the diagnostic process requires a
comparison of features of disease and normality (56). Understandably,
there are many aspects that influence each diagnostic process. The
scientific basis for oral diagnosis has been recently comprehensively
reviewed by Dabelsteen and MacKenzie ( 1985) (57). Disease
classification on the whole provides a useful and systematic
arrangement of disease entities based on differing characteristics
(56) .
The main emphasis in this thesis is related to differences between
lichen planus and leukoplakia and reference is made to the other
keratoses only where they are relevant to the study of these two
conditions. The main groups of disease included under the term "oral
keratoses" are listed below:
Genetic and Developmental - oral epithelial naevus
Traumatic - frictional and smokers keratosis
Infective - candidiasis
Dermatological - lichen planus
Idiopathic - leukoplakia
Neoplastic - squamous cell carcinoma
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Lichen Planus
Lichen planus is a distinctive mucocutaneous disease presenting with a
variety of morphological features. A systematic classification of
clinical oral lichen planus has been considered by numerous
investigators. Classification according to aetiology, clinical
appearance and treatment have been used and aspects of classification
shall now be examined.
In the 19th and early 20th centuries papular, reticular and plaque
forms of oral lichen planus were reported (34,38). At the turn of the
century a bullous form of lichen planus was described by Poor (1905)
(58). The use of histopathology to identify typical features of
biopsy material of oral mucosa helped define the clinical range of
lichen planus (47). Indeed it was considered that the oral biopsy was
helpful in determining the diagnosis of cutaneous lichen planus (59).
Fordyce et al (1919) included oral lichen planus in their assessment
of clinical types of lichen planus (60). Similarities in clinical
presentation with lupus erythematosus and leukoplakia were noted for
the oral involvement (60). Additionally, White (1919) described oral
papules and large plaques in a patient with lichen planus (61).
Culver (1920) endorsed the value of oral examination in doubtful cases
of cutaneous lichen planus where "white lace-work eruptions so
characteristic of lichen planus" may be identified on the oral mucosa
(62). Tompkins (1 952) suggested separating two main groups of lichen
planus: a generalised form and a localised form (63). He considered
that the generalised form presented with acute onset and rapid spread
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of cutaneous and mucosal lesions, but carried a better prognosis as it
had a shorter duration; the localised form followed a "chronic course
with slower spreading of lesions..." (63). Within this latter group
Tompkins included those with mucosal lichen planus "and all these
carry a poor prognosis as to duration" (63) .
During the latter half of this century four authors have put forward
useful categorisations of the clinical types of oral lichen planus
(Table 3). Cooke (1954) described lichen planus with eight
morphological types of oral mucosal lesion (64). Andreasen (1968)
described six morphological types, simplifying the keratotic types to
papular, plaque and reticular and excluding the pigmented type of
lichen planus (48). Shklar ( 1972) described four types; the first
being papular variations that would present a range of keratotic
lesions from linear to plaque-like (65). Shklar made bullous and
atrophic lichen planus into the third and fourth types in his
classification of lichen planus (65). The erosive type described by
Shklar differed from the group of atrophic, erosive and ulcerative
types described by Cooke ( 1954) and Andreasen (1968) (48,64, 65).
Tyldesley (1974) simplified the clinical presentation of lichen planus
into three groups (66). The first group includes all the keratotic
variations of lichen planus, the second group applies to the erosive
variety, and the third group to a major erosive variety that may
relate to the bullous types described by Cooke (1954), Andreasen
( 1968) and Shklar (1972) (48, 64,65). The World Health Organization
International Disease Classification (Dental Application), WHO.IDC.DA,
has numerical codes for the disease types; these have however been
restricted to five types - 697.00 to 697.04 (3). They relate to the
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types as illustrated by Table 3 and bear a close relation to the types
described by Andreasen (47).
Cooke, Andreasen and Shklar used their classifications to confer
morphological differences seen in the disease (48,64,65). Tyldesley
(1974) however, using a term adopted from Lehner's description in 1968
of recurrent oral ulceration, distinguishes widespread and rapid onset
of ulceration from the other milder forms of lichen planus (66, 67).
This classification is similar to the interpretation Tompkins made in
1952 (63) and may be useful in the clinical management of oral lichen
planus.
Authors have regarded desquamative gingivitis as a manifestation of
lichen planus when it is associated with oral or cutaneous lichen
planus (68, 69). There are however other dermatoses that may be
associated with desquamative gingivitis (69). It would appear that
the presence of desquamative gingivitis alone is not diagnostic of
lichen planus.
For the purposes of describing the clinical features of oral lichen
planus in this thesis, Andreasen's categorisation will be adopted
(43). The clinical appearances of oral lichen planus and oral
leukoplakia will be examined next.
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TABLE 3
Categorisation of Oral Lichen Planus
1954 1968 1972 1974 1978
AUTHOR WHO.
Cooke Andreasen Shklar Tyldesley IDC.DA
DESCRIPTION
1 linear
2 discrete 1 papular 1 papular 1 non erosive 1 697.00
papular
3 confluent 2 plaque 2 697.04
papular
4 reticular 3 reticular 3 697.01
5 annular
6 pigmented
7 bullous 4 bullous 2 bullous 2 major erosive 4 697.03
8 atrophic 5 atrophic 3 atrophic 3 atrophic and 5 697.02
erosive 6 erosive 4 erosive minor erosive
ulceration ulceration
This table represents the author's interpretation of types of lichen
planus. See text for explanation.
Clinical Appearance of Oral Lichen Planus
i) PAPULAR (WHO. ICD. DA 697.00) . Papules on the oral mucosa are small,
less than one millimetre in diameter, slightly raised and white.
Clusters of papules may form lines producing a reticular appearance.
The papules are most frequently seen on the non keratinizing mucosal
sites. Occasionally non elevated papules may signify early lichen
planus (49). This is illustrated in Figure 1 where papules on the
buccal mucosa are present together with reticular lichen planus.
ii) PLAQUE (WHO. ICD.DA 697.04). White plaques, often irregular in
texture and outline, can be seen most often on the dorsum of the
tongue and buccal mucosa. Reticular and papular elements can surround
the plaques. In the absence of these typical features of lichen
planus a clinical misdiagnosis of leukoplakia may easily be made.
Plaque lesions are more common in smokers. Variation in the outline
of these plaques has been shown to occur within a four week period
(48). An example of plaque lichen planus involving the dorsum of the
tongue is illustrated in Figure 2.
iii) RETICULAR (WHO. ICD. DA 697. 01). This is the most common form
detected on oral mucosa (49). Fine white lines, slightly raised,
spread irregularly over the mucosa, making a lace like pattern.
Papules can be seen at the periphery of the migrating lace patterns
(49). Buccal mucosa is most commonly affected (49). The lateral and
ventral surfaces of the tongue can also manifest the reticular
patterns. Andreasen ( 1968) described the pattern varying as the
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FIGURE 1. Papular and Reticular Lichen Planus.
disease progressed (48). Figure 3 illustrates reticular lichen planus
involving the buccal mucosa.
iv) ATROPHIC (WHO.ICD.DA 697.02). Atrophic lichen planus appears as
an erythematous area, the periphery of which is quite often made up of
the reticular pattern. The redness is due to epithelial atrophy and
frequently erosions will be seen. Again, the buccal mucosa is most
frequently involved (48,49). Figure 4 illustrates atrophic lichen
planus involving the hard and soft palate.
v) EROSIVE (WHO. ICD. DA 697.02). This form usually occurs in sites of
atrophy, however discrete erosive lesions may exist singularly. The
tongue and buccal mucosa are commonly involved. Tyldesley ( 1974)
found it useful to classify minor and major erosive forms of lichen
planus (66). The major erosive lesions affected four patients out of
115 and appeared with sudden and widespread, painful ulceration of the
oral mucosa. The minor erosive form of lichen planus had a chronic
clinical history, and included the clinical variants of erosive,
atrophic, ulcerative and bullous lichen planus. The justification of
this category was based on the similarity of histological and clinical
symptoms (66). Erosive lichen planus involving the lateral and
ventral surfaces of the tongue is illustrated in Figure 5. Note
additional involvement of reticular lichen planus on the dorsum of the
tongue and the buccal mucosa.
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FIGURE 3. Reticular Lichen Planus.
FIGURE 5. Erosive and Reticular Lichen Planus.
vi) BULLOUS (no WH0._1CD.DA number). Bullous lesions are the most
rarely encountered manifestation of lichen planus (65). The bullae
are difficult to identify: the epithelium is easily removed by normal
masticatory forces from the lamina propria leaving large erosive
lesions. While bullae are infrequently observed intact, the
combination of bullae and erosive mucosa is illustrated in Figure 6.
vii) DESQUAMATIVE GINGIVITIS (WHO.ICD 523. 1 3) . This variant of the
erosive lichen planus involves the free and attached gingivae (69).
White reticular lines may also be seen clearly on the gingivae in
affected patients (68). The erosive variant of desquamative
gingivitis may be difficult to diagnose. Accompanying mucosal
involvement with lichen planus often substantiates a diagnosis of
lichen planus. Histological confirmation of desquamative gingivitis
is often difficult especially since non-specific plasmacytic gingival
inflammation is reported to complicate the histological picture (69) .
Other dermatoses, including pemphigus vulgaris, bullous pemphigoid and
cicatricial pemphigoid may also have an associated desquamative
gingivitis (68, 69).
viii) CUTANEOUS LICHEN PLANUS (WHO.ICD 697.0). This is variable in
its occurrence with oral mucosal lesions. Tompkins ( 1952) reported
cutaneous involvement in 37% of his group of patients with mucosal
disease (63). Oral lichen planus may preceed any cutaneous eruption
and Dubreuilh (1906) was reported to have stated that, in his
experience, mucous membrane was more frequently affected without skin
than is skin without the mucous membrane involvement (47). Table 2
illustrates the numerous terms that have been used in describing the
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clinical presentation of lichen planus. The essential clinical
feature of a cutaneous lichen planus lesion is a papular, slightly
erythematous lesion with a flat surface, often with grey white striae
(Wickham's striae) (44). This is illustrated in Figure 7 where
cutaneous lesions involve the dorsal surface of the hand. Other sites
susceptible to cutaneous lichen planus include flexor surfaces of
wrists and anterior surfaces of legs (36). Additionally, sites of
previous or recent trauma may also produce an isomorphous reaction
known as the Koebner phenomenon (66,69). Cutaneous lichen planus
resolves in almost 90% of patients within two years; however relapse
is common (20%) and melanotic pigments may persist in the lesion site
(70-72).
The morphological patterns of cutaneous lichen planus are broadly
similar to oral mucosal variations of lichen planus. There are
follicular, linear, annular, hypertrophic, atrophic and bullous type
lesions (64). These may be usefully viewed as having a white or
ulcerative presentation as previously described for the classification
of oral lichen planus. While cutaneous lichen planus is variably
associated with oral mucosa lichen planus, for the purposes of this
thesis the cutaneous form shall be referred to only to elucidate the
discussion of the oral disease.
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FIGURE 7. Cutaneous Lichen Planus.
Leukoplakia
In the past the term leukoplakia was used to describe any white patch
in the mouth, but it now has a more restricted meaning. The WHO
definition (1978) defined leukoplakia as a white patch which cannot be
removed by scraping and cannot be attributed to any other diagnosable
disease (3). More recently this definition has been altered in view
of the possible effects of tobacco on the oral mucosa, so that while
the term leukoplakia should not be associated with lesions resulting
from known physical or chemical trauma, if a white lesion is thought
to result from the use of tobacco it can still be described as
leukoplakia (73).
Leukoplakia is characterised clinically by the presence of single or
multiple white patches of the oral mucosa. They may be distinctly
circumscribed or merge with the surrounding mucosa (74). Although the
original WHO definition required the white patch to be five millimiter5
or greater and this definition was used by some authors (74), the use
of size for this diagnosis was subsequently dropped (3). The surface
texture may be smooth, fissured, or nodular (75). The colour of the
lesion varies also, depending on the patient habits, mucosal site,
keratin thickness and degree of erosion and atrophy of the lesion.
Commonly, grey white or yellow white is seen, however tobacco use may
stain the lesion brown (76). Leukoplakia has an International Disease
Classification coding of I DC. DA. 528. 6X ( 3). The broad morphological
types of leukoplakia are homogeneous, speckled and nodular and
combinations of these appearances may be seen (72-84).
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Clinical Appearance of Leukoplakia
i) HOMOGENEOUS LEUKOPLAKIA (WHO. I CD. D A. 529. 6X) . This appears as
an irregular white area of mucosa with a surface that may be smooth,
fissured or raised. There may be a defined margin or the lesion may
merge into the surrounding mucosa. Where there is marked
hyperkeratosis, a plaque type lesion may be seen. The term verrucous
leukoplakia is used where marked hyperkeratosis occurs producing an
irregular or papuliferous surface (84). Homogeneous type lesions
are illustrated in Figures 8 and 9 involving the ventral surface of
the tongue and the buccal mucosa respectively.
ii) SPECKLED LEUKOPLAKIA (WHO. IC D. DA. 529. 6X). This presents with
erythematous areas and white keratotic areas of mucosa. The keratotic
areas appear granular or as small white plaques. The erythematous
base is considered to be erythroplakia and the clinical entity may
also be described as speckled erythroplakia (85-86). A combination of
homogeneous and speckled leukoplakia is seen on the mucosa involving
the floor of mouth and ventral surface of tongue in Figure 10.
iii) NODULAR LEUKOPLAKIA (WHO.ICD.DA.529.6X) . This presents with
keratotic nodules, which are excrescences, irregularly scattered on an
erythematous base that merges into the adjacent normal mucosa. The
nodules vary in size however but do not usually exceed three to four
millimeters in diameter. They may appear a few millimeters raised
from the surface of the mucosa.
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FIGURE 9. Homogeneous Leukoplakia.
iv) CANDIDAL LEUKOPLAKIA ( WHO. IC D. DA. 529.72) . This commonly
appears as a plaque or speckled keratotic lesion affecting the buccal
or commissure mucosa. Diagnosis is reliant on histopathological
staining to reveal the spores and hyphae of the candidal organism.
The aetiological significance of the organisms is speculative, as
discussed later. It is recognised that this type of leukoplakia may
be impossible to distinguish clinically from speckled leukoplakia.
The association of leukoplakia with other white lesions of the mucosa
is poorly documented in the literature. Differences in categorisation
of leukoplakia into the types specified above have existed between
authors throughout this century. Thoma ( 1950) classified oral
leukoplakia in four groups according to the degree of keratinization
and associated monocytic infiltrate, thereby the microscopic
appearances contributed to the categorisation of the lesion (20). The
grade (I) leukoplakia described the initial reaction of the mucosa to
irritation showing a clinically erythematous area. Grades (II) and
(III) were leukoplakias with smooth or wrinkled white patches, the
grade (III) being more advanced and quite obvious in the mouth "even
by the layman" (20). The lesions were reported to frequently affect
the tongue and the buccal mucosa. The grade (IV) was "often called
neoplastic leucoplakia" and showed papillomatous or verrucous changes
(20). Ulceration and restriction of movement were futher features of
this grade of leukoplakia and neoplasia was heralded with induration
and "down growths of epithelium" (20). This classification has been
superseded in clinical practice by the WHO International
Classification for Disease terminology as described above (3).
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EPIDEMIOLOGY OF ORAL KERATOSES
Prevalence studies relate to the amount of a disorder existing in a
chosen population at a stated time (87). In addition to the provision
of health care, prevalence studies assist in understanding "the
natural history of disease" (88). Axell ( 1976) carried out a
prevalence study of oral mucosal lesions in an adult Swedish
population (74). The keratotic lesions comprised a large proportion
of the lesions recorded. If lesions of lichen planus, pre-
leukoplakia, leukoplakia, nicotinic palate, snuff dipper's lesion,
frictional keratosis, cheek and lip biting, discoid lupus
erythematosus and white sponge naevus are cummulated, oral keratoses
were detected in 31.95% of the population examined (74) (Table 4). It
must be noted however that the figure of 31.95% includes the nebulous
entity of "pre-leukoplakia" which is of doubtful clinical
significance. Also the extraordinary high incidence of "snuff
dipper's lesion" can only be explained on the basis of the selected
nature of the adult Swedish population.
Prevalence of Oral Keratoses
Lichen Planus
Lichen planus is reported to have a prevalence in the Swedish adult
population of 1.89% (74). Females are more commonly affected, 2.19%
compared to males 1.59%. The inclusion of lichenoid type reactions
which are tissue responses to medications and seen to subside after
cessation of the particular medication, increased the prevalence
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TABLE 4
Prevalence Study of Oral Mucosal Lesions
in an Adult Swedish Population (20, 333 Individuals)
Percentage
Lichen planus + (1.89)*




Snuff Dipper's lesion 8.04
Frictional keratosis 5.47
Cheek and lip biting 5.14
Discoid lupus erythematosus 0.01
White sponge naevus 0.02
Total (%) 31.95
After Axell (1976) (74)
* Value for lichen planus only
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to 2.201 (74). Earlier studies on special populations, provided
varying prevalence values for lichen planus (74). Pindborg et al
(1965a, 1 965b, 1 966) in three studies on the Indian subcontinent
reported a prevalence of between 0.02 and 0.22% for oral lichen planus
(89-91).
Table 5 illustrates the range of values that different investigators
obtained from both general and special populations (48, 89-102).
Hellier (1940), McCarthy (1941) and Arndt (1971) noted oral lichen
planus in patients attending dermatological clinics (95, 96, 102). The
prevalence remains between 0.1 and 1.7% with McCarthy recording the
highest value. Studies have been carried out in Europe, the Indian
subcontinent and North and South America (48,89-91 ,98, 100). No
obvious differences in prevalence appear to exist between major
geographical locations.
Oral lichen planus may be concommitant with cutaneous lichen planus
(2,72). Dermatology clinics have provided substantial numbers of
patients for such investigations and generally oral lichen planus is
seen in up to 77% of patients with dermatological lichen planus
(72, 103). Hellier ( 1940) recorded between 0.1 and 1.25% of
dermatology outpatients to have oral lichen planus (95), 0.442% in
676373 dermatological patients were calculated by Arndt in 1971 to
have dermatological lichen planus (96). The prevalence of cutaneous
lichen planus in patients attending with oral lichen planus is
variable. Andreasen (1 968a) reported 44%, Cooke ( 1954) 10% and
Tyldesley (1 974) 35% of patients with both oral and cutaneous
involvement of lichen planus(48, 64,66).
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TABLE 5
Prevalence of Lichen Planus
o
o Group Investigated Number 1st Author Date Ref,
0.02 Indian Dental 10000 Pindborg 1966 91
Attenders (IDA)
0.14 Dermatology patients 32879 Rufenacht 1968 99
0.19 (IDA) 10000 Pindborg 1965a 89
0.22 (IDA) 1 0000 Pindborg 1 965b 90
0.28 Male 2 0 year olds 2174 Borghelli 19741 100
0.3 General population 50915 Mehta 1971 93
0.442 Dermatology 676373 Arndt 1971 96
outpatients
0.6 Dental clinics - Shklar 1972 65
0.6 Textile workers 5751 8 Smith 1975 98
1.1 45-97 year old 785 Bhaskar 1968 101
soldiers
1.2 General population - Moschella 1975 94
1 .25 Dermatology - Hellier 1940 95
outpatients
1.5 Indian villagers 7639 Pindborg 1972 99
(Kerala)
1.7 Dermatology patients 927 McCarthy 1941 102
1 .89 General population 20333 Axell 1976 74
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Leukoplakia
The prevalence of leukoplakia in general and special populations has
been well documented. Numerous studies in Europe and India of general
populations show a prevalence of leukoplakia of 2 to 4% (table 6)
In three surveys by Pindborg et al ( 1965a, 1 965b, 1966) that recorded
mucosal lesions of patients attending dental schools in different
areas of India, a prevalence of 1.55 to 3.28% was noted for
leukoplakia (89-91). Similarly, other surveys recorded prevalence
values ranging between 1 and 4% in special populations(104-107) (Table
6). Increased prevalence values of 11.7% are recorded where an older
and predominantly male population is examined as Smith et al reported
in 1975 (93). Indeed a prevalence of up to 54.1% has been recorded in
East European industrial workers but the reason for this high
percentage is unclear(108, 109) . Patients younger than twenty years
are infrequently found to have leukoplakia (81-82). Axell (1976)
recorded prevalence of 6.2% for a 55 to 64 age group and a lower





0 Group Investigated Number 1st Author Date Ref.
1.3 Danes >65yrs 557 Gabrowski 1974 107
1 .55 (IDA)# 10000 Pindborg 1965a 89
1.7 Indian 50915 Mehta 1971 93
2.1 25-34 year olds* - Axell 1976 74
2.36 Indian 5000 Zachariah 1966 105
2.84 (IDA)# 10000 Pindborg 1965b 90
3.0 Denture wearers >65yrs 201 Chrigstrom 1970 106
3.28 (IDA)# 10000 Pindborg 1966 91
3.53 European 20333 Axell 1976 74
3.6 European 5613 Bruszt 1962 104
4.0 65-74 year olds* - Axell 1976 74
6.2 55-64 year olds* - Axell 1976 74
11.7 Indian males >35yrs 5751 8 Smith 1975 98
12.0 Industrial workers - Chiechanovicz 1968 108
54.1 East Europeans - Smoljar 1971 109
# Indian Dental Attenders from different regions in India.
* The population studied by Axell (74) consists of these sub-
populations according to age.
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Sex Prevalence of Oral Keratoses
Lichen Planus
Oral lichen planus is commonly reported to involve females more
frequently than males (59, 61 , 62,68). However dental clinic attendance
patterns may influence the ratio. Pindborg et al ( 1 972) found no
difference in prevalence of lichen planus between sexes. Evidence
that males are predominantly affected with lichen planus is also
reported (110,111).
Leukoplakia
Oral leukoplakia historically was reported to be a predominantly male
disease (20). During the present century, this feature has altered
from a reported male to female ratio of 19:1, to 1:1 (20,81 ,82).
Factors reported to be associated with this changed ratio include
increased tobacco use by females (112). Examples of local tobacco
customs such as reverse cigarette smoking, seen in the women of Andhra
Pradesh and snuff use in the Southern States of America are reported
to be associated with an altered sex ratio (113,114,115).
Site Prevalence in Oral Keratoses
Lichen Planus
Lichen planus has been reported to involve all oral sites (48,49).
Most commonly affected is the buccal mucosa, Andreasen (1968)
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reporting such involvement in 114 patients out of the study number of
115 patients (48). The buccal site adjacent to the position of a
standing third molar tooth is reported to be most frequently involved
with lichen planus. The least commonly affected site reported was the
upper vermilion border of the lip (66) (Table 7).
Leukoplakia
Leukoplakia may involve any oral site but no particular site is
predominantly affected (81,82). VValdron and Shafer (1975) found the
mandibular alveolar mucosa and sulcus followed by the buccal mucosa to
be the most commonly affected (82) (Table 8). Simpson ( 1957) found
the buccal mucosa to be most commonly affected, with the tongue more
frequently involved in males than females and the floor of mouth
more frequently involved in females than males (116). The tongue,
alveolus, lips and palate were individually less frequently involved
than buccal mucosa but when these sites were considered together they
comprised the largest proportion of leukoplakias (116). As with other
studies patients were seen to have lesions in more than one site
(116). Thoma ( 1950) reported the tongue as being the most common site
affected, this being often associated with tertiary syphilis (20,117).
Silverman ( 1968) reported on the clinical aspects of leukoplakia in
117 patients and found the buccal mucosa was most commonly affected,
more so in men (20%) than in women (6%) (118). He also reported
leukoplakia to be four times more prevalent on the tongue in denture
wearers than in non denture wearers (118).
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TABLE 7







Buccal gingivae (mandible) 39
Vermilion border (lower) 24
Buccal gingivae (maxilla) 23
Hard palate 23
Palatal gingivae 11
Labial mucosa (lower) 9
Lingual gingivae (mandible) 9
Floor of mouth 9
Labial mucosa (upper) 7
Vermilion border (upper) 3
From Andreasen (1968) (48).
* Number of patients.
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TABLE 8
Site Location of Leukoplakia in 650 Cases
Site Percentage
Mandibular mucosa and sulcus 25.1
Buccal mucosa 21.9
Palate 10.7
Maxillary mucosa and sulcus 10.7
Lips 10.3
Floor of mouth 8.6
Tongue 6.8
Retromolar 5.9
From Waldron and Shafer (1975) (82).
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Malignant Potential of Oral Keratoses
Oral keratoses have been observed to undergo neoplastic change
(5-14, 75, 1 1 9-122). Early investigators, observing pathological
changes in keratoses that apparently heralded neoplastic change, saw
an opportunity of reducing the morbidity and mortality of oral cancer
through identification of the premalignant lesion (13). The term
'leukoplakia' became associated, non specifically, with precancerous
keratotic lesions. Kerr (1958) addressed this problem, stating that
"not all white lesions are precancerous; for that reason they should
not all be designated 'leukoplakia'" (117). Lichen planus in plaque
form may clinically feign leukoplakia when other identifying features
are not available. This diagnostic problem remains today.
Lichen Planus
Oral lichen planus has been reported to undergo malignant
transformation (123-126), Hallopeau (1910) providing one of the
earliest descriptions of the occurence of malignant change in oral
lichen planus (51). However, Krutchkoff et al ( 1978) and Kabani et al
( 1982) consider there to be insufficient evidence to regard lichen
planus as a premalignant disease ( 127, 128).
Malignant change recorded in oral lichen planus has been reported to
be between 0.3 and 3% ( 123, 125, 127-133). Murti et al ( 1986)
calculated a relative risk of 3.3 for developing cancer in oral lichen
planus (133). Although this value did not appear statistically
significant, an observation that cancer developed in younger patients
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(average age 39) in lichen planus was made. This compared with an
overall average age of 55 years for oral cancer patients in an earlier
study by Mehta et al (1971) (93). Erosive and atrophic forms of lichen
planus are thought to be more likely to undergo malignant change than
other forms (1 23, 132, 133, 134-137) and Holmstrup and Pindborg ( 1979)
reported an association of erythroplakia and squamous cell carcinoma
with lichen planus (126). Numerous investigators have published case
reports of the occurrence of oral carcinoma in patients with oral
lichen planus (126, 127, 138, 139) and Pindborg ( 1980) in his evaluation
of malignancy in oral lichen planus which included data published by
Fulling (1 973) and Holmstrup ( 1 975), reported five patients out of 470
who had developed oral carcinomas within sites of lichen planus
(123,140,141).
This malignant potential of oral lichen planus was further reviewed
and accepted at an international seminar on oral erythroplakia and
lesions related to tobacco habits, where lichen planus was considered
as a probable precancerous condition (142). This was 24 years after
Warin ( 1 960) presented case reports of the development of carcinoma in
oral lichen planus and noted that "..it has usually been taught that
malignancy never develops in lichen planus of the mouth. .."(143) .
Holmstrup et al (1988), in the most recently reported long term study
of malignant change in oral lichen planus, concluded that oral lichen
planus fulfills the WHO criterion of a premalignant condition, with a
fifty fold increased risk of malignant change over that expected in
the general population (140). 1.5% of cases were reported where
squamous cell carcinoma arose in sites of oral lichen planus (144).
The study comprised 611 patients (409 Female, 202 Male) followed for
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periods from 1-26 years. The observed number of carcinoma cases was
significantly higher than the estimated number expected to develop
oral carcinoma in a general Danish population sample of similar size
and age distribution (p<0 .00001 ) (144).
Contrary views were presented by Krutchkoff et al ( 1978) and Kabani et
al (1982)(127, 128). Krutchkoff et al (1978) reviewed the world
literature on malignant change in lichen planus and considered that
only 15 of the 223 cases reported were substantiated by valid records
of pre-existing lichen planus followed by neoplasia and concluded that
there was insufficient evidence to confidently regard oral lichen
planus as a premalignant condition ( 127, 128).
The assessment of epithelial dysplasia may provide a method for
determining malignant potential (145,146), but there are conditions in
which epithelial dysplasia can be identified but does not necessarily
imply a malignant potential (141). The occurrence of epithelial
dysplasia in lichen planus has been examined (127-132, 147, 148) and
Krutchkoff and Eisenberg ( 1985) put forward criteria for identifying
"lichenoid dysplasia" with a view to sub-classification of lichenoid
lesions of the oral mucosa (131). Kabani et al ( 1982) however
suggested that lichen planus and lichenoid dysplasia are different
diseases (128). While the criteria detailed by Krutchkoff ( 1985)
provide description for both lichenoid dysplasia and lichen planus
diagnoses (131), it is difficult to apply these criteria in the
diagnosis of biopsies from individual patients. In addition, while
Krutchkoff's aim "..to eliminate individual diagnostic variation based
on training, experience, or idiosyncratic bias of the pathologist so
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that diagnoses can be considered reliable and accurate.." is
commendable, the system he has suggested perhaps will increase the
numbers of diagnoses returned as lichenoid dysplasia and reduce those
of lichen planus; without any major benefit.
There is however no general agreement among pathologists concerning
the relationship between epithelial dysplasia and malignant change in
lichen planus and it must always be remembered that the simultaneous
occurence of lichen planus and squamous cell carcinoma in the same
mouth may be a chance occurrence. Moderate or severe dysplasia seen
in lichen planus has been suggested to carry increased risk of
malignant change (129,134,137). A high proportion of moderate and
severely dysplastic lesions of the tongue and floor of mouth for
lichen planus and control studies were reported by Odukoya
(1985) (129). This would suggest that certain oral sites may indeed
carry greater risk for the development of epithelial dysplasia in
chronic inflamatory conditions.
Leukoplakia
The malignant potential of leukoplakia has been widely documented and
is generally accepted (80-82, 149, 150). Reported malignant
transformation rates range from 0.8 to 9.9% for different populations
(151,152). Centres vary in their diagnosis and management of
leukoplakia and this is recognised as a possible influence on the
transformation rates found (141). The follow up periods vary in the
reports on malignant transformation, however the malignant
transformation in a ten year period provides a useful gauge of the
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disease. Mehta et al ( 1972) reported a study of 3674 Bombay
policemen, of whom 117 had leukoplakia and one (0.91) developed oral
cancer in the ten year period of follow up (151). It was reported
that almost all leukoplakias detected in chewers of tobacco regressed
while persistent leukoplakias occurred in the smoking habit group.
The one policemen who died from oral cancer had leukoplakia and he
practised both "pan" chewing and "bidi" smoking (151).
Waldron and Shafer (1975) in their long term study (13 years) showed
that the risk of developing epithelial dysplasia, carcinoma in situ or
invasive carcinoma varied between the anatomical locations of
leukoplakia (82). The high risk sites included the floor of mouth,
the tongue and the lips where 43%, 24% and 24% of cases respectively
showed epithelial dysplasia or carcinoma histologically. Furthermore
where leukoplakia occurred with erythroplakia, the number of cases in
which epithelial dysplasia or carcinoma was determined histologically,
rose to 45-65% (141,150). Erythroplakia is a flat velvety red lesion
that may occur singularly or in association with leukoplakia as
speckled leukoplakia (85). While there did not appear to be
significant differences in frequency of occurence of erythroplakia
between male and female, there were more cases in the fifth decade or
younger presenting with leukoplakia (39%) compared to erythroplakia
(19%) (82). Mandibular, maxillary, tongue and floor of mouth mucosa
was more frequently affected by erythroplakia in females while the
lips, palate, buccal, and retromolar mucosal sites were more
frequently affected in the males (82).
The evaluation and monitoring of the malignant potential of
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leukoplakia is ultimately dependant on the microscopic changes
observed in the epithelium (80, 139). The subjective nature of this
morphological evaluation has led to attempts to develop a system of
photographic standardisation or computer aided analysis of features
observed (146,149, 153, 154). More recently, morphometric methods of
image analysis for evaluating epithelial cells and immunocytic
infiltrates have been shown to be valuable in a more objective
assessment of epithelial dysplasia in leukoplakia (150). As
epithelial dysplasia may not singularly determine the malignant
potential of the lesion (138, 156, 157), other parameters, notably
immunological aspects, have been investigated in oral premalignant
conditions and neoplasia ( 158, 159). The value and implication of
these investigations is unclear at present.
A review of the literature relevant to clinical and histological
features of leukoplakia was available in 1 980 following an
international symposium on premalignancy (82, 1 60). This has been
supplemented by the work of Katz ( 1 985) in which the Smith-Pindborg
method of standardisation of epithelial dysplasia was performed on 214
cases in which the clinical features were known (161). For the
idiopathic keratoses in the non keratinizing sites, floor of mouth and
oropharynx, half the samples comprised severely dysplastic lesions
while buccal alveolar mucosa and gingivae showed mild dysplasia in
general (161). Although these features did not reach statistical
significance, they convey the problem of evaluating dysplasia in oral
tissues (161).
The problems encountered with studies of idiopathic keratoses include
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the evaluation of malignant potential, prevalence of dysplasia,
associated clinical and aetiological factors and the subjectivity of
interpretation of all these aspects. Comparison of the study by Katz
( 1985) with that of VValdron and Shafer (1975) shows differences in
male to female ratios and site incidence for dysplasia (82,161). Katz
(1985) examined the distribution of 214 cases of "mild, moderate and
severe dysplasia" and found no significant differences for race, sex
or age (161). However lesions on the floor of mouth and oropharynx
included 50% of the severe dysplasias (161). These features parallel
Waldron and Shafer (1975) who found that 43% of biopsies from the
floor of mouth showed epithelial dysplasia (82). Leukoplakias
affecting the floor of mouth have been connected with increased risk
of malignant change which may not neccessarily be related to the
histological picture (10,162). In the United States where the topical
use of tobacco is particularly prevalent, carcinoma is a distinctive
feature in the site of tobacco placement (163).
At the 1 980 symposium on premalignancy, the consideration of
carcinomas arising from pre-existing lesions or (de novo) was put
forward (164). Johnson ( 1 980) was of the opinion that most cases of
oral squamous cell carcinoma had no previous history of a long
standing lesion, "perhaps as many as 80% appeared to be overtly
invasive at presentation..." ( 164, 165). Pindborg ( 1980) in discussion
did not agree and considered that the "majority arose in altered
tissue" referring primarily to idiopathic keratoses (164). Pindborg
(1968) observed that dysplasia more often accompanied speckled
leukoplakia and, in agreement with Shafer and Waldron (1975),
considered that these lesions were more likely to become malignant
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(82, 1 63). Furthermore, after treatment of the candidal infections
demonstrated in speckled leukoplakia by Jepsen ( 1965), the clinical
appearance was seen to be improved (166).
It is useful to examine erythroplakia as this may occur in areas of
oral leukoplakia or separately (34,86). The study by Shafer and
VValdron ( 1 975) showed that 91% of erythroplakia biopsies were
histologically either invasive carcinoma, carcinoma in situ or severe
epithelial dysplasia (82). The remaining 9% of biopsies were of a
mild or moderate dysplasia (82). Follow up studies for erythroplakia
have not been completed to date and thus the malignant potential
cannot be commented upon. It remains a lesion with strong
histopathological indicators of malignant change (167). Grading of
epithelial dysplasia from mild to severe dysplasia and "carcinoma in
situ" is seen to be variable between studies (147). The need remains
for an internationally accepted set of criteria for evaluation of such
epithelial dysplasia (147). Earlier work by Fischman (1982)
demonstrated that the clinical diagnoses of "leukoplakia" or
"hyperkeratosis" revealed frank carcinoma after biopsy in 13% of cases
(148). This worrying aspect of clinical and pathological assessment
is further complicated when we realise that the clinician already is
aware that leukoplakia carries a malignant risk. The use of
antifungal treatment of candidal leukoplakia has been initially
promising in the reduction of dysplastic features (168).
-45-
AET10LOGICAL FACTORS OF ORAL KERATOSES
a. Genetic Factors
Lichen Planus
Genetic predisposition to lichen planus may be shown by the occurrence
of lichen planus in familial cases. As families may occupy a similar
environment overall, the effect of infective or allergenic agents has
also to be considered in such cases. A number of familial occurences
of lichen planus have been reported (169-171). The majority of these
cases are cutaneous; there appears to be only one report of oral
lichen planus existing within twins (172). In these twins, oral and
cutaneous involvement was extensive (172,173). Overall, the familial
occurrence of oral lichen planus, indicating a genetic predisposition,
is scant. The human transplantion antigen system, commonly called the
human lymphocyte antigen (HLA) system, enables histocompatibility
typing. Initial studies into the frequency of certain loci have shown
that HLA-A28 has an increased frequency amongst non diabetic patients
with lichen planus and the examination of familial occurrences of
lichen planus has suggested that locus HLA-B7 is associated with the
condition (173-175).
Leukoplakia
While there is evidence for genetic involvement for certain keratoses,
for example white sponge naevus (176, 177), leukoplakia appears to be
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largely associated with environmental factors ( 178, 1 79). Aspects of
leukoplakia relating to "genetic control have been reviewed by Harnden
(1984) (180). Evidence indicates that the incidence of leukoplakia
may be attributed to variations of oral habits rather than hereditary
differences in the populations examined (178,179).
b. Environmental Factors
1. Tobacco
Tobacco can be used in many forms, the most common being inhalation of
the burnt products. The tobacco may be air dried or cured before use,
these procedures altering the chemical constitution of the leaf and
providing the flavour (181). Various substances may be used in
conjunction with tobacco in accordance with local customs (vide
infra). Conventional smoking of cigarettes is familiar but reverse
cigarette smoking which involves the retention of the burning end of
the cigarette within the mouth is also practiced in some ethnic groups
(182). Bidi smoking involves the use of a type of cigarette made with
a temburni leaf to form a conical shape. The length varies between
four and eight centimetres and is smoked conventionally. Pipe and
chutta smoking consists of the inhalation of smoke produced by burning
tobacco in the body of a pipe.
Chewing tobacco retains the leaves within the mouth. Variations
adopted by different ethnic groups include the use of the 'pan1. A
pan consists of betel leaf, areca nut, lime and tobacco to form a
"quid". This is placed within the sulci of the mouth. The use of
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snuff, which may be in a dry or moist form, and "Skoal Bandits" which
largely contain tobacco similarily require the placement of the
manufactured product in the oral sulci.
Lichen Planus
There is little evidence to support an association between tobacco
smoking and the prevalence of oral lichen planus except that there
does appear to be a significant relationship between plaque lichen
planus and tobacco smoke (125, 183). Tobacco and betel chewing have
been reported to be associated with an increased prevalence of oral
lichen planus (97,184). Indeed amongst chewers an "oral lichen
planus-like lesion" has been described in the site of placement of the
quid (849,185). The question of whether a plaque type lesion of
lichen planus could be regarded as leukoplakia arising in oral mucosa
affected by lichen planus was raised by Neumann-Jensen et al ( 1977)
(183).
Leukoplakia
Tobacco use has been reported to be associated with leukoplakia since
1851 (5). A significant relationship between tobacco habits and
leukoplakia has been reported by numerous investigators
(83, 146, 151 , 1 79, 183, 185-187). Roed-Petersen et al ( 1972) reported
bidi smoking as the strongest aetiological factor in leukoplakia
(186). In a ten year Indian study by Gupta et al ( 1980), it is stated
that oral cancer, leukoplakia and erythroplakia occurred almost solely
amongst those who practised tobacco habits in one form or other (185).
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The association between tobacco use and leukoplakia was further shown
by evidence from a study of Bombay policemen in which all cases of
leukoplakia were found in the tobacco-using group of which tobacco use
was mainly pan chewing with tobacco and the smoking of bidis
(151,188). A further study by Gupta (1984) showed that a positive
relationship exists between tobacco habits and leukoplakia, a smoking
habit having a greater relationship than a chewing habit (189).
Confirmation of the aetiological role of tobacco has been shown when
leukoplakias have regressed after tobacco use has been stopped
(151,185), regression occuring more frequently in tobacco chewers than
smokers (151).
The products of tobacco, either burnt or unburnt, have a chemical
effect while reverse cigarette smoking has both physical and chemical
effects, the combination of heat and burnt tobacco products thus being
seen to exert a combined influence on the epithelium of the palate
(190). Epithelial hyperplasia is a characteristic feature of snuff
induced lesions (191). Palatal nicotinic stomatitis arises in
smokers, particularly pipe smokers, the oral lesions presenting
clinically as a distinctive array of red spots (minor salivary gland
ducts) against the white epithelium. The pathological picture of the
epithelium is that of hyperkeratosis with acanthosis. These changes
in the oral mucosa may be reversible if the tobacco habit is stopped.
Keratotic lesions elsewhere on the oral mucosa caused by tobacco use
cannot be clinically distinguished from those caused by other factors.
If resolution of the keratosis does not follow cessation of the
smoking or chewing habit and elimination of other traumatic factors,
the clinical diagnosis of leukoplakia is then generally considered to
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be valid.
As previously described, smoking habits have changed markedly in the
British population during this century. The Royal College of
Physicians in London stated in 1981 that tobacco, in any form,
increases the risk of developing neoplasia not only in tissues in
direct contact with the products, but also in organs such as the
bladder and uterine cervix which are not in direct contact (181). The
carcinogenic effects of tobacco may not be apparent for a long time.
Increased cigarette tar raises the risk of developing cancer of the
lung, mouth and pharynx. The effect of tobacco is further
demonstrated in the different cancer incidence between the use of
filter and non-filter cigarettes ( 181, 192, 193).
2. Galvanism, Corrosion and Allergy related to Dental Restorations
The occurrence of electrogalvanic cells and corrosion is made
possible in the mouth by the presence of the aqueous phase, saliva.
Dissimilar metal restorations and associated electrical currents were
considered in the assessment of aetiological aspects of oral lesions
by early authors (13, 27, 28). Metal restorations have been shown by
spectrophotometric methods to produce corrosion products that have
been found in the adjacent mucosa (19).
Lichen Planus
Lain (1932) first presented case reports concerning oral
electrogalvanic phenomena (25). Lain and Caughran ( 1933) later
-50-
presented observations on an examination of more than 1000 patients
having dissimilar metallic restorations (28). In their differential
diagnosis of mucosal lesions, seen in association with electrogalvanic
injury, lichen planus and lupus erythematosus were included in their
list (28). Corrosion of oral restorations and allergic reactions to
dental materials are thought to have an aetiological role in lichen
planus and the association of gold and amalgam restorations with both
leukoplakia and lichen planus have been reported (18,23). Numerous
investigators have since reported an association between lichen planus
and amalgam restorations (18,194,195). Lichen planus involvement of
the buccal mucosa in contact with amalgam fillings in posterior teeth
is reported to resolve after restoration with other materials (195).
Patch tests of different restorative metals have been recently
reported for patients with oral lichen planus by Eversole and Ringer
(1984) (19). While differences were seen between lichen planus
patients (21%) and controls (8%) in response to challenge by a panel
of amalgam and gold samples, the differences did not reach statistical
significance. Eversole and Ringer (1984) considered both their own
results and those they reviewed in the literature did not support a
major role for metal allergens in the pathogenesis and aetiology of
lichen planus (19). Finne et al (1982) discussed the dilemma posed by
oral and cutaneous lichen planus in relation to oral restorations and
reported that just over half of their 29 patient cohort developed a
cutaneous reaction to mercury in a standard test whilst the control
population produced only a small positive cutaneous reaction to
mercury (3.2%) (195).
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Lundstrom (1984) found a mercury reaction with a dermal patch test in
twelve of a cohort of 48 patients presenting with lichen planus,
clinical signs of amalgam corrosion occurring in 72% of the oral
lichen planus patients and in only 28% of the 40 controls (181).
While Finne et al (1 982) used 0.5% metallic mercury for patch testing
(190), Lundstrom (1984) used 0.1% (196). The additional consideration
of irritation of the skin rather than hypersensitivity may be of
importance as mercury may be toxic, acting as a non reversible
competitive respiratory enzyme inhibitor. A recent communication at
the British Society for Oral Pathology ( 1987) examined patch test
responses in oral lichen planus patients and controls : no evidence
for hypersensitivity to dental restorative metals in these skin tests
or in biopsies of oral lichen planus taken adjacent to amalgam
fillings was found (197). These reported studies show widely varying
prevalences of mercury sensitivity in both patients and controls
indicating that further investigations are required.
Leukoplakia
Bloodgood (1932) considered leukoplakia to be occasionally caused by
irritation from a tooth "especially one with a metallic filling" (13).
Other authors, including Ullmann ( 1932), considered the
electrogalvanic current generated in the oral cavity by dissimilar
metal fillings to be important ( 198, 199). Hollander et al (1 933)
showed the regression of leukoplakia when amalgam restorations were
removed (24)- Lain's summary ( 1933) showed 6.2% of the patients
examined had leukoplakia in association with the presence of
dissimilar metals in the oral cavity (28). More recently Bonoczy
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( 1979) considered that "electrogalvanic white lesion" may be a useful
term to describe a keratosis in association with a definite
electrovalent potential (200).
Removal of the dissimilar metals has led to resolution of some
leukoplakic lesions (195, 198-200). There is evidence that leukoplakia
and lichen planus can both arise in mucosa adjacent to metal
restorations (190). While the electrogalvanic effects may be
important, the allergic reaction to metallic ions may also contribute
to the development of the mucosal lesion.
3. Local Irritation
Since the early observations on oral leukoplakia, lichen planus and
neoplasia, decayed or jagged teeth and poor oral hygiene have often
been said to be associated with the diseases (5, 6, 7, 8, 13, 15,22,23, 25,
26,30). Teeth or prostheses present in the mouth may provide a
persistent source of irritation or provide a surface on which products
may deposit and affect the adjacent mucosa (13). Partly cured
vulcanite dentures were considered by Bloodgood ( 1932) to form
sulphurous products (14). Local irritation may affect oral mucosa in
a mechanical, thermal or chemical way, for example burning tobacco
exerts both a thermal and a chemical irritant effect that can be seen
in nicotinic stomatitis of the palate. Mechanical trauma has long
been reported as an important cause of oral lesions (13-15,119,201,
202) .
The clinical appearance of oral mucosa in response to friction may be
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either an ulcer or epithelial thickening with hyperkeratinization
(203). The ulcer is an acute response while chronicity more often
produces frictional keratosis (203). The identification and
elimination of an irritant related to a white patch and subsequent
resolution of the lesion usually confirms the diagnosis of a
frictional keratosis. However when there is little change after
removal of the putative cause, a diagnosis of idiopathic keratosis
generally must be accepted. Sturgis et al (1934) summarised
aetiological aspects of oral keratoses and reported that Bloodgood
(1932) considered rough teeth and poor oral hygiene to be important in
the aetiology of oral cancer (13,195). Mechanical irritation itself
is not generally considered to be carcinogenic (202). Historically
irritants, including tobacco, chronic periodontitis and carious teeth,
were considered to have a small role in the aetiology of oral cancer
(204-206). Furthermore there are rare case reports of neoplasia
arising in scar tissue (207) .
Lichen Planus
There is limited evidence to suggest an association of friction with
lichen planus. As with other dermatoses, frictional stimuli may
aggravate the lesion and the experimental evidence shows both inter
and intra-cellular oedema within the epidermis with friction (208).
Damage may also be caused by suction though this may be restricted to
the nuclear regions of epidermal keratinocytes (209). Other
investigators have examined the effects of trauma to unaffected
epidermis of patients with lichen planus and shown induction of
eosinophilic bodies in the tissues similar to bodies often found in
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lichen planus (210). The lesions in cutaneous lichen planus may
sometimes be detected in a linear pattern along a scratch mark or scar
(Koebner Phenomenon).
Leukoplakia
The contribution of a frictional component to leukoplakia is evaluated
when making the differential diagnosis. Early investigators
considered the smoothing down or extraction of rough teeth a useful
therapy for oral leukoplakia (13,15,20). In contrast Thoma ( 1950) did
not consider frictional or irritating causes to be aetiological in
oral leukoplakia (20). He suggested, in agreement with Hollander
(1933), that the occurrence of "leukoplakia" in other sites such as
the pelvis of the kidney supported a systemic aetiology (20,23).
Cooke (1 956) suggested that friction may contribute to leukoplakia as
a secondary factor (211). More recently the definition for
leukoplakia specifically excludes lesions with a primary frictional
cause (73,75).
4. Alcohol
Alcoholic beverages have been ingested by man for thousands of years.
Alcohol is taken essentially as an aqueous dilution of ethyl alcohol
produced as a by-product of fermentation of sugar by yeast. The
fermentation process and distillation of the ferment may concentrate
other biologically active products which may be more important than
the alcohol in relation to effects on the oral mucosa. The illegal
distillation of calvados in France has been reported to provide a high
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concentration of carcinogens, though these were not characterised,
within the spirit produced (165, 204). There is little evidence to
implicate ethanol with a direct effect on oral tissues. However the
metabolism of ingested ethanol induces cytochrome P-450 and this is
reported to activate carcinogens which may be important in the
enhanced incidence of cancer in alcoholics (212). A reduction in the
thickness of human oral lingual epithelium, primarily in the
maturation cell layer due to cell shrinkage, caused by alcohol and
tobacco use has been shown by Valentine et al ( 1985) ; the changes
seen histologically were more severe with alcohol (213).
Alcohol has not often been reported as being associated with lichen
planus or leukoplakia (68, 205). Wilsch (1978) showed that a cohort of
leukoplakia patients contained a 1.5 times greater percentage of
people using 80 grams or more of alcohol a day (214). This suggests
that higher alcohol consumption may be a factor contributing to the
aetiology of leukoplakia and Valentine et al (1985) suggested that the
functional reductions in the thickness of epithelium may be associated
with an increased vulnerability to carcinogens (213,214).
5. Medications
Lichen planus or lichenoid lesions have frequently been reported to be
associated with the administration of chemicals and drugs. Bazemore
et al (1946) showed that quinacrine used in antimalarial treatment
produced oral lesions of lichen planus in almost half the patients
receiving therapy (215). Clinical remission on withdrawal of the drug
and relapse on subsequent challenge is necessary to demonstrate a
-56-
causal relationship with the drug. The clinical and histopathological
features of lichenoid lesions and lichen planus are remarkably similar
if not identical (203,21 6). The presence of an eosinophilic or
perivascular infiltrate, although variable, is reported to indicate a
drug induced lichenoid reaction (216,217). The main categories of
chemicals and drugs reportedly associated with lichenoid drug
eruptions and lichen planus are illustrated in Table 9.
There is little reported association between drug therapies and the
development of leukoplakia (20,23).
-57-
TABLE 9























Summarised from Scully and El-Kom ( 1985) (68)
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6. Viral Infection
A viral aetiology for both leukoplakia and lichen planus has been
suggested (218,219). In one study HPV type 16 was detected in more
than 80% of oral leukoplakias while HPV types 1,2,4,6,11,13,18 were
not detected (220). Fry et al ( 1969) failed to demonstrate viruses or
mycoplasmas in lichen planus lesions (221), although more recently HPV
types 11 and 16 have been identified in such lesions using DNA
hybridization techniques(222) .
Papillomavirus DNA has also been found in other keratotic lesions as
well as normal oral mucosa (223,224). There is therefore a
possibility that pathological changes in oral mucosa may predispose to
secondary viral infections and the role of HPV in oral keratoses
remains to be substantiated.
Oral hairy leukoplakia seen in patients with Acquired Immunodeficiency
Syndrome (AIDS) has been shown to contain Epstein Barr virus (EBV) and
Cytomegalovirus (CMV) (225), but the significance of these viruses in
an immunocomprmised host is beyond the scope of the present review.
7. Bacterial Infection
Syphilis historically has been implicated with oral leukoplakia
(1 3, 1 8,20,22,24,33). Leukoplakia of the tongue, associated with
atrophic glossitis and a positive Wasserman reaction, was reported by
Thoma (1941) to occur in up to 27% of oral leukoplakia patients (20).
Syphilis is associated with plaque like keratotic lesions commonly
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affecting the lip and tongue (20, 23). The pathogenesis is unclear
although endarteritis obliterans is considered to contribute to the
progression of the disease and syphilitic patients show a deficient
cell mediated immune response (26). Tertiary syphilis is now a very
uncommon disease in Western Europe and serological investigations for
syphilis are not now carried out routinely in patients with oral
leukoplakia.
Jacobi et al (1933) suggested that a gram negative bacillus may be
important in cutaneous lichen planus (226). Other than this report
there has been little evidence for a bacteriological aetiology of
lichen planus (68).
8. Fungal Infection
The oral cavity provides an environment suitable for the survival of
fungi. Candida albicans is a common commensal of the mouth and
infects the soft tissues in certain instances (227) .
Lichen Planus
In one study yeasts were cultured from swabs of 44% of patients with
oral lichen planus (228). Candida albicans accounted for 83% of
isolates, other isolates including C. parasilosis and T. glabrata.
37% of the control group of patients also showed positive cultures
(228). Histopathological examination of the lesions showed hyphae in
three patients, who had either insulin dependent diabetes, Crohn's
disease or rheumatoid arthritis. Lundstrom et al ( 1984) concluded
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that Candida hyphae seldom invade the oral tissues affected by lichen
planus unless debilitating disease is concurrent (228).
Leukoplakia
Cawson ( 1 966) reported Candida hyphae infiltrating the superficial
layer of the epithelium in some cases of human leukoplakia (229).
Furthermore Candida was also reported to occur in speckled varieties
of leukoplakia, including erythroplakias (86, 166). Shear ( 1972)
regarded the fungus as a secondary invader and its role in the
aetiology of leukoplakia remains unclear (86). Evidence from a study
on rats with induced oral candidosis implied that the organism may
indeed be a co-causative factor in human leukoplakia (230). Earlier
work by Roed-Petersen and co workers (1970) described the association
of cellular atypia with candidal invasion in 671 of sections but they
found no relationship between between the intensity of Candida
invasion and the cellular atypia in the sections of leukoplakia (231).
More recently, the salivary secretor status for blood group antigens
has been shown to influence the incidence of infection with Candida
albicans in the oral cavity (232). An aetiological role for Candida
albicans in candidal leukoplakia has been recently supported, with
carcinogenic products being detected in the hyphae invading the
epithelium (233). These products have also been shown to affect





Haematological disorders have long been recognised as affecting the
oral mucosa. Angular chelitis and atrophic glossitis are associated
with iron deficiency anaemia, Vitamin B12 and folate deficiency (235-
240). Candidal infection of mucosa may also be associated with iron
or folate deficiencies (239). Recurrent aphthous stomatitis has been
reported to present with underlying haematological abnormalities which
after correction lead to resolution of the disease (241). Atrophy of
oral epithelium has been associated with anaemia but it is unclear
whether the atrophy preceeds or follows the deficiency.
Evidence that oral keratoses are associated with haematological
deficiencies is scant. In a study in which patients with lichen
planus, leukoplakia, candidiasis and non specific stomatitis
represented 75% of the study population, between two and three per
cent were shown to have deficiencies of iron, Vitamin B12 or folate
(242). Tyldesley ( 1983) reported 18.6% of patients with stomatitis to
be haematologically abnormal (243). More recently, Challacombe ( 1986)
found that 20.5% of a group of 322 patients with lichen planus,
leukoplakia, candidiasis, stomatitis or glossitis had haematological
abnormalities (244). This compared with an incidence of 7% in the
control population. The number of patients with haematological
abnormalities was shown to be significant (p < 0.05) for patients with
lichen planus (244). Haematological abnormalities were shown to be
present in significantly higher numbers in the erosive lichen planus
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subgroup than in the non erosive and control groups (243). This may
simply be related to those patients with ulcerative lesions in the
upper intestinal tract who show iron deficiency anaemia (245) . Rennie
(1 982) has shown an association between iron deficiency anaemia and
reduced oral epithelial thickness (246) and this has been supported by
more recent studies by Scott et al (1985) (247). Furthermore, the
features of epithelial atrophy and high malignant risk seen in Kelly-
Paterson syndrome show the potential effects of iron deficiency on the
oral mucosa (248).
2) Endocrine Aspects
Evidence implicating an association between an endocrine abnormality
and oral keratoses is scant. The reported increased incidence of
lichen planus in females is evidence that endocrine status may be an
aetiological factor. Early research on treating monkeys with
oestrogens showed hyperkeratinization and hyperplasia of the prickle
cell layer of the oral epithelium sometimes with an inflammatory
infiltrate in the lamina propria being present (249). The incidence
of diabetes has been reported to affect patients presenting with
lichen planus (68). The aetiological role of diabetes mellitus
remains unclear and antidiabetic medications have been shown to
produce a clinical and histological picture of lichen planus (see page




Stress and the psychological status of patients with oral and
cutaneous eruptions have been reported since the nineteenth century.
An early association between the nervous condition of patients and
lichen planus was made by Wilson in 1866 (38), who also reported
cutaneous lichen planus being associated with a spell of good weather
(37). Reference to the nervous condition of patients was frequently
made by Wilson and other early investigators who recognised the
association of lichen planus, both oral and cutaneous, with the level
of patient anxiety (41). Andreasen (1968) reported on articles by
three earlier twentieth century investigators who had attributed a
"nervous or neurogenic theory" and changes in the "vegetative nervous
system in the affected areas" as factors in the aetiology of lichen
planus (41). This has been supported by case reports of cutaneous
lichen planus where the eruption was associated with the "inferior
gluteal nerve and popliteal nerve" (50). Severe depression was
reported by Pringle (1900) to be associated with the cutaneous
eruption of lichen planus (50). Furthermore Waldo ( 1 900) questioned
whether the "neurotic sex suffers more than males?" but reported no
evidence to support the predeliction of lichen planus for the female
(50). Fox (1 900) reported a case history of a stockbroker who lost
30, 000 pounds sterling and subsequently developed severe lichen
planus, endorsing the "neurotic causation of lichen planus" (50).
More recently Lowenthal and Pisanti (1984) examined symptoms in
patients with erosive lichen planus who reported more precipitating
stressful events than did those patients with other forms of oral
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lichen planus (250). Aspects of stress and anxiety relating to oral
lichen planus were examined by Allen et al (1986) using Spielberger's
State-Trait Anxiety Inventory (STAI) (251). In this study control
patients undergoing similar clinical routines, such as biopsy,
returned no significant differences to those patients with oral lichen
planus (251). It was therefore suggested that oral lichen planus
patients have no greater tendency towards anxiety and no more
stressful life events than other dental patients (251). In subjects
attending the dentist, a degree of anxiety is felt, with 5 to 14% of
patients being so anxious that they avoid dental treatment completely
(252). This suggests that there remain a group of patients with oral
lichen planus with high stress and anxiety who have not attended for
dental treatment.
An association between leukoplakia and psychological disease has not
been reported.
4) Treatment
The treatment of oral keratoses has varied considerably during the
last century but has contributed in a small way to an understanding of
their pathogenesis.
Lichen planus
A number of remedies for cutaneous lichen planus were reported during
the nineteenth century but there was little information concerning the
treatment of oral lichen planus. For cutaneous lichen planus, Wilson
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(1 866) commonly prescribed "Fowler's solution, three times a day with
the use of a lotion of bichloride of mercury, two grains to the ounce,
in emulsion of bitter almonds, night and morning; the skin being
previously thoroughly washed with the juniper tar soap" (38). It is
unclear what Fowler's solution contained. A fero-arsenical mixture to
be taken orally, together with mercury bichloride lotion and calcium
pentasulphate was endorsed by Wilson (38). Flebra ( 1 868) was reported
to advocate arsenic preparations for cutaneous lichen planus (36).
The earliest reported treatment of oral lichen planus was given by
Crocker in 1882 (39). The medication consisted of "gentian and
magnesia, with thymol locally" (39). Oil of pine was another topical
agent considered to be useful (39). However the use of an arsenic
adjuvant was encouraged when the patient could tolerate that
treatment (39). Fox (1883) was reported to use "inunction of olive
oil and mineral acids internally" (39).
Little (1919) presented a paper related largely to cutaneous lichen
planus where the treatment comprised an intramuscular injection of a
combination of arsenic and mercury every two days for six weeks (59) .
Other physicians also recommended the treatment of cutaneous lichen
planus with mercury (253) . This medication proved useful in reducing
the itch and controlled acute and chronic eruptions (59, 253).
Interestingly, dietary restriction was recommended by Bulkley (1919),
with a diet of bread, butter, rice and water recommended at the onset
of the disease (52). X-rays proved disappointing but cryofreezing of
hypertrophic lesions was reported as a more satisfactory form of
treatment of skin lesions (59).
Bismuth injections, soothing ointments, ultraviolet light, vitamins,
sedatives and X-rays were reported treatments for cutaneous lichen
planus carried out in the University of Chicago between 1942 and 1952
(63). In addition, Tompkins ( 1952) noted that reassurance was
valuable in the management of the patients (63). Recurrences were 12%
of the 41 patients in the study and it was noted that mucous membrane
involvement tended to prolong the duration of the disease (63). Thoma
(1950) continued to recommend arsenic and mercuric preparations in the
treatment of oral lichen planus (20). In Britain, Cooke ( 1958)
reported the use of 2% aureomycin mouth washes for oral lichen planus
(64). The smoothing of rough teeth and dentures was also reported as
valuable (64). Ulcers in lichen planus were painted with one per cent
aqueous gentian violet to prevent secondary infection (64). Cooke
(1 958) also suggested that treatments for cutaneous lichen planus were
valueless in the treatment of oral lichen planus (64). Shklar (1972)
endorsed the more resistant nature of oral lichen planus to treatment,
compared to cutaneous lichen planus (65).
By 1 970 corticosteroid preparations were widely available and Shklar
( 1972) restricted their use in either topical or systemic form to
erosive lesions of oral lichen planus (65). Sleeper ( 1967) described
the use of intralesional and sublesional injections of Triamcinalone
acetamide for oral lichen planus with success (254). Betamethasone
was also reported to be a successful medication for oral lichen planus
(255). A wide range of steroid preparations for topical,
intralesional and systemic use now exist. Topical and intralesional
steroids are useful for localised areas of oral lichen planus and are
administered to the lesion in the form of gels, creams, aerosols or
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lozenges or into the connective tissues beneath the lesion by means of
injection. The use of systemic steroids is generally restricted to
those cases of more severe lichen planus where erosion and atrophy
involve oral or genital sites, the administration of steroid tablets
being more common in outpatient clinics. Steroids generally available
are illustrated in Table 1 0 (68, 256).
The possible mechanisms of action of corticosteroids are described by
Pedersen and Klausen (1984) (257). Corticosteroids inhibit many of
the processes associated with inflamation when administered in supra-
physiological concentrations (257). These include the stabilisation
of cell membranes and thus a reduction of prostaglandin and lysosomal
release in the inflamed tissues (257). In lichen planus and other
inflammatory conditions, steroids may exert an anti-inflammatory
effect on lesional and circulating lymphocytes, thus modifying the
level of tissue inflammation. Lichen planus is more often than not
controlled by the administration of steroids although cure is
infrequent for this chronic condition.
Other treatments used include the administration of griseofulvin and
levamisole (258,259). Although griseofulvin is concentrated in
keratin, the action of this antifungal medication on lichen planus is
unclear. There are also reported side effects from these medications
including the appearance of lichenoid eruptions with the use of
levamisole which is an immuno-suppressant agent (259). Antibiotic
treatment of cutaneous lichen planus has been attempted, but Samman
(1954) abandoned a trial of chloromycin, aureomycin and terramycin
when no beneficial effect was seen (70).
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The use of sedatives and tranquillizers has been unhelpful in the
management of lichen planus (63) however psychotherapy has been
reported to have some value (260,261 ). Thoma ( 1950) reported the use
of mercury and arsenic preparations and valued "..hygiene, good food,
sunshine and freedom from worry." in the treatment of lichen planus
(20). More recently the periodontal and prosthetic treatment of
patients with oral lichen planus has been evaluated and it was found
that gingival involvement may be improved by optimum plaque control
and periodontal treatment (262). The use of chlorhexidine in a 0.2%
aqueous solution as a mouthwash has recently been suggested to be
remarkably beneficial in the control of oral lichen planus (Holmstrup
P. personal communication).
Leukoplakia
A variety of treatments for oral keratosis were in use during the
nineteenth century most of which related to the elimination of
possible factors causing local irritation (page 53). Bloodgood ( 1932)
even advised dental clearance to eliminate local factors (13).
Otherwise local excision of the lesion using surgery, cryotherapy or
laser treatment has been advocated. The main reason for such
treatment is the prevention of malignant change and there is no record
in the literature of steroid therapy being recommended for the
management of leukoplakia.
Historically small lip keratoses were treated with single radium
applications while larger lesions could receive various radium
therapies and, in certain cases, high X-ray dosing (24). If the
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removal of local irritants did not resolve small oral leukoplakias
after three months then removal effected by electro-dessication under
local anaesthesia was often instigated (27,30,54).
Symtomatic treatment of leukoplakia with weak alkaline mouthwashes
such as sodium bicarbonate and the use of chromic acid application for
ulcerated areas was recommended by Fitzwilliams (1927) (26).
Discomfort, especially of the tongue, indicated application of
lanoline type creams with topical anaesthetic agents (26). Systemic
associations, including syphilis and Vitamin A deficiency, were
investigated when local irritant causes had been eliminated and the
lesions persisted (20,22). The concern for malignant transformation
persisted and observation of the leukoplakia becoming thickened or
ulcerated indicated excision of the lesion at the earliest opportunity
(27,30).
Thoma's classification of leukoplakia, described earlier, included
four types or grades which varied in clinical appearance (20). The
fourth type was a "neoplastic leukoplakia" which presented in a
verrucose form and had a recognised neoplastic potential (20).
Treatments directed at these specific types of leukoplakia varied and
were dependent on histopathological features (20). Interestingly, the
inflammatory infiltrate in the subepithelial tissues was a common
picture with all the grades of leukoplakia, however the variation of
keratinization was seen to help to distinguish these gradings (20).
The "neoplastic leukoplakia" was probably early carcinoma invading the
deeper tissues and the treatment by excision and endothermy was the
only appropriate course of action (20,26).
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Today there are three main ways in which leukoplakia is treated, the
choice being determined by the clinicians' view as to whether or not
the lesion has a local cause and evaluation of its malignant
potential, the latter being influenced by the site of the lesion and
the degree of epithelial dysplasia.
1. Management limited to removal of local irritants including tobacco,
either in smoke or leaf form and the regular monitoring of the
lesions (81,82). As there is definite risk of malignant
transformation that remains unpredictable, the maintenance of regular
review is essential (74, 263).
2. Medical management for candidal leukoplakia involving antifungal
therapies (119). A variety of other therapies for leukoplakia have
been suggested, including topical or systemic treatment with Vitamin A
and fibroblast interferon (54,264,265).
3. Surgical removal by means of cryotherapy or surgery of the
leukoplakia (20, 119, 120,264,265).
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MICROSCOPIC FEATURES OF ORAL KERATOSES
Before describing the microscopic features of oral keratoses, a short
account is given of the structure of normal oral epithelium.
a. Normal Oral Epithelium
Human oral mucosa is derived from ectoderm. It is a moist surface
tissue and has many characteristics of skin. Oral mucosa provides a
continuous covering of stratified squamous epithelium, functionally
divided into three types (266).
1. A covering mucosa, involving buccal and labial surfaces, ventral
surface of tongue, floor of mouth and soft palate, which is
normally non-keratinized.
2. A masticatory mucosa, restricted to gingivae and hard palate,
which is normally keratinized.
3. Specialised mucosa is seen on the dorsum of the tongue where
gustatory buds and papillae are present.
The supporting connective tissue is adapted to the functional
requirements of the mucosa. Masticatory mucosa is adherent to
underlying bone by dense fibrous tissue. Covering mucosa is attached
by less dense connective tissue to the underlying muscle (266).
Connective tissue papillae interdigitate with the epithelium and vary
in both density and height according to site (267,268). The metabolic
supply for the epithelium is provided by the vessels permeating the
connective tissue papillae (268,269). The epithelium consists
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predominantly of keratinocytes but there is an estimated 10% component
of non-keratinocyte cells consisting predominantly of Langerhans cells
and melanocytes (270). In inflamed tissues the percentage of non-
keratinocytes and inflammatory cells may increase (271). External
physical stimuli such as chemical agents and friction and the presence
of subepithelial inflammation may affect the turnover rate of the
epithelium (271-273).
1 . Keratinocytes
The site of cell proliferation in the epithelium is the germinal cells
that exist adjacent to and within three cell layers of the basement
membrane (274). Additionally cell division may be clustered
(266,274). Accounting for the greatest proportion of cells in the
oral epithelium, keratinocytes divide at the basal and parabasal
layers, mature and progress to the surface. Non-keratinized
epithelium matures with the production of tonofilaments that are in a
loose network (275,276). The cells become increasingly stratified
towards the surface. Keratohyalin granules and glycogen may be
present in the superficial part of the epithelium (276,277). In
keratinised epithelium maturation of keratinocytes in the prickle cell
layer produces tonofilaments which are visible microscopically (276).
At the granular layer, keratohyalin granules dominate and associate
with the tonofilaments to form the sulphurous matrix of microfibrils
at the keratinized surface (276, 278). The keratinized surface is a
microfibrillar mass. In orthokeratosis, the keratinocytes lose all
visible signs of organelles except for the filaments and in
parakeratosis, pyknotic nuclei remain within the keratin matrix (277).
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The keratin surface is tough and insoluble in normal oral conditions
but this may be altered (279).
Keratinocytes produce a family of proteins called keratins (275),
different types of epithelium producing different types of keratin.
The keratins comprise 19 polypeptides that can be divided into two
groups, I and II, according to immunoreactivity, isoelectric focusing
and DNA hybridisation (275). Keratins are gene products and are
produced in different quantities according to the type of epithelial
keratinization (275). There is no evidence to suggest that different
types of keratin are produced in oral keratoses compared to normal
oral mucosa and they have not been investigated in this study.
Keratinocyte cell surface carbohydrates provide a wide range of
epitopes including the blood group antigens. The significance of the
distribution of blood group antigens in keratiocytes is discussed on
page 78.
2. Langerhans cells
These are a dendritic type of cell seen in the epithelium, the cell
being part of a family of cells often termed dendritic leukocytes.
Langerhans cells are thought to be continuously seeded out of the bone
marrow to the epidermis where mitotic activity may also occur. Their
role in both normal and pathological tissue is not fully determined
but primary antigen processing is a major function (280-283).
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3. Melanocytes
Melanocytes are pigment (melanin) producing cells that are found i
the basal layer of epithelium. Embryologically, melanocytes are
derived from the neural crest. Melanin is conveyed to the
keratinocytes as melanosomes by dendritic processes (284). Melani
granules are visible under light microscopy in melanocytes and
keratinocytes, and may also be seen in melanophages which are
macrophages containing melanin seen in the upper parts of the
connective tissue (285).
b. Lichen Planus
The histopathological features of oral lichen planus were first
reported by Dubreuilh in 1906 (47). It was clear that histological
features of oral lichen planus are similar to those of cutaneous
lichen planus (47). The following histopathological features are
commonly described in oral lichen planus (47,48,5 9,61,62,64,65,286
299) .
1. Epithelial Features
1 . Generally hyperplastic or acanthotic but not
infrequently is atrophic
2. Hyperkeratosis- either parakeratin or orthokeratin
3. Increased intercellular spaces in basal epithelium
(liquifactive degeneration) (287, 288).
4. Presence of colloid bodies which are thought to
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represent apoptosis (287,290).
5. Pointed rete ridges (saw tooth) (65).
6. Prominent prickle cell layers (47,66).
7. Presence of a granular cell layer (290).
8. Mononuclear cell inflammatory infiltrate in the basal
layers of the epithelium (65) .
2. Epithelial/Connective tissue interface
1. Basement membrane zone damage (291).
2. Thickening of basement membrane with fibrin or
immunoglobulin (292-294).
3. Disruption of basement lamina (292).
4. Oedema and splitting away of epithelium from
connective tissue (295).
3. Connective tissue
1. Apoptotic bodies (as within the epithelium) (296-299).
2. Presence of colloid bodies which are thought to
represent apoptosis (287,289).
3. Dense band of mononuclear cells in the upper lamina
propria, almost entirely composed of lymphocytes and
with plasma cells inconspicuous or absent.
4. Distinct delineation between mononuclear cell
infiltrate in the upper lamina propria and deeper
connective tissue (47).
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No single histological feature is diagnostic for lichen planus. In
practice a pathologist makes a subjective diagnosis based on a study
of the features described above. Similar microscopic features are
seen in lichenoid drug reactions when the diagnosis must be related to
the appearance of clinical lesions upon challenge by the respective
drug or drugs, and re-introduction of the drug after cessation of the
therapy should then re-establish the clinical condition.
The earliest changes, illustrated by electron microscopy, in lichen
planus appear to be within the epithelium (297). Injury of the basal
cells leads to damage and the development of intercellular spaces
(280). The hemidesmosomes between basal epithelial cells and the
basement membrane appear to deteriorate, leading to splitting of the
epithelium from the basement membrane (288). Disruption of the basal
lamina is thought to be followed by attempts at repair, perhaps
leading to loss and irregular thickening of the basal lamina (292).
Ultrastructural studies indicate that colloid or Civatte bodies retain
a filamentous structure consistent with the epithelial or keratinocyte
origin of these masses (287,300,301 ). Since these epithelial changes
may be seen in other inflammatory conditions, their significance for
lichen planus remains unclear (300). Blood group substances are lost
in the prickle cell layer (302) and the basement membrane shows
antigen loss by reduced carbohydrate binding with Concanavalin A
(ConA) and Ricinus communis agglutinin (291 , 293). Vascular dilation,
oedema and disruption of the basement membrane zone occur (303-305).
More recently the use of monoclonal antibodies to identify epitopes
present in lichen planus has helped in the understanding of pathogenic
processes and this will be described in the next section.
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c. Leukoplakia
The histological features of leukoplakia are not specific and reflect
varying degrees of keratosis, epithelial thickness, epithelial
dysplasia and chronic inflammatory cell infiltrate (164, 306). The
keratin may vary in thickness, be ortho or parakeratin, or a mixture
of both. The lamina propria may be irregularly infiltrated by
mononuclear cells, predominantly lymphocytes and plasma cells
(20, 81 , 82). The important histopathological feature of idiopathic
keratosis regarding behaviour is thought to be the degree of dysplasia
of the epithelium (82, 83, 203, 307). Although this has been questioned,
it would appear that there are no better indicators at present (161).
Objectivity in histological assesment remains a major problem and
attempts to standardise this evaluation have been made (141,161,307-
309). A system using photographic standards for the evaluation of
epithelial dysplasia was put forward by Smith and Pindborg ( 1969)
(141). This was followed by work from Kramer and co-workers (1970)
which used computer aided analyses for the evaluation of
histopathological features of oral keratoses including lichen planus
( 153, 154). Franklin et al (1 980) reported stereological methods for
assessment of epithelial dysplasia (309). Distinction between
dysplastic and normal epithelium was made using stereological
examination of nuclear/cytoplasmic ratios and nuclear density (309).
The following histopathological features of epithelial dysplasia are
commonly described in oral idiopathic keratoses (145,146)
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Gross Structure
a. irregular epithelial stratification
b. drop-shaped rete processes
c. hyperplasia of basal cell layer; cell crowding creating
appearance of multiple layer of basal cells
d. keratinization in prickle cell layer
(disturbed maturational sequence)
e. reduced intercellular coherence
f. disturbed polarity of basal and or supra basal cells
Cellular features
g. increased mitoses and abnormal mitoses within the
thickness of the epithelium
h. pleomorphism
i. hyperchromatism
j. increased nuclear/cytoplasmic ratio
k. prominent nucleoli
Since 1 950 the infiltrate in idiopathic keratoses has been largely
overlooked in the histological assessment. Shafer and Waldron (1961),
while recognising that an infiltrate was present in the underlying
connective tissue, stated that "the presence of inflammation in
leukoplakia has been noted (54% of biopsies) . However, the
significance of this finding is not understood and possibly may not be
related to the lesion per se..." (81). Later Shafer and Waldron
(1975) disregarded the inflammatory infiltrate of the lesions
examined, concentrating on the dysplastic features of the epithelium
(82).
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d. Histopathology of Discoid Lupus Erythematosus
Lupus erythematosus is generally regarded as an autoimmune process
involving both humoral and cell mediated immunity, in which a large
number of autoantibodies directed against nuclear and cytoplasmic
components have been identified. In the discoid type of the disease
(DLE), clinical lesions are confined to skin and mucosal surfaces. On
the oral mucosa, erythematous plaques or erosions associated with
white striae radiating from the periphery of the lesion are seen. In
the systemic type (SLE), skin and mucosal lesions are relatively mild
and the disease is dominated by multiple systemic involvement
affecting joints, kidneys, heart and lungs. The histopathological
diagnosis of discoid lupus erythematosus is based on the presence of
the following major features (310,311).
1. Pseudoepitheliomatous hyperplasia
2. Hyperorthokeratosis with vertical clefts in the surface plugged
with keratin
3. Liquifactive degeneration of basal epithelial cells
4. Deep inflammatory infiltrates (diffuse, perivascular or focal
aggregates)
5. Thickening of the basement membrane zone.
There are further, less important, histological features presenting in
discoid lupus erythematosus. These include the presence of colloid or
Civatte bodies, an eosinophilic cell free zone separating epithelium
from the inflammatory infiltrate and the predominance of a mononuclear
cell infiltrate with occasional plasma cells (310,311). Pathologists
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value the distribution of lymphoid aggregates in the differential
diagnosis of oral discoid lupus erythematosus. Pindborg ( 1980)
included discoid lupus erythematosus in his list of precancerous
conditions but Schiodt (1989) noted that the literature had not
documented intraoral carcinoma arising in pre-existing lesions of
discoid lupus erythematosis (191,311).
e. Histopathology of Frictional Keratosis
It is a commonplace observation that chronic friction to the skin
leads to thickening and the formation of epidermal callus. The only
proper study of the effects of friction on oral mucosa was that
described by Mackenzie and Miles ( 1973) who subjected hamster cheek
pouches to controlled frictional stimuli (312). Friction for periods
up to 19 days produced thickening of the keratin, an increase in the
size and number of prickle cells, and increased mitotic activity
f. Histopathology of Smoking Keratosis
While the smoking of tobacco is widely regarded as an important cause
of oral keratoses, there is little specific information in the
literature concerning histological changes directly attributable to
tobacco smoke. Experimental animal studies have not been helpful. An
exception to this is the lesion of the palatal mucosa frequently seen
in persons who are heavy pipe smokers. Nicotinic stomatitis of the
palate shows epithelial thickening and hyperkeratinization with the
ducts of the mucous glands dilated and the orifices partially occluded
by keratin. Pindborg et al ( 1980) described a chevron like
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keratinization in a number of tobacco smoke induced lesions of the
oral mucosa, with vertical streaks of parakeratin in the upper layers
of the epithelium (313). The epithelial cells in between the vertical
streaks of parakeratin sometimes have enlarged vacuolated cytoplasm.
Smokeless tobacco directly applied to the buccal mucosa produces a
parakeratinized surface with epithelial thickening (or occasionally
atrophy), often with vacuolisation of prickle cells. Stromal
inflammation is variable and epithelial dysplasia is unusual (149).
In summary therefore, the effects on the oral mucosa of smoking
tobacco are likely to be hyperkeratinization or parakeratinization (if
the epithelium was previously non-keratinized), epithelial thickening
(or occasional atrophy) and variable stromal inflamation.
g. Histopathology of Hereditary Keratoses
Several hereditary keratotic disorders of the oral mucosa are
characterised by disorders of keratinization and share a common
clinical finding of a mucosal white lesion. White sponge naevus is a
autosomal dominant transmitted condition that may be mistaken
clinically for leukoplakia. It presents as a deeply folded white
lesion affecting several mucosal surfaces, the lesions being thick
with a spongy consistency and showing bilateral symmetry. The buccal
mucosa is generally involved. Microscopically the epithelium is
acanthotic and parakeratinized . The prickle cells show marked
hydropic or clear cell change with nuclei somewhat pyknotic and often
eccentric in location.
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IMMUNOLOGY OF ORAL KERATOSES
Introduction
During the latter half of this century significant advances in
understanding immune mechanisms and disease have been made. Early
experiments, largely using micro-organisms, showed basic immune
responses but more recently it has been realised that the gut and skin
associated immune mechanisms have major controlling functions. It is
still unclear how oral mucosal disease is influenced by such immune
systems and further studies are therefore required. The humoral and
cellular immune aspects of lichen planus and leukoplakia will now be
reviewed.
a. Humoral Immunity in Lichen Planus
1. Immunoglobulins
Shuttleworth et al ( 1 986) reviewed the literature pertaining to
immunoglobulins and autoimmunity in studies on lichen planus (314).
Some previous studies had suggested that systemic immune mechanisms
are important in the pathogenesis of lichen planus (315,316). However
this appears to be an inconsistent feature if serum immunoglobulins
are evaluated as markers of immunological abnormality. Table 11
summarises values reported by nine investigators. While the
similarity of clinical features in lichen planus and graft versus host
disease may be suggestive of a common aetiology, this does not appear
to be reflected in humoral immune profiles of lichen planus (317).
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a) Serum Immunoglobulin G. Lundstrom ( 1985) found a higher level of
serum IgG in patients with lichen planus than in a control group
(318). An important feature of this patient group was that the
majority, twenty eight out of thirty four, had atrophic-erosive type
lichen planus (318). This association of raised IgG levels with
lichen planus has also been reported by Schroeder (1981) who noted
raised levels of IgG in erosive lichen planus and mucocutaneous lichen
planus (319). While Griffiths et al (1974) did not show differences
in mean levels of serum immunoglobulin values between patients and
controls, elevated levels of IgG were present in 44% of patients with
erosive lichen planus and this was attributed to secondary infection
(320). Sklavounou et al (1983) were able to show raised serum IgG
levels for both ulcerative and reticular lichen planus compared to
controls (321).
b) Serum Immunoglobulin A. Serum IgA normally accounts for
approximately one fifth of the serum immunoglobulins (322). Reduced
levels of serum IgA in lichen planus were reported by Stankler (1975)
and Sklavounou et al (1 983) (321 , 323). However Mayhood (1981)
reported raised levels of serum IgA for resolved cutaneous lichen
planus when compared to previous active lichen planus (324). Other
investigators have failed to show any change in the serum IgA level in
lichen planus (31 4,31 8,31 9,325-32 7).
c) Serum Immunoglobulin M. The pentameric IgM molecule is generally
restricted to the vasculature. Being a strong binder of complement,
IgM can activate the complement reaction (322). IgM is raised in
systemic lupus erythematosus, rheumatoid arthritis and may have a role
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in other chronic inflammatory conditions (311).
Stankler (1975) and Jacyk and Greenwood (1978) recorded decreased
levels of IgM in cutaneous lichen planus (323, 326), while Mahood
(1981) reported raised levels of IgM in patients after resolution of
lichen planus (324). Other investigators have found no major
alteration of serum IgM in lichen planus (see Table 11). Furthermore
patients with oral erosive lichen planus have not been shown to have
any alteration of serum IgM (320, 321 ).
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TABLE 11
Serum Immunoglobulins in Lichen Planus
IgG IgA IgM No. of Patients Reference
1969 Lehner Dec - N 20 (325)
1974 Griffith et al N - - 35 (320)
1975 Stankler N Dec Dec 13 (323)
1978 Jacyk & Greenwood N N Dec 42 (326)
1981 Mahood Inc Inc Inc 31 (324)
1982 Scully N N N 35 (327)
1983 Sklavounou Inc Dec N 50 (321)
1985 Lundstrom 1 nc N N 34 (318)
1986 Shuttleworth N N N 54 (314)
Serum Immunoglobulins in Erosive Lichen Planus
1974 Griffith et al Inc Inc N 35 (320)
1981 Schroeder Inc N N - (319)
1983 Sklavounou Inc Dec N 13 (321)
Adapted from Shuttleworth et al (314)
(Dec = Decreased, N = Normal, Inc = Increased)
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2. Complement
The series of serum proteins known as complement provides a variety of
biological mechanisms that may amplify humoral and cellular immune
functions. The C3 component has been shown to be present in normal
values in the serum of lichen planus patients (320, 321 ). Complement
is present at the basement membrane zone in the oral lesions of lichen
planus (31 1 ,328-330). Additionally complement is seen to be present
frequently in other oral inflammatory conditions including leukoplakia
and discoid lupus erythematosus (329). The presence of C3 does not
appear to contribute to the differential diagnosis of these white
patches (311,329).
3. Autoantibodies
Lichen planus has been suspected of being an autoimmune disorder
(314, 330). Shuttleworth et al ( 1986) assessed fifty four patients
with lichen planus for autoimmune disorders and failed to show any
increased prevalence in the patient group over the control group
(314). Lundstrom (1985) also failed to find any significant evidence
for autoimmunity (318), despite 27% of oral lichen planus patients,
compared to 9% of controls, showing positive titres of rheumatoid
factor (RF) and antibodies to antinuclear factor (ANF) (318). Schiodt
et al (1 982) failed to show significant anti-DNA antibodies in lichen
planus patients (330). Furthermore the presence of markedly raised
anti-DNA antibodies was found in 4% of patients with discoid lupus
erythematosus, lichen planus and leukoplakia and this parameter had no
differential diagnostic value (31 1,330). Lichen planus has also been
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associated with late onset hypogammaglobulinaemia, thymoma and
alopecia areata but the relationship between these conditions and
lichen planus remains unclear (331,332).
b. Humoral Immunity in Oral Leukoplakia
The assessment of humoral immunity in patients with oral leukoplakia,
including serum levels of immunoglobulins has not been reported in the
literature. Immune changes in oral cancer may be the progression of
those identified in leukoplakia and so may be relevant to leukoplakia.
For oral cancer the main classes of immunoglobulin have been assessed
with a view to prognostic indicators (333-336). Serum IgG, IgM and
IgD levels appear to be unaltered in patients with oral cancer
(334,335).
Parotid saliva has also been reported to be unaltered in oral cancer
patients compared to controls (334,335). Salivary IgA in
oropharyngeal cancer has been reported to be raised but this was
considered to be an association with tobacco and alcohol use and not
directly related to the assessment of oropharyngeal malignancy (337).
Patients with primary oral and pharyngeal cancer demonstrated a two
fold increase in IgA in whole saliva over a control group (336). It
can be anticipated that the oral or pharyngeal sites of ulceration may
have contributed to the raised levels of IgA in the whole saliva
through exudate of tissue fluids from these carcinomas. It is
therefore not surprising that patients with recurrences of oral or
pharyngeal carcinoma showed the greatest elevations of salivary IgA
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(346). Other studies however do not confirm these results and do not
indicate that any major differences in salivary IgA levels exist
between oral neoplasia and healthy controls (338).
Reviews of immunology of oral cancer do not attribute humoral immune
defects to the acquisition or progression of cancer ( 159, 1 65, 339, 340).
The assessment of serum complement and autoantibodies has not been
reported for idiopathic keratoses.
c. Cellular Immunity in Oral Lichen Planus and Leukoplakia
Limited (in vitro) studies of cellular immunity in lichen planus and
idiopathic keratosis have been reported and understanding at present
is dependent largely on the morphological information obtainable from
the immune infiltrates of these lesions (69, 1 65,204). The presence of
immunocytes in the epithelium or lamina propria is indicative of
immune mechanisms in operation.
Lichen Planus
The cell infiltrates in oral and cutaneous lichen planus have been
identified using various techniques including sheep red cell tests,
enzyme histochemistry and monoclonal antibody studies. The presence
of predominantly T lymphocytes of either suppressor or helper
phenotypes has been shown (341 ,342) . Suppressor lymphocytes have been
shown both in the lamina propria (in large numbers) and within the
epithelium (342, 343). Macrophages have also been demonstrated in oral
lichen planus using immunoperoxidase techniques and monoclonal
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antibodies (344-346). Langerhans cells have been shown to be present
in the epithelial para-basal cell layer and juxta-epithelial tissues
(341,345,347).
The presence of HLA-DR epitopes on epithelial cells in oral lichen
planus is considered to be part of keratinocyte antigen processing
(345, 348, 349). Langerhans cells have also been shown to express
surface and cytoplasmic HLA-DR sites (345,349). This expression has
been shown in other mucosal diseases, notably oral candidosis,
gingivitis and graft versus host disease (350, 351 ). The distribution
and number of T lymphocytes are reported to be directly related to the
epithelial expression of HLA-DR epitopes (350).
B lymphocytes and plasma cells are an infrequent finding in cutaneous
and oral lichen planus (343,352). There has however been recent
evidence suggesting that some B cells do exist in close proximity to
helper T cells in the infiltrates seen in lichen planus (349).
An unidentified substance, designated lichen planus specific antigen
(LPSA), has been demonstrated in the lesions of cutaneous lichen
planus but not in oral lichen planus lesions (353,354). This antigen
is present in the granular and upper prickle cell layers (353).
Incubation of serum from four patients having oral lichen planus with
allogeneic cutaneous lichen planus Iesional sections showed positive
LPSA in two of the four patients (354).
Deposits of IgG, IgA, IgM and fibrin have been reported in lichen
planus in the basement membrane zone (352,355). A particular
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epidermal protein, involucrin, has also been shown in oral lichen
planus (356). The importance of these immunoglobulin deposits and
involucrin is unclear.
Obtaining cells for (in vitro) assessment of the immune infiltrates of
tissues is difficult. Lichen planus has a dense and distinctive
immune infiltrate and this has not been fully examined with such
techniques (357). Preliminary investigations by Sarkony and Gaylarde
( 1972) showed lymphocyte transformation of autologous lymphocytes when
cultured with a homogenate of the dermal lesion (358). The dermal
infiltrate appeared to be proliferating lymphoblasts (359).
Leukoplakia
Phenotypic characterisation of immunocytes present in leukoplakia has
not until recently been possible (350). As with studies on lichen
planus, the advent of monoclonal antibodies has been useful in
identifying the phenotypes of the infiltrates. Migliorati et al
( 1986) when studying sections from twenty one biopsies of red or white
oral lesions (6 hyperkeratosis, 3 mild dysplasia, 4 severe dysplasia
and 8 squamous cell carcinoma) found a predominance of T lymphocytes
on immunostaining (360). Helper (T4) cells were present in higher
numbers than suppressor (T8) lymphocytes (360). Differences were
reported between mild and severely dysplastic lesions for the T4/T8
ratio and the mononuclear cell infiltrate contained low numbers of B
cells (B1) while in the hyperkeratotic and mild dysplastic tissues
examined B cells comprised 37% of the total and in the severe
dysplastic and squamous cell carcinoma tissues comprised 58% (360).
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Monocytes and null cells were not found when using the 0KM1 monoclonal
antibody (360). Activated T lymphocytes, Langherhans cells, monocytes
and B cells distinguished by the appearance of HLA-D/DR and la like
antigens, produced intense reactions (360). Langherhans cells were
noted in epithelial cell layers (360). Migliorati et al ( 1986)
further showed a low proportion of natural killer and killer type
cells distinguished by a leu-7 monoclonal antibody (360). These cells
were invariably seen in the connective tissues.
Interestingly, follow up of one patient over a year showed an increase
of helper cells (T4) in the lesion from the original hyperkeratosis to
mild dysplasia. The suppressor cell T8 population remained relatively
constant, the increase in T4 cells accounting for a raised T4/T8 cell
ratio (360).
The infiltrate associated with carcinoma, when pronounced, has been
associated with improved prognosis for the patient (361) but this
simplistic concept has been questioned as understanding of
carcinogenesis and immunology has developed (362). Woodruff ( 1978)
considered reduced immunity to facilitate the emergence of altered or
neoplastic cells (207). Den Otter (1986) reviewed the concept of
immune surveillance and natural resistance and suggested three points:
"1. Tumour cells do not arise frequently
2. Tumour cells may be antigenic or not
3. There is no need to postulate a very strong immune surveillance or
natural resistance system." (362).
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This implies that immune responses in malignancy may vary
significantly between individual patients.
1. Lymphocyte Transformation
Lehner (1970) studied lymphocyte transformation of peripheral blood
lymphocytes against homogenates of leukoplakia tissue (363). Although
this represented a mixed lymphocyte response of T and B cells,
transformation appeared to become increasingly impaired with the
severity of the epithelial dysplasia. The homogenate, while probably
containing the epithelial antigens against which the lymphoblasts are
reacting, must have also included numerous other proteins that can
initiate blastic transformation of lymphocytes. Lehner suggested that
depression in "cell mediated" immune responses may accompany the onset
of carcinoma (363).
2. Migration Inhibition
Both T and B lymphocytes can produce migration inhibition factors.
The method for demonstrating migration inhibition relies on
immunologically active cells inhibiting the migration of macrophages
(364). Roed Petersen et al (1973), using soluble extracts of
leukoplakia tissue and homologous oral mucosa, investigated migration
inhibition and tested eleven patients with leukoplakia (365). Of
these patients, five showed inhibition of migration. However the
assessment of cell mediated activity against the epithelial tissue of
leukoplakia has to be viewed in light of toxic effects as well as
specific immune effects (365). The function of peripheral blood
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lymphocytes may also be different from the function of the lesional
cells present. Indeed the lesional cells are more likely to be of a
specific population that associate with the lesional site due to
chemotactic information (366).
3. Cytotoxicity Assays
While extensive work has been done in relation to neoplasia and
cytotoxic effects of immunocytes, little has been reported for oral
keratoses. There are problems obtaining appropriate controls for
patient lymphocytes and the effects of killer and natural killer cells
within the test sample make the interpretation of results difficult.
Indeed there is evidence that virally induced tumour cells are killed
by cytotoxic T lymphocytes and natural killer cells and the immune
activity against other tumour cells is weak (362,367).
4. Anti-Viral Immunity
While the Herpes simplex viruses types 1 and 2 has been implicated in
both oral cancer and leukoplakia, papilloma virus antigens have also
been detected in the lesions (368,369). This implies that the
infiltrate seen in a leukoplakia may be a response of viral specific
cytotoxic T lymphocytes. This is confirmed by results obtained by
Becker et al (1 985) which showed suppressor/cytotoxic T cells more
common at the basement membrane area of leukoplakias (370, 371).
Qualitative and quantitative immunocyte differences appear to exist
between lichen planus, leukoplakia and carcinoma in both the
epithelial and the connective tissue compartment suggesting they do
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not contain a common virus (371 , 372). Penetration pathways for
different compounds through oral epithelia have been recently
described by Squier and Leisch (1988) (373) and permeability
characteristics of oral epithelium may have an important bearing on
the aetiology of oral keratoses.
7. Study Aims and Objectives.
From the literature review it appears that the diagnosis and
management of oral keratoses is generally staight forward, but
destinguishing different types of keratoses eg. lichen planus, may be
more difficult. Many reports restrict assessment to pre-selected
groups of oral keratosis patients and avoid those cases where
difficulties in diagnosis and management are perceived to complicate
the study.
The aim of this thesis was to assess clinical, pathological and
immunological aspects of oral keratoses using a new system of
classification sensitive to the presence of an underlying population
of infiltrating immunocytes. It was also necessary to retain the
conventional diagnostic groups so comparisons could be made with other
studies.
The present thesis is based on a personal clinical and laboratory
study of 159 patients presenting in a dental hospital with oral
keratoses over a three year period.
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The objectives of the present investigation therefore were to provide
answers to the following questions.
1. Are the following investigations of value in the distinction





2. Does histological examination always clearly distinguish between
oral keratoses and does the categorisation of oral keratoses into
infiltrated and non infiltrated groups provide a useful basis for
clinical management?
3. Are certain general or systemic factors such as hypersensitivity to
substances used in dentistry associated with different types of oral
keratoses?
4. Are smoking and alcohol habits linked to particular oral keratoses?
5. Is the local infiltrate associated with the keratotic lesion
destinct from peripheral blood lymphocytes when assessed using 'in
vitro1 cell cultures and are there quantifiable differences between
patients and controls for peripheral blood lymphocyte transformation?
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The hypothesis that the cellular infiltrate, present or absent from
the oral keratosis, is important in determining the malignant
potential of the lesion was formulated at the beginning of the study.
There was no evidence in the literature that the cellular infiltrate
had been assessed for patients attending a clinic with a range of oral
keratoses. This aspect of the lesional infiltrate has been largely
overlooked in favour of the features of epithelial dysplasia during
the clinical management of oral keratosis.
Consideration of this hypothesis is contained within the thesis and
while the recording of malignant change in patients with oral
keratoses was undertaken and recognised as important, it was not






This thesis considers clinical and laboratory data accumulated from
159 patients attending Edinburgh Dental Hospital. All patients
included in this study were personally examined clinically and
investigated, the patients being either self-referred or referred by
their General Dental Practioners, General Medical Practioners or
Hospital Consultants. A detailed clinical history and examination was
recorded for each patient in the hospital records and on a proforma.
This proforma was subsequently computerised for the purpose of
analysis. Each patient was assigned a study number so as not to
contravene the Data Protection Act 1985.
Patients had blood removed for standard haematological and certain
biochemical investigations. In addition, venous blood was removed for
storage and subsequent analysis as discussed in detail below.
Once the haematological status of the patients was known, deficiencies
were investigated and treated appropriately. Thus patients displaying
a nutritional or haematological deficiency were further investigated
to establish an aetiology for their deficiency. Medical evaluations
where appropriate were performed, either by the Department of
Haematology in the Royal Infirmary Edinburgh, or by the Department of
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Gastroenterology, the Western General Hospital, Edinburgh. Subsequent
to these investigations patients with deficiencies were treated for
their underlying disease whenever possible before replacement therapy
was initiated.
132 patients contributed to the histopathological assessment of the
study. Patients presenting with simple frictional or smoking
keratoses did not undergo biopsy as this was not thought to be
clinically indicated. Additionally one patient (no.126) on
anticoagulant therapy was considered unsuitable for biopsy under
outpatient conditions.
When necessary, patients were referred to other Departments within the
Dental Hospital for specialist dental treatment.
After investigation and diagnosis, the keratoses were treated using
accepted methodology including alteration of smoking and drinking
habits, surgery and the use of topical and systemic corticosteroids.
The controls used for various investigations of the study will be
described with the appropriate results section.
a) Clinical History
A clinical history was obtained from each patient; this always
included the following
A. Clinical disease details including age at onset, duration of
illness, involvement of other mucosal surfaces and skin, symptoms,
periods of remission and previous treatment provided.
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B. Previous dental, medical and drug and habit histories.
Patients currently under care for oral keratoses within the department
formed the intial study group. The follow up period for these
patients ranged from 3 to 10 years by the end of the 3 year study.
Patients joining the study were subsequently followed for the
remainder of the study period.
b) Photography
An attempt was made to obtain a photographic record of oral lesions in
all patients on their first visit and subsequently when changes were
observed. This provided objective records of the clinical appearance
as an adjunct to the physical descriptions recorded in the dental
notes and on the proforma. In addition photography allowed
retrospective analysis of the clinical appearances of each particular
lesion and longitudinal assessment of the changes seen during the
follow up. 35mm colour film (Kodachrome 25) was used with a Nikon
camera and a 100mm lens. A ring flash mounted at the end of the lens
provided consistent flash illumination.
c) Physical Examination
The patient's appearance, including facial and limb skin was recorded
including their height and weight. Using two dental mirrors and good
dental illumination an assessment of the oral mucosa was performed.
The mucosa was examined for colour and the extent of mucosal
keratinization. For the purposes of tabulating site involvement a
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site list was developed (Table 12). A code for the clinical
appearance of the keratosis was devised and could thereby be
crosstabulated with the site and the diagnostic category.
d) Haematology and Biochemical Evaluation
50mls of peripheral venous blood were taken from each patient and the
following parameters were measured by the Haematology Department in
the Royal Infirmary, Edinburgh:
1. Haemoglobin, red cell count, haematocrit, mean cell volume (MCV),
mean corpuscular haemoglobin concentration (MCHC) and mean cellular
haemoglobin (MCH).
2. Total and differential white cell counts.
3. Assessment of a stained blood film.
4. Erythrocyte sedimentation rate (ESR).
5. Serum iron and total iron binding capacity, or serum ferritin.
6. Serum vitamin B12 and serum folate.
7. Blood glucose.
8. Serum complement assessment.
The haemoglobin concentration and the red and white cell counts were
measured on a Coulter S counter. The stained blood cell films were
examined according to standard methods and differential white cell
counts were obtained (374). ESR's were determined using standard
techniques (375). Serum iron and total iron binding capacity were
measured according to an automated method (376). Iron deficiency was








3 Upper Buccal Sulcus
4 Lower Buccal Sulcus
5 Buccal Surface
6 Buccal Mucosa (3rd Molar Region)
7 Palatal Mucosa
8 Upper Alveolar Ridge
9 Lower Alveolar Ridge
10 Retromolar Region
11 Gingivae
12 Dorsum of Tongue
13 Lateral Border of Tongue
14 Ventral Surface of Tongue
15 Floor of Mouth
16 Pharynx and Fauces
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than 16% or a serum ferritin of <10 micrograms per litre for males and
<8 micrograms per litre for females on two consecutive occasions
(375).
Patients who had values below the normal range were retested to
confirm the deficiency before referral for haematological consultation
and treatment. Addisonian pernicious anaemia was diagnosed on the
basis of blood and bone marrow findings, histamine fast achlorhydria,
the presence of gastric parietal cell antibodies, a characteristic
Schilling test result and a therapeutic response to Vitamin B12.
Patients with persistently reduced serum folate were referred for
further investigation which included assessment of dietary intake and
exclusion of malabsorption, and jejeunal biopsy.
e) Mucosal Biopsy
Biopsies were obtained from 132 patients for whom there was a clear
indication for biopsy to be carried out. Where multiple sites were
involved, clinical judgment was used to select a biopsy site that
appeared to be representative of the disease generally. In certain
cases biopsy of different sites was performed to enable assessment of
the histological variation of the presenting clinical features.
Previous biopsy material was sometimes available for examination and
this helped in the allocation of patients to the appropriate
diagnostic category.
Standard clinical procedures were used to obtain the biopsy specimen.
Local lignocane anaesthetic solution with 1 :80000 Adrenaline was used
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to infiltrate the tissues adjacent to the selected site. A 3/0 black
silk suture secured the selected tissue which was excised using a
number 15 scalpel blade. Closure of the wound was achieved using a
3/0 black silk suture on an atraumatic needle. A chlorhexidine mouth
wash 0.2% B.P.C. (Corsodyl) was provided for symptomatic use in the
post operative period. Analgesia was obtained post-operatively by
using minor analgesics such as aspirin and paracetamol at the
patient's discretion. Patients were reviewed after one week for
suture removal. Each patient was informed of the results of the
histological examination and any necessary treatment was then
implemented.
The excised tissue was immediately transported in RMPI 1640 (Flow
Laboratories, Rickmansworth, U.K.) with added penicillin and
streptomycin at 100ug/ml concentrations. After arrival at the
laboratory it was divided into two parts to provide specimens for
pathological and experimental purposes. The pathological specimen was
submitted for routine histopathological fixation as described in
chapter 5. The experimental material was further divided and used for
(in vitro) tests of immunocyte function and the remainder stored at -
40°C for subsequent immunocytochemistry.
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f) Experimental Diagnostic Groupings
After assessment of the histopathological appearances of the biopsy,
the microscopic features were collated with the clinical features and
the patients were assigned to experimental diagnostic categories.
These categories evolved during the three year period when the work
for this thesis was being carried out. For the purposes of
consistency however it is convenient to describe these categories now
before further description and analysis of the work and justification
for their adoption is given as the results are displayed and
interpreted.
The experimental diagnostic categories were developed from current
classifications of oral keratoses adapted to facilitate segregation of
the patients according to differences which emerged during this study
at clinical, histological and immunological levels.
The 159 patients were divided into two main groups:
1. Infiltrated Keratoses (IK)
2. Non Infiltrated Keratoses (NIK).
A third group was also identified and called Intermediate Infiltrated
Keratoses (INT). These will be described in turn.
1) Infiltrated Keratoses (IK)
The criteria for placing patients into the "IK" group was the presence
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of a distinct mononuclear cell infiltrate in the lamina propria
adjacent to the keratotic epithelium. IK could be further subdivided
into Lichen Planus (LP), Infiltrated Leukoplakia (ILK), Discoid Lupus
Erythematosus (DLE), Candidal Leukoplakia (CL) and Squamous Cell
Carcinoma (SCC). These will be described later.
2) Non Infiltrated Keratoses (NIK)
In the "NIK" group the keratoses were devoid of significant
mononuclear cells, the numbers and distribution of such cells being
comparable to that seen in normal mucosa. This group could be further
subdivided into Non Infiltrated Leukoplakia (NILK), Frictional and
Smoking Keratoses (FSK) and Hereditary Keratoses (HK). Again these
keratoses will be discussed later.
3) Intermediate Infiltrated Keratosis (INT)
A third group showing intermediate levels of mononuclear cell
infiltrate had to be introduced. The infiltrate in these cases
appeared distinctly patchy or variable suggesting an intermediate
status. Although this may appear a somewhat indefinite group it was
considered to be useful to separate these patients from the IK and NIK
groups.
Thus patients were assigned to one of the following categories:
1. INFILTRATED KERATOSES (IK)
A) Lichen planus (LP). This category included those patients who had
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clinical and histological evidence of lichen planus, that is those
patients who had an oral keratosis which clinically was consistent
with the features of lichen planus described in the literature review
and in addition displayed histological features of lichen planus as
described in the microscopic section of Chapter 1. An example of the
histopathology for lichen planus is illustrated in Figure 11. The
absence of some of the typical histological and clinical features of
lichen planus did not exclude a patient from this category but the
presence of a band like lymphocytic infiltrate was a prerequisite to
inclusion within this category. Due to the subjective nature of the
distinction between lichen planus and lichenoid drug reactions, all
suspected lichenoid drug eruptions were included in this diagnostic
experimental group for purposes of analysis in this thesis.
B) Infiltrated Leukoplakia (ILK). Clinically these lesions were
diagnosed as leukoplakia. Histologically the features were variable
but a significant mononuclear cell infiltrate was a prerequisite for
inclusion in this category (Figure 12).
C) Discoid Lupus Erythematosus (DLE). Clinically these oral lesions
often appeared erythematous with a whitish margin. However
histological examination showed both superficial and deeper
infiltrates in the connective tissue of lymphoid cells, the deeper
infiltrates often being perivascular in distribution.
D) Candidal Leukoplakia (CL). Clinically these patients had
idiopathic keratoses of a plaque or nodular appearance. Site
involvement generally was restricted to the buccal mucosa and
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FIGURE 11. Histopathology of Lichen
(Low Power Magnification)
Planus.
FIGURE 12. Histopathology of Infiltrated Leukoplakia.
(Low Power Magnification)
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commissure. On histopathological examination, using Periodic Acid
Schiff (PAS) staining, candidal hyphae and spores could be detected in
the superficial layers of the keratin. In addition, dense collections
of mononuclear lymphoid cells were present in the connective tissue,
with collections of polymorphonuclear leucocytes and micro-abcesses in
the epithelium related to the Candida hyphae.
E) Squamous Cell Carcinoma (SCC). Cases of squamous cell carcinoma
were categorised as infiltrated keratoses in light of the distinct
mononuclear cell infiltrates associated with the neoplasm.
2. NON INFILTRATED KERATOSES (NIK)
These patients were assigned to one of the following categories:
A) Non Infiltrated Leukoplakia (N1LK). These patients presented
clinically with idiopathic keratotic lesions (leukoplakia) and
histopathological examination of the tissue revealed an oral keratosis
with scant or absent mononuclear cell infiltrate (Figure 13).
B) Frictional and Smoking Keratoses (FSK). These keratoses,
identifiable clinically, were examined histopathologically in certain
cases where doubt existed as to the precise nature of the keratosis.
These lesions exhibited a range of clinical signs and displayed only a
scant mononuclear cell infiltrate.
C) Hereditary Keratoses (HK). Hereditary keratoses did not display
significant infiltrates of lymphoid cells on histological examination
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and justified classification as non infiltrated keratoses,
g) Site Involvement
The oral cavity was divided into 16 sites to illustrate the occurrence
of keratoses in each particular site. The topographical system used
in this thesis was developed from that described by Roed-Peterson and
Renstrup (1 969) and that used in the WHO oral mucosa manual (377,378).
Distinction between left and right was not incorporated into the
computation of the oral sites involved due to the complexity involved
in analysis of the data. The sites used are defined as follows:
1. Vermilion border. Vermilion border applies to the upper and lower
lip area between the labial mucosa and the skin of the lip.
2. Commissure. This is an area of approximately 1.5cms diameter of
mucous membrane extending distally from the angles of the mouth.
3. Buccal Sulcus (Upper). The upper buccal sulcus refers to the
reflected mucosa from the upper ridge to the flat surface of the
buccal mucosa. It includes the labial sulcus as a continuous sheet of
mucosa from left to right.
4. Buccal Sulcus (Lower). This, like the upper sulcus, refers to the
reflected mucosa between the lower ridge and the flat surface of the
buccal mucosa from left to right including the labial sulcus.
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5. Buccal Surface. This includes the area between the maxillary and
mandibular buccal sulci". It is a rectangular area that extends from
the commissure to the anterior faucial pillar.
6. Buccal Surface (Adjacent to Lower Third Molar Region). This
describes an area relating to the lower buccal mucosa adjacent to
standing or non standing mandibular third molars. This specification
was developed to aid topographical details of lichen planus,
frequently seen at this site.
7. Palate. This includes the ventral surface of soft and hard palate.
8. Upper Alveolar Ridge. This includes edentulous or dentate ridge
from the upper left third molar region to the upper right third molar
region.
9. Lower Alveolar Ridge. This likewise includes the ridge from lower
left third molar region to the right third molar region.
10. The Retromolar Region. This is a triangular area distal to the
lower ridge on the mesial surface of the anterior border of the
ascending ramus of the mandible.
11. Gingivae. This included both upper and lower free and attached
gingivae adjacent to all standing teeth.
12. Tongue, Dorsal Surface. This includes an area of the tongue from
the tip to the circumvalate papillae. This area is bordered by the
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lateral surface as noted next.
13. Tongue, Lateral Surface. This is an area covering approximately
one centimetre of mucosa that joins the dorsal surface to the ventral
surface of the tongue. It comprises the mucosa extending from the
dorsal surface to the ventral surface of the tongue.
14. Tongue, Ventral Surface. The ventral surface of the tongue
extends from the lateral border of the tongue and includes that mucosa
which is raised when the tongue is elevated to the roof of the mouth.
The distinction between ventral surface of the tongue and floor of
mouth remains controversial.
15. The Floor of the Mouth. This includes the mucosa that comprises
the surface of the mucosa in a horseshoe shape that extends from lower
left third molar region to the lower right third molar region. This
area is bounded by the attached gingival mucosa of the lower ridge and
the ventral surface of the tongue.
16. Other Sites. Includes such sites as the pharynx, faucial groove
and fauces.
These sites are recorded individually in the results section to
describe the distribution of the keratoses examined.
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h) Cellobiose/Mannitol Sugar Permeability Test
This test of gastro-intestinal absorption assesses the permeability of
the gastro-intestinal system and abnormalities are detected by
assessing patient urine for the probe molecules. The tests were all
performed under the direction of Dr Anne Ferguson, Professor of
Medicine, Western General Hospital. The investigative procedure for a
cellobiose/mannitol sugar permeability test is described in detail
elsewhere (379). Briefly, following an overnight fast the patient
drank the sugar test solution after bladder emptying. The composition
of the test solution was as follows; 2 grams mannitol, 5 grams
cellobiose, 20 grams lactose, 20 grams sucrose made up to 80mls with
boiling water to give an osmolality of approximately 1 500 osmols.
The sugar test solution was drunk within 5 minutes. The patient
fasted for a total of 5 hours after ingestion of the sugar solution
with the exception of water, tea or coffee without milk or sugar which
were allowed after two and a half hours. All urine passed within 5
hours of the sugar drink was collected, the volume measured and an
alliquot stored at -20°C. Mannitol in the urine was measured by the
method of Corcorran and Page (1947) (380) and the cellobiose was
measured by the method of Strobel et al (1984) (381 ). For each of the
two administered probe molecules, cellobiose and mannitol, the
percentage urinary recovery over 5 hours was calculated. The final
ratio of percentage recovery of cellobiose to percentage recovery of
mannitol was calculated. A cellobiose/ mannitol ratio of <.037 was
regarded as abnormal (379). The test was carried out on 27 patients




Skin patch tests were carried out on 86 patients who agreed to
participate in this part of the study. A panel of Finn chambers
(Finn chambers on Scaripon for cutaneous testing. Epitest Ltd Oy.,
Paijolo 54 SF-04300, Hyryla, Finland) in adhesive tape provided a
vehicle for eight commercially available allergens (Table 13). The
panel was applied to the patient's arm. In certain cases where a
restorative metal might be causing an oral reaction, a powdered form
of this metal was also placed in a vaseline base within a Finn chamber
and adhered to skin.
Any delayed type hypersensitivity reaction was assessed at 72 hours
and patients noticing reaction after this time were requested to
identify the number of the test and to contact the department.
Reactions occuring within a few hours of the chambers being applied,
sufficient for the patient to remove the pannel because of irritation
were not considered as hypersensitivity. Photographic verification
for the patch test results enabled accurate recording. The tests were
later graded on a scale of 0 to 3. The values indicated as follows:
0 - no detectable reaction
1 - mild erythema, restricted to the Finn chamber circumference
2 - raised erythematous reaction within the Finn chamber - palpable
3 - swelling outwith the circumference of the Finn chamber, often with
vesicle formation and marked erythema, also extending beyond the
circumference of the Finn chamber.
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TABLE 13
Substances Used Routinely in Skin Patch Testing
Batch/Lot No. E No.
1. Nickel Sulphate11 42296 E0003
2. Epoxy Resin* 1 42306 E0021
3. Mercury* 0.5 43072
4. Potassium Dichromate* 0.5 42288 E0001
5. Cobalt Chloride* 1 42289 E0002
6. Wood Alcohols* 30 41087 E0020
7. Formaldehyde* 1 42519 E0004
8. Acrylic Polymer#
All in white petroleum jelly.
* Trolab, Hermal-Chemie Kurt Herrmann, D-2057, Reinbek b. Hamburg.
# Poly-Methylmethacrylate liquid
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j) Tobacco and Alcohol Assessment
The clinical history included details of the patients' tobacco and
alcohol consumption. The data was collected in an informal manner to
encourage patients to state accurately their tobacco and alcohol use,
rather than feel it neccessary to underestimate their consumption
figures. The patient was asked to recall the number or amount of
cigarettes, cigars or tobacco smoked and to recall the amount of
alcoholic beverages consumed during a representative week. The
patient was further asked to recall the number of years of each habit.
It was therefore possible to record the patients who had stopped and
those who maintained the respective habits. These details were
computerised and a program written to enable extrapolation of the
reported daily or weekly consumption of tobacco or alcoholic beverages
for the number of years related to the habit. The mean consumption
for the various types of tobacco and alcoholic beverages for the
respective diagnostic categories could then be expressed as a
numerical value. It was also possible to combine the tobacco and
alcohol beverage consumption for each patient and thus calculate the
mean for the total amount of tobacco and alcohol consumed for the
respective categories and similarily for the infiltrated, intermediate
and non infiltrated keratoses groups. The assessment of the alcoholic
beverage consumption was restricted to the recognised volumes of the
different liquids, for example one unit would be equivalent to a half
pint of beer or a glass of wine or a quarter gill of spirits. In
recording the tobacco consumption, a cigarette or a cigar represented
one unit and the amount of tobacco smoked by pipe was recorded in
grams per week.
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k) Clinical Experimental Requirements
For the lymphocyte transformation and suppressor cell assays, ethical
committee approval was obtained to allow age, sex and tobacco habit
matched controls to provide venous blood. A consent form was signed
and up to 120mls of venous blood was removed from both patient and
control using standard techniques which included the use of a
butterfly needle.
Simultaneous attendance of the patient and a suitable control could
not always be relied upon but the control blood was always obtained
during the morning of the same day. Heparin at 20 units per ml of
venous blood was added after delivery of venous blood into a 60ml
syringe and mixed gently. The blood was then transported to the
laboratory immediately for lymphocyte separation.
Fifty controls were also used to provide blood samples for comparison
of immunoglobulin levels with the patient group. Ten mis of venous
blood was removed from patients attending the casualty service of the
Dental Hospital. The blood, once collected, was allowed to clot in




In an attempt to evaluate stress induced anxiety in patients with oral
keratoses, the State-Trait Anxiety Inventory (STAI) (382) was used to
assess two aspects of anxiety in 126 patients and the data compared
with normal values of comparison groups (383). The two aspects of
anxiety assessed were state-anxiety, a transitory state characterised
by feelings of apprehension and by heightened autonomic nervous system
activity, and trait-anxiety, which denotes the personality trait of
the individual. Both State anxiety and Trait anxiety were assessed by
means of a questionnaire sent out to patients for completion and
return. Anonymity was maintained by the use of a coding system. The
state-anxiety and trait-anxiety were each measured by 20 self report
questions which assess general feelings related to anxiety(A-Trait)
and the feelings at the time of completing the questionaire (A-Stait).
The range of scoring was from 20 to 80, with a higher score indicating
a greater level of anxiety for both state and trait characteristics.
The data were compared to reported normal values for medical and
surgical patients (382,383).
In addition, the State-Trait Anxiety Inventory (STAI) was used to
assess anxiety in 69 patients with recurrent aphthous stomatitis as
patients with recurrent oral ulcers are also reported to develop







Patients attending with identifiable local causes of an oral keratosis
had these corrected and patients were subsequently reviewed to
evaluate improvement. Patients presenting with an oral keratosis
associated with an oral prothesis that was beyond reasonable
adjustment, were treated in association with the Prosthodontic
Department and again reviewed to evaluate improvements with the new
prosthesis. Amalgam restorations adjacent to and associated with oral
keratoses were removed and replaced with composite resin restoratives
when feasible. In certain cases where cast metal restoratives were
related to the keratosis, replacement with cast ceramic crowns was
carried out and the keratoses reviewed.
b) Haematinic Therapy
Patients with iron deficiency were treated with ingestable forms of
iron over a period of six months after which their iron levels were
monitored. Patients with Vitamin B12 and folate deficiency were
referred to the Department of Haematology at the Royal Infirmary,




Patient tobacco and alcohol histories were recorded amnestically. All
tobacco use was considered to exert an irritant effect on the oral
mucosa and patients were encouraged to reduce its use. This, however,
proved to be of limited effect although the patients often accepted
the reasons for the advice being given.
d) Treatment
Some patients with lichen planus had symptoms of pain, especially with
certain foods. Treatment with 0.1% triamcinalone in a dental paste
(BPC) was applied to the ulcerated and non ulcerated areas of oral
mucosa causing the symptoms. The response was assessed subjectively.
If there was no response to triamcinalone, other corticosteroid
therapies were used for treatment. Patients were instructed to use an
aqueous mouthwash made up using a Betamethasone five gram tablet (BPC)
dissolved in a beaker of water, four times daily. The solution was
held in the oral cavity for up to five minutes and then expectorated
to prevent systemic effects of ingested steroids. In some patients
Becotide inhaler spray (BPC) was prescribed and the patient was
instructed to direct the spray onto the oral lesion or lesions.
Treatment using systemic corticosteroids in the form of prednisolone
(BPC) was initiated in patients with large areas of erosive lichen
planus. These ( 5mg) tablets swallowed twice a day on alternate days
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for short periods proved satisfactory in the majority of patients
treated in this way. Symptomatic treatment for non erosive and
erosive lesions were evaluated and a variety of mouthwashes, including
0.2% chlorhexidine (Corsodyl) and benzydamine hydrochloride 0.15%
(Difflam Oral Rinse), were prescribed. In addition, a protective oral
gel containing lignocane (Xylodase) was prescribed where painful
ulceration restricted eating.
e) Surgical Treatment
Treatment in some patients consisted of excisional biopsy while in
others, local surgery was sufficient to completely excise the lesion
following incisional biopsy. Patients were referred for treatment to
the oral surgery department if a diagnosis of squamous cell carcinoma
was confirmed.
f) Follow up
Following diagnosis, all keratoses were followed up and progress was
monitored at regular intervals. Where severe ulceration was present
and patients were using systemic steroids the reviews were made at two
and four weekly intervals. Due to the subjective nature of assessing
the response of the disease to treatment quantification of this was
not attempted. The response was recorded in the dental notes at




Clinical data on patients in the study were transferred to the
Edinburgh University mainframe computer. Care was taken to ensure
data protection regulations were adhered to for the interests of these
patients in the study. Evaluation of these data primarily involved
the use of the Statistical Package for Social Sciences (SPSSX) (385).
Advice and assistance in establishing the data base was obtained from
the Computer Officer, Barrie Wohlgemuth. Data were put into the
computer with the help of the Data Input Service within the
University. Control files for data manipulation were developed as the
extent of the data base became apparent. Again the author, in
association with the computer officer, generated and effected these
control files in the analysis of data. The statistical analysis




LABORATORY METHODS 1 - IMMUNOLOGICAL
a) Nephelometric Quantification of Serum Immunoglobulins
Serum samples, previously described, were obtained from centrifuged
clotted whole venous blood from the patient and control groups. The
serum was stored at -40"C, until analysis, in sealed 5ml polyethylene
tubes.
Samples were then thawed and agitated. Those that appeared
excessively turbid due to fat were cleansed using Lipoclean (Fisons
Pic, Loughborough, England) in a ratio of 1 to 1.5 parts Lipoclean to
serum. The serum was aspirated after centrifugation for 10 minutes at
400g. The serum samples were subsequently retained on crushed ice
until dispensed. Total class specific immunoglobulin concentrations
for IgG, IgA and IgM were determined using rate nephelometry on a
Hyland Laser Nephelometer PDQ. Antiserum specific to human IgG, IgA
and IgM was obtained from the Scottish Antibody Production Unit (SAPU)
(386) (at Glasgow and West of Scotland Blood Transfusion Service, Law
Hospital, Carluke, Lanarkshire, Scotland).
An international reference standard serum (SPS01) was obtained from
Milford Ward, Royal Hallamshire Hospital, Sheffield. The
concentrations for IgG, IgA and IgM were 9.97, 1 .69 and 1.10 grams per
litre respectively. Dilutions of SPS01 permitted construction of a
standard curve. Controls of pooled sera were also used to evaluate
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consistency of method. Reference and test samples were accurately
dispensed using automated and programmed diluter dispensers
(DILUTREND, Clinicon Manheim GMBH and Microlab-P).
A rack system of 10mm x 75mm Borosilicate glass tubes (Corning N.Y.
USA) was arranged to provide a row for each antibody class and a
background specimen. To the glass tubes, the reference and test
samples were added and subsequently 1ml of the specific antiserum
solution.
The antiserum solution consisted of the antiboby in a phosphate buffer
saline with 4% polyethylene glycol (PEG) molecular weight 6000 (387).
This was made up using 80 grams PEG (Fisons Pic, Loughborough,
England), 4.32 grams anhydrous NajOH^, 2.43gramsNa (H2pOjj) .2H2O, 3m Is
tween 20 and Baxters 0.9% saline to 2 litres. This was Millipore
(20um) filtered prior to dispensing appropriate amounts of antisera
(Table 16) to separate volumes of the PEG solution. After 30 minutes
the PEG was filtered again before dispensing 1ml volumes to the
appropriate rows of reference and test specimens. The background row
consisted of PEG solution and serum sample, without any antiserum.
The racks of test samples were sealed using Nescofilm (Nippon Shoji
Kaisha Ltd, Japan) and agitated. Samples were left for 90 minutes at
1 5°C to permit immune complex formation. The Hyland nephelometer was
set up according to the manufacturer's instructions. The background
and test values were computed to provide a value for each specimen for
IgG, IgA and IgM. The value in light scatter units is a product of
the amount of immune complexes formed which depends directly on the
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concentration of antigen (test serum) and excess antibody (SAPU
antihuman serum). These values were recorded and the construction of
a reference curve permitted test samples to be read in grams per
litre.
Statistical analysis of the control sample values, obtained on
different days, permitted calculation of the variation of the
differences (Table 14). These were within acceptable limits for
repeat test procedures (see Table 14).
b) Enzyme-Linked Immunosorbent Assay (ELISA)
Quantification of Class Specific Immunoglobulins
Supernatant samples from (in vitro) immunoglobulin production
experiments, described later, were collected and stored at -40°C. The
total class specific immunoglobulins, IgG, IgA and IgM, were measured
using a one step microtitration plate ELISA technique.
Reagents
A carbonate-bicarbonate buffer (pH 9.6) consisting of 1.59g of Na2C02,
2.93g of NaHCO^ and 0.2g of NaNO^ made up to 1 litre with distilled
water, was used to sensitise the plates (387). This was made up, from





Class Source Dilution Batch No.
IgG Sheep (chain specific) 1/100 0368J
igA Sheep (chain specific) 1 / 8 0 0859J
IgM Sheep (chain specific) 1 / 20 5000L
Variation of Control Values




Coeff. Var. Diff. - Coefficient of Variation of Differences.
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The phosphate buffered saline-tween 20 mixture (PBS-tween) consisted
of 8g of NaCI, 0.2g of KF^PO^, 2.9g of Na2HPO^. 121^0, 0.2g of KCI and
0.5mls of tween-20 in 1 litre of distilled water. The pH of the
solution was 7.4.
The alkaline phosphatase conjugate p-nitrophenyl phosphate (Sigma 104
phosphate substrate tablets, 5mg, Sigma Chemical Company) was
dissolved in diethanolamine buffer prior to use. A ratio of one 5mg
tablet of p-nitrophenyl phosphate to 5mls of diethanolamine buffer at
room temperature was used throughout the ELISA tests.
Diethanolamine buffer consisted of 97mls diethanolamine (Fisons Pic,
Loughborough, England), 800mls of distilled water, 0.2g of sodium
azide and 100mg of MgC12• 6H20. A pH of 9.7 was obtained by adding
1M.HC1 and the solution was finally made up to 1 litre with distilled
water.
Methods
The class specific antibody was attached to the solid phase using a
concentration of 30mg/ml protein per 1ml of carbonate buffer. Class
specific goat anti-human IgG, IgA and IgM (Sigma Chemical Company)
were used to sensitise the appropriate plates.
Disposable polystyrene microtitration plates (Flow Laboratories lot
70921 1 and Northumbria Biologicals Ltd Product No. M420) consisting of
96 flat-bottomed wells were used as the solid phase. 150 microlitres
of prepared buffer were added to all the wells and the plates were
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left overnight at 4°C for sensitisation by passive absorption. The
plates were subsequently drained, washed three times with PBS-tween
and tapped dry. Volumes of 100 microlitres PBS-tween containing 1|
newborn calf serum (Flow Laboratories, Rickmansworth, U.K.)
were added to all wells. Subsequently the test supernatants and
reference samples were added in 50 microlitre volumes. The
supernatant samples were each diluted 1:3, 1:9, 1:27, 1:81. The
reference sera were used in dilution of 1 in 3000, 1 in 9000 and
further serial dilutions. The reference sera, SPS01, were obtained
from IViilford Ward, Royal Hallamshire Hospital, Sheffield, courtesy of
Edinburgh Regional Blood Transfusion Service. The concentrations of
IgG, IgA and IgM were 9.97g/1, 1.69g/1 and 1.1 Og/1 respectively. The
plates were incubated in a humidified atmosphere at room temperature
for 90 minutes. The plates were then drained, washed three times in
PBS-tween and tapped dry.
100 microlitres of goat anti-human IgG, IgA and IgM alkaline-
phosphatase conjugated antisera (Sigma Chemical Company) diluted
1 :1 000 with PBS-tween containing 1 % newborn calf serum were then added
to the appropriate plates. These were incubated for 90 minutes before
the plates were drained, washed three times and tapped dry.
One hundred microlitres of enzyme substrate p-nitrophenyl phosphate,
diluted in diethanolamine buffer was then added to the plate and
incubated at room temperature. The colour change, indicated by the
substrate degradation, is proportional to the antibody concentration
in the test samples. A Titertek Multiscan (Flow Laboratories,
Rickmansworth U.K.) was used to read the absorbance of yellow colour
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at a wavelength of 405mm. Readings were taken to obtain optimal
curves for the dilutions of test and reference samples.
The plate readings were directly transferred and stored on computer
5.25 inch magnetic minidisks (Verbatim Ltd, Limerick, Ireland) using a
BBC master computer. The plate readings were subsequently analysed
using a microtitre plate computer system (Flow Laboratories Ltd,
Rickmansworth and Silicon Lab Ltd, Birmingham) used on a BBC master
computer with a second processor. The programme enabled curves for
the test samples to be compared to the reference curves for each plate
read. The reference curves were run at columns 2 and 12 on the plate
and test samples were run in triplicate. The original concentration
of the sample could then be calculated.
c) Lymphocyte Transformation
One hundred and twenty millilitres of venous blood was removed from
patients and age, sex and tobacco habit matched controls. In the
clinic heparin was added at 20 units/ml venous blood (Sodium Heparin,
1 000 units/ml, Leo Laboratories Ltd, Risborough, England) and gently
mixed. In a unidirectional laminar flow hood (Envair Class II
microbiological safety cabinet. BS55726) 25ml volumes of the whole
venous blood diluted 1:1 with RMPI 1640 medium (Flow Laboratories,
Rickmansworth, U.K.) was layered onto 20ml volumes of ficoll-hypaque
lymphocyte separation medium (Flow Laboratories, Rickmansworth U.K.)
of specific gravity 1.077 in 50ml disposable polypropylene conical
tubes (Flow Laboratories, Rickmansworth, U.K.). The tubes were then
centrifuged at 20°C for 30 minutes at 400g. The mononuclear
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lymphocytes and monocytes were aspirated from the ficoll-hypaque-
plasma interface and washed twice for 10 minutes at 200g in RMPI 1640.
The viable leukocytes were counted in a Neubauer counting chamber
using 0.2% trypan blue exclusion. They were subsequently adjusted to
an appropriate working concentration for the experimental aliquots.
Sterile Microtitre culture plates with 96 flat bottomed wells (Flow
Laboratories, Rickmansworth, U.K.) were selected. Cultures of 2x10
leukocytes in a final volume of 0.2ml consisting of 10% foetal calf
serum, 100 units/ml of penicillin, 100 units/ml of streptomycin and
2mM. L-Glutamine in RMPI 1640 were dispensed. The cultures were
arranged in triplicate.
Mitogens were used to induce leukocyte proliferation at the following
concentrations: Phytohaemagglutin (PHA) (Flow Laboratories,
Rickmansworth, U.K.) was used at 5ug / ml. Pokeweed Mitogen (PWM) (Flow
Laboratories, Rickmansworth, U. K.) was used at 5ug/ml. Concanavalin A
(ConA) (Sigma Chemical Company) was used at 10ug/ml (383). Cultures
were incubated at 37°C in 100% humidity with 5% C02 for 72 hours.
Tritiated thymidine, H-TdR, (37MBq/ml 1mCi/ml, Amersham International
Pic, Buckinghamshire, England) was added at 0.5 irCi per well for the
last four hours of incubation.
The cultures were harvested using a semi automatic cell harvester
(Titertek Cell harvester, Flow Laboratories, Rickmansworth, U.K.) on
to glass fibre filter paper (Titertek, Flow Laboratories,
Rickmansworth, U.K.) following a standard sequence of hot, cold and
final rinse stages. The filter papers were air dried overnight and
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placed in individual 25ml glass vials containing 3mls of scintillation
fluid (Optiphase 'X', Fisons Pic, Scientific Equipment Division,
Loughborough, England). The Beta radioactivity was subsequently
counted in a liquid scintillation counter (Packard tricarb 300) for 60
seconds. The amount of H-TdR incorporated in the harvested cells was
expressed as net counts per minute (cpm). These values were
subsequently stored on the Edinburgh multi access system computer and
evaluated using SP5SX (385).
d) Macrophage Mediated Suppression
The macrophage is central to regulatory controls of immune reactions.
Lymphocyte proliferation (in vitro) can be suppressed by activated
macrophages by their production of oxygen radicals and prostaglandins
(389). The role of macrophage mediated suppression was examined in
oral keratosis patients and controls to determine whether macrophage
stimulation was significant in hyporesponsive proliferation of
leukocytes.
Microtiter leukocyte cultures were set up similar to that described
for lymphocyte transformation studies. Indomethacin at a final
concentration of 50ug/ml (Sigma Chemical Company, USA) and Vitamin E
at final concentration of 50ug/ml (Sigma Chemical Company, USA) were
added to each culture. The cultures, in triplicate, were harvested
after Thymidine labelling and counted as previously described. The
data similarly were stored on computer and analysed using the SPSSX
package on the University computer.
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e) T-Cell Mediated Suppression
The role of T-suppressor cells in lymphocyte function was also
investigated. Two aspects were investigated: a) (in vitro)
proliferation of T and non-T cells under mitogenic drive of
Phytohaemagglutinin, Pokeweed mitogen and Concanavalin-A,
b) (in vitro) production of immunoglobulin by plasma cells under the
influence of different ratios of T suppressor cells stimulated with
the polyclonal activator Pokeweed mitogen.
Methods Leukocytes harvested from the lymphocyte separation procedure
were allocated to the separation of T and B cells. T cells were
separated from non-T cells by rosetting them with sheep erythrocytes
(Tissue Culture Services, Slough, England) treated with 2-amino
ethylisothiouronium bromide hydrobromide (AET, Sigma Chemical
Company).
In preparation of the treated sheep erythrocytes, the fresh sheep
erythrocytes were washed four times in Hanks balanced salt solution
HBSS (Flow Laboratories, Rickmansworth, U.K.). The packed cell
volume was gently mixed with four volumes of 0.143M AET solution and
incubated in a water bath for 15 minutes at 37°C. The cells were then
washed four times with ice cold HBSS and finally once with HBSS
containing 20% foetal calf serum (FCS) (Flow Laboratories,
Rickmansworth, U.K.).
The treated sheep erythrocytes were then added to the allocated
mononuclear cells in a ratio of 150:1 to 200:1 and gently mixed. The
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erythrocytes were permitted to rosette with the T lymphocytes' during a
15 minute incubation at 37°C before centrifugation at 200g for 5
minutes at 4°C. The mixture was then left on ice for 60 to 120
minutes before resuspending the cells and layering on 20mls of ice
cold ficoll-hypaque (Flow Laboratories, Rickmansworth, U.K.) in 50ml
conical tubes, Centrifugation at 300g for 35 minutes at room
temperature provided an upper cell fraction and a pellet of sheep red
cell rosettes. The cell rosette fraction was resuspended and sheep
erythrocytes lysed by hypotonic shock by placing 9mls of sterile
distilled water in the test tube and which was then agitated. 1ml of
10N HBS5 (Flow Laboratories, Rickmansworth, U.K.) was immediately
delivered into the suspension and agitated again. The cell fractions
were twice washed in RMPI 1640 and finally with RMPI 1640 containing
20% FCS to remove cytophilic antibody from the B cell population.
A proportion of the harvest populations of T and non-T cells were
allocated to iymphocyte transformation and macrophage suppression
experiments. The cells were assessed for viability using trypan blue
0.2% and adjusted to a final concentration of 2 x 10 /ml. The
remainder of the separated T and non-T cell populations were used to
assess T cell suppression of B cell function.
f) T Cell Mediated Suppression of B Cell Function
An indirect method of assessing the immune effects of the immune
infiltrate seen in the lamina propria of oral keratoses, is to
evaluate the systemic relationship of these cell populations. It was
felt that the evaluation of T cell control of B cell function may
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provide insight into aetiological aspects of the disease on both a
systemic and a local level. Helper and suppressor cells regulate
immunoglobulin production, which is a B cell function. Normal
immunological events, such as overcoming infections, require a complex
interplay between helper and suppressor cells on B cell function.
In an attempt to examine immunoregulatory mechanisms in oral
keratoses, the T and non-T cells, separated as described above, were
utilised as follows. Cultures were set up in duplicate or triplicate
in 6ml round bottomed polyethylene tubes with loose caps (Flow
Laboratories, Rickmansworth, U.K.). In RMPI 1 640 medium supplemented
with penicillin and streptomycin, L-glutamine and 10% newborn calf
serum (NCS), the cells were apportioned in T:B ratios of 20:1 to 1:10
to a volume of 1.5mls at a final concentration of 1x10 /ml B cells
(390). In addition, single cultures of T cells and B cells were
performed to confirm adequate subset cell separation.
Mixed mononuclear cell preparations were also alliquoted to assess the
immunoglobulin production of the patient, control and lesional cells
obtained as described later. Pokeweed mitogen at 50ug/ml was added to
the co-cultures and the racks of cultures were incubated for twelve
days at 37°C in 100% humidity and 5% C02 (400). Infected samples were
removed during regular checks on the incubation. The cultures were
then centrifuged and supernatants collected and stored at -40°C until
analysis of class specific immunoglobulin concentrations using the
ELISA method detailed above.
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g) Extraction of Lesional Immunocytes
Fresh biopsy tissue removed at the time of venepuncture was used to
supply a source of lesional immunocytes. The lymphoproliferative
ability of these cells was investigated using the lymphocyte
transformation and suppressor cell assay techniques previously
described.
The tissue was weighed and then divided to provide histopathological
and frozen specimens with the remainder placed in a polystyrene Petri
dish (Flow Laboratories, Rickmansworth, U.K.). Using a sterile
technique in the lamina flow cabinet, the epithelium and deep fat were
removed from the remainder using a scalpel and tweezers. Medium
containing 20% NC5 was added and the tissue was diced to very fine
pieces (less than 1mm cubed). The mixture of fluid and tissue
remnants were transferred to a 50ml conical tube and made up to 50mls
with rinsings of the Petri dish. This was agitated over a period of
60 minutes and then left vertical to allow larger pieces of tissue to
sediment to the bottom of the tube. The supernatant was removed and
25mls layered on 20mls ficoll-hypaque lymphocyte separation medium.
Centrifugation at 200g for 30 minutes at room temperature provided a
layer of mononuclear cells at the medium, ficoll-hypaque interface.
This was carefully aspirated and the cells washed before being
assessed for viability using 0.2% trypan blue. The mononuclear cells
were identified morphologically and counted using a Neubauer counting
chamber.
It was only possible to extract lesional lymphocytes if the biopsy
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specimen was sufficiently large, so this investigation was restricted
to the larger clinical lesions.
h) Computer and Statistical Methods
The counts per minute of the lymphocyte transformation tests were
formatted for computerisation and transferred to the Edinburgh
University computer by the Data Preparation Service. This system
permitted assessment of data for the subgroups and the total test
population. Further data manipulations for net counts per minute
(cpm) and stimulation index were evaluated for this study.
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CHAPTER 5
LABORATORY METHODS 2 - HISTOPATHOLOGY
a) Initial Preparation of Pathological Tissue
Fresh biopsy specimens were transported from the clinic to the
laboratory in RMPI 1 640 (Flow Laboratories, Rickmansworth, U.K.)
containing 50ug/ml each of Penicillin and Streptomycin at room
temperature. On arrival within the hour, the tissue was examined and
divided according to experimental requirements. A part of the tissue
was always taken for histopathological diagnosis.
For the immunological experiments outlined in the previous section,
the tissue was divided to provide two additional pieces. The larger
piece was processed as previously described to yield lesional
immunocytes. The smaller piece was embedded in O.C.T. compound
(Tissue-Tek II, Mile Laboratories, Naperville, Illinois, USA) and
frozen on a rapid carbon dioxide delivery chuck. The embedded tissue
was stored in 5ml sealed glass vials at -40°C until sectioned on a
Slee cryostat (South London Electrical Equipment Co. Ltd.). The
dimensions and appearance of the biopsy specimen are dependent on the
clinical choice of biopsy site and subsequent surgical procedure.
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b) Histopathological Methods
The tissue allocated for diagnostic purposes was processed along with
routine specimens in the laboratory. The specimen was fixed in 10%
neutral buffered formalin for 24 hours, 5um thick paraffin embedded
sections prepared, and stained with haematoxylin and eosin. In
addition. Periodic Acid Schiff (PAS) was used routinely.
1) Haematoxylin and Eosin Staining
The following procedure was adopted:
1. Sections were dewaxed then dehydrated in graded alcohols and washed
in water
2. Placed in Meyer's haematoxylin for 3 minutes
3. Washed in water
4. Sections were then saturated in lithium carbonate until the
haematoxylin turned blue
5. Washed in water
6. Sections then stained in 1% eosin in 1% calcium chloride for 2
minutes
7. Washed in water
8. Dehydrated in graded alcohols and mounted with DPX.
2) Periodic Acid Schiff Staining (PAS)
1. Sections taken to water as in 1. above
2. Treated with 1% periodic acid for 5 minutes
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3. Washed in water
4. Stained with Schiff reagent for 10 minutes
5. Washed in water for 10 minutes
6. Counterstain with Meyer's haematoxylin for 30 to 60 seconds and
washed with water
7. Blued with lithium carbonate for 10 seconds
8. Washed with water
9. Dehydrated in graded alcohols and mounted in DPX.
c) Immunocytochemical Methods
Serial 5um thick frozen sections were cut on a Slee cryostat (South
London Electrical Equipment Co. Ltd.) and collected on poly L-Lysine
coated slides (Sigma Chemical Company, USA) (391). The sections were
air dried for 60 minutes at room temperature and stored at -40°C in
slide trays enclosed in sealed plastic bags to prevent further
dessication. The slides were uplifted to a 4°C freezer to enable
initial re-equilibration without excess condensation.
The slides were then further dried for 30 minutes before fixation in
acetone for 30 minutes (392).
Frozen reactive human lymph nodes were used as tissue controls for the
staining technique. These were stored at -40°C before serial 5um
cryostat sections were cut and collected on coated slides. The
procedure outlined above was also followed for the control sections.
Working titres for the monoclonal antibodies (Table 15) were
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determined using a range of monoclonal antibody dilutions from 1 :5 to
1:100 on trial mucosal specimens. The monoclonal antibodies were
stored in 25 microlitre volumes in sealed 5ml polyethylene tubes (Flow
Laboratories, Rickmansworth, U.K.) at -40°C until immediately before
use.
The imrnunoperoxidase technique was carried out as follows. The
sections, after dehydration and fixation with acetone, were flooded
with rabbit buffer consisting of normal rabbit serum (Scottish
Antibody Production Unit, Lanarkshire, Scotland) diluted 1:5 with Tris
buffered saline (TBS). The stock TBS formula used was as follows:
normal hydrochloric acid (HCI) was added to 500mls of 0.5M tris until
pH equalled 7.6. This was then made up to two litres with distilled
water and the pH checked. Prior to use the stock was diluted 1:10
with saline. The sections were incubated for 10 minutes in humidified
chambers before dabbing off the excess rabbit buffer.
The monoclonal antibodies (Table 15) were made up to their working
dilution with rabbit serum buffer and added to the appropriate
sections. The slides were incubated for 60 minutes, wiped carefully
and washed twice in TBS for 5 minutes.
Rabbit buffer was then pipetted onto the sections and incubated for 10
minutes. This was wiped off and horse radish peroxidase-conjugated
rabbit anti-mouse immunoglobulin (Dakopatts, Copenhagen, Denmark) was
added to the sections in a ratio of 1 :20 with rabbit buffer. This was
incubated at room temperature in humidified trays for 30 minutes. The
slides were then washed twice in TBS for 10 minutes after excess
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peroxidase conjugate was removed.
3,3' Diaminobenzidine Tetrahydrochloride (DAB) (Sigma Chemical
Company, St Louis, M.O. USA) was added at approximately Img/ml to TBS
containing 0.01M imidazole (Sigma Chemical Ltd.). Immediately prior
to flooding the sections, a drop of 1 % hydrogen peroxide (BDH
Chemicals Ltd., Poole, England) was added and mixed carefully.
The colour change to brown was observed and, after approximately 5
minutes, the sections were washed in water. Counterstaining of the
sections was found unsuitable for the analysis of leukocyte subsets on
the Micromagiscan (Joyce Loebl, Gateshead, England), (vide infra)
and was not used. The sections were routinely dehydrated in graded
alcohols, cleared and mounted for assessment.
For each set of slides, two control slides had the monoclonal antibody
omitted to ascertain cross reaction. In addition, for each set of
slides, sections of reactive lymph node were stained with monoclonal
antibodies, examined for distribution of T and B lymphocytes and to
confirm specificity for the appropriate monoclonal antibody
(349,393, 394). The T4 helper cells were identified predominantly in
the paracortical area while B cells were observed in germinal centres.
d) Image Analysis
The micro-magiscan (Joyce Loebl, Gateshead, England) permitted the
quantification of positive staining for the sections examined. The
procedure involved examination of the sections using a Nikon Optiphot
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microscope. This microscope was equipped with a video camera to which
adjustments were made" for focus and illumination to present a
satisfactory image on the computer screen. Following the instructions
specified for image analysis, the image was captured and adapted in a
systematic fashion for computer evaluation. A low power objective
lens (x10) was used to orientate the section. This was followed by
using the (x20) objective lens to achieve focus on the area being
measured. It was necessary to adjust illumination between each
section as the stained area would vary in intensity.
Once the image was seen clearly on the monitor screen, it was captured
and the area of detected stain was quantified by the computer. The
procedure was repeated for another two fields of that slide for the
specific phenotype being examined. The fields were chosen, after
initial examination of the section, by selecting three areas in the
lamina propria and the epithelium which were representative of the
study area as a whole. The total detected area for each of these
fields examined were recorded and a mean value obtained for each
section. The computer calculation of area was therefore used in each
case thereby maintaining identicle parameters for the analysis. This
system was repeated for all the stained sections for antibodies T1,
T4, T8 and B1. In addition the infiltration into the epithelium by T8
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A total of 159 patients were included in the study of oral keratoses.
The patients were assigned an identity number ranging from 1 to 159
which will be used to discuss and examine aspects of the study.
Patients were seen prospectively and included in the study group
during the three year clinical study which was carried out in the Oral
Medicine clinic in Edinburgh Dental Hospital between 1984 and 1987.
EPIDEMIOLOGICAL FEATURES
a) Diagnostic Categories
The patients were allocated to diagnostic categories (table 16) on
the basis of clinical and histopathological criteria. The criteria
for the diagnostic categories have been stated in Chapter 2, and are
reported in two forms; a numerical code used in the computer analysis
and a notational abreviation for the diagnosis (Tables 16,18,19).
The division of the patients into the two categories; Infiltrated
Keratoses (IK) and Non Infiltrated Keratoses( Nl K) is illustrated in
Tables 16 and 17. Idiopathic keratosis is further divided into three
categories (Table 17) based on the presence or absence of an
inflammatory infiltrate associated with the keratosis. The group 12,
or Intermediate Infiltrated Keratosis (INT), is included in the IK
category as these patients show variable and diffuse infiltrates of
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immunocytes in the keratotic lesions during the course of the study.
The squamous cell carcinoma category was divided into three groups.
The code of 09 refers to patients with squamous cell carcinoma that
was seen to arise de novo. The codes 19 and 29 refer to those
patients who developed carcinoma in association with lichen planus and
leukoplakia respectively (Table 19).
b) Age
The ages of the patients ranged from 15 to 81 years with a mean age of
54 years. The ages of the male patients ranged from 15 to 80 years
(mean 52.2 years). The ages of female patients ranged from 17 to 81
years (mean 55.8 years). The ages of the patients in each diagnostic
category are displayed in decades (Table 20). The fifth and sixth
decades contain the greatest proportion of patients. The mean ages of
patients in the diagnostic groups are illustrated in Table 21. All
groups have a mean age in the sixth decade except for 5CC with a mean
age in the seventh decade, and both HK and the CL categories have a
mean age in the third decade.
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Table 16
Diagnostic Categories for 159 Oral Keratosis Patients
Diagnostic Category Abreviation Computer
Lichen planus LP 01
Idiopathic keratosis IK 02 12 22*
Discoid lupus erythematosus DLE 06
Candidal leukoplakia CL 07
Squamous cell carcinoma see 09 19 29*
Frictional, smoking keratosis FSK 04
Hereditary keratosis HK 08
* These codes qualify the category of patients within each respective
















Diagnostic Categories among 159 Patients with Oral Keratoses
Infiltrated Keratoses Abrev. Code No.
Lichen planus LP 01 59
Int. Infiltrated leukoplakia* INT 12 9
Infiltrated leukoplakia* ILK 22 26
Discoid lupus erythematosus DLE 06 4
Candidal leukoplakia CL 07 3
Squamous cell carcinoma* see 09 1
Squamous cell carcinoma* sec 19 3
Squamous cell carcinoma* sec 29 2
Subtotal 107
Non Infiltrated Keratoses
Frictional, smoking keratosis FSK 04 24
Non Infiltrated leukoplakia* NILK 02 26
Hereditary keratosis HK 08 2
Subtotal 52
Total 159
* See Table 19.
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Table 19
Subgroups and Computer Codes for Idiopathic Keratosis







Assoc. with lichen planus











Age Distribution of 159 Oral Keratosis Patients
AGE* <20 20+ 30+ 40+ 50+ 60+ 70+ 80+ Total
IK
LP 5 7 12 15 15 3 2 59
INT 4 4 19
ILK 123974 26
DLE 1 21 4
CL 1 1 1 3
SCC 24 6
Subtotal 1 7 9 17 30 32 8 3 107
NIK
NILK 2 7 3 8 6 26
FSK 21325443 24
HK 2 2
Subtotal 2 3 5 9 81210 3 54
Total 3 10 14 26 38 44 18 6 159
* Age in decades (1987)
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Table 21
Mean Ages for the Diagnostic Categories
Diagnostic Category Mean Age Yrs. SD* No
LP 51.9 13.7 58
INT 57.8 5.1 8
ILK 56.7 12.6 26
DLE 59.5 13.2 4
CL 29.0 14.9 3
see 63.2 5.3 6
NILK 57.9 13.5 26
FSK 52.5 20.2 22




The mean height for males and females was 173.2cms and 161.5cms
respectively (Table 22). The FSK category which had 17 males and
seven females, was significantly taller than the LP, ILK, NILK and SCC
categories (p<0.05).
d) Weight
Patient weights illustrate no significant differences between
diagnostic categories (Table 23).
e) Sex
The male to female patient ratio was almost 1:1 with 82 male and 77
female patients. The distribution of male and female patients by age
bands is recorded in Table 24. The number of male and female patients
in each diagnostic category is displayed in Table 25. There are a
higher number of female patients (34) with lichen planus than male
patients (25). There are 16 male patients and 10 female patients in
the ILK category. The NILK category contains 14 female and 12 male
patients. The FSK category however contains a predominance of males
(17) compared to females (7).
f) Race
Of the 159 patients with oral keratoses, 153 were North European
Caucasians, four were Asian and two were African negros.
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Table 22
Patient Heights for the Diagnostic Categories





































Distribution of Male and Female Patients by Age
Age Male Female Total
<20 2* 1 3
20+ 6 4 10
30+ 7 7 14
40+ 18 8 26
50+ 19 19 38
60+ 21 23 44
70+ 6 12 18
80 + 3 3 6
Total 82 77 159
* Number of patients.
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Table 25
Distribution of Male and Female Patients
According to Diagnostic Category
Diagnostic Category Male Female Total
LP 25* 34 59
INT 5 4 9
ILK 16 10 26
DLE 1 3 4
CL 2 1 3
see 3 3 6
Subtotal 52 55 107
NILK 12 14 26
FSK 17 7 24
HK 1 1 2
Subtotal 30 22 52
Total 82 77 159
* Number of patients.
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g) Clinical Lesional Appearance and Site
During the three year period of the study it was recognised that the
oral lesions may both arise and disappear. It was therefore useful in
recording the topographical involvement of oral keratoses, to attempt
to register all sites presenting or arising during the study in a
cumulative fashion. The purpose of recording the clinical appearance
of the keratoses was to evaluate the range of presenting features for
all patients in the study.
1. Oral and Systemic Involvement The keratotic involvement of oral,
skin and genital sites was recorded and the data are illustrated in
Table 26. Skin involvement was found in 15 of 41 patients with lichen
planus. In the INT category, four of the nine patients had
dermatological disease. Involvement of the genital mucosa was
reported by three patients in the LP category and by one in the CL and
NILK categories respectively. The patient with genital mucosa
involvement in the CL category had candidal endocrinopathy syndrome
and the limited involvement of the nail cuticles was not recorded as
dermatological disease.
2. Oral Involvement The distribution of the oral keratoses recorded
clinically and photographically was crosstabulated with the diagnostic
categories. The Tables 27(i) to 27(xvi) show the range of clinical
appearances affecting various oral sites in patients with different
diagnoses. The clinical appearances of the lesions were coded and are
displayed in Table 27.
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The clinical appearance of reticular lichen planus was seen in the
diagnostic categories INT, ILK, DLE, NILK and FSK as well as in LP.
This feature occurs frequently on the buccal mucosae, sulci and the
third molar regions. Furthermore an atrophic appearance of lichen
planus was also seen in ILK and DLE for the lower buccal sulcus,
buccal mucosa and the third molar region. An appearance of erosive
lichen planus occurred frequently on the buccal surface for the LP and
ILK categories. Plaque lichen planus, while occurring infrequently
for the LP category on buccal sites, was a common presentation on the
dorsum of the tongue (10 cases). Furthermore the appearance of plaque
lichen planus occurred also in the INT and ILK categories for the
buccal surface and lower buccal sulcus. It was also interesting to
note plaque lichen planus on the lateral border of the tongue for the
LP category. In only one case was bullous lichen planus observed and
this occurred in the lower buccal sulcus for the patient in the LP
category.
The clinical appearance of leukoplakia in homogeneous forms occurred
in the lower buccal sulcus and the buccal surface only for the NILK
category. Moreover plaque leukoplakia affected the lower buccal
sulcus, buccal surface and third molar regions more frequently for the
ILK and INT categories than the NILK category (5:1 cases
respectively). Homogeneous leukoplakia occurred infrequently on the
floor of mouth and ventral surface of tongue sites for ILK (4 and 2
cases) but frequently for the NILK category (9 and 10 cases).
Speckled and nodular leukoplakia occurred infrequently but, when
presenting, appeared on the buccal surface for the ILK and INT
categories (2 cases). The upper alveolar ridge was a further site
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affected with a speckled leukoplakia for ILK (1 case). The dorsum,
lateral border and ventral surface of tongue was affected with a
plaque leukoplakia in the LP, NILK and INT categories, but not the ILK
category. The occurrence of speckled or nodular leukoplakia was not
seen on the tongue and floor of mouth (0 cases). Frictional and
smoking keratoses were common on the buccal mucosa (12 cases) for the
FSK category. The alveolar ridges also were affected with both
frictional and smoking keratoses (9 cases).
Squamous cell carcinoma associated with lichen planus as assessed
clinically and histopathologically was recorded in four instances in
the following regions: lower alveolar ridge, gingivae, lateral border
of tongue and the floor of mouth. One patient (no. 116) displayed
involvement in the first two sites described. Two sites with
carcinoma associated with leukoplakia were recorded: buccal surface
and the lateral border of the tongue. The occurrence of de novo
squamous cell carcinoma was on the lateral border of the tongue. It
was interesting to note the clinical presentation of reticular lichen
planus on buccal and lingual mucosa within a year of the excision of
the neoplasia. The lateral border of the tongue was an oral site
common to all three categories of squamous cell carcinoma, endorsing
this site as a high risk region of oral mucosa (82,83). Leukoplakia
occurs most commonly on the ventral surface of tongue (14 cases) and
the floor of mouth (13 cases). Lichen planus most frequently affects
the buccal mucosa in the third molar region (43 cases). The other
buccal sites also constituted a significant involvement of lichen
planus with 38, 34 and 20 cases occurring on the buccal surface, lower
and upper buccal sulci respectively.
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3. Previous Involvement 44 (29.91) patients presented with a previous
history of oral keratosis of which the involvement ranged from one to
thirty one years. In two patients this information was not available.
The remaining patients reported no previous involvement prior to the
detection and referral of the abnormality by the General Dental or
Medical Practitioner.
4. Size of Lesions The area of oral mucosa involved by keratoses was
evaluated subjectively. Lesions ranged in size from a few millimetres
to areas greater than an estimated 10 square centimetres. Furthermore
in one patient (no. 121) disseminated squamous cell carcinoma was
present on examination, however the oral lesion was estimated to
involve eight square centimetres of oral mucosa including the
ulceration. It was appreciated that the size of the keratotic lesions
could vary during the course of the study and these estimates of area
were taken during the initial examination. The range of lesional area
involvement of mucosa is illustrated in Table 28. The greatest
proportion of patients had lesional involvement greater than one
square centimetre but iess than or equal to four square centimetres.




Oral, Skin and Genital Involvement for 159 Patients
with Oral Keratoses
Only Oral+ Oral+
Diagnostic Category Oral Skin Cenital Total
LP hi* 15 3 59
INT 5 4 9
ILK 25 1 26
DLE 3 1 4
CL 2 1 3
see 5 1 6
Subtotal 31 22 4 107
NILK 24 1 1 26
FSK 24 24
HK 1 1 2
Subtotal 49 2 1 52
Total 130 4 5 159
* Number of patients.
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Table 27
Clinical Appearances of Lesions and Respective Codes
Code Appearance












29 Squamous cell carcinoma





Other Diseases 72 Candidal leukoplakia
81 White sponge naevus
82 Squamous cell papilloma
86 Candidosis
89 Graft
09 Squamous cell carcinoma (De Novo)
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Table 27(i)
Lesional Involvement: Site Vermilion Border
Clinical Diagnostic Category




* See Table 27.
















* See Table 27.
** Number of patients.
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Table 27(iii)
Lesional Involvement: Site Upper Buccal Sulcus
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK








* See Table 27.
** Number of patients.
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Table 27(iv)
Lesional Involvement: Site Lower Buccal Sulcus
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK
11 34** 571 141
12 5 2 1











* See Table 27.
** Number of patients.
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Table 27(v)
Lesional Involvement: Site Buccal Surface
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK
11 33** 6 13 1 14
12 9 11
13 6 1 1











* See Table 27.
** Number of patients.
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Table 27(vi)
Lesional Involvement: Site Buccal Mucosa (3rd Molar Region)
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK
11 43** 4 11 1 13











* See Table 27.
** Number of patients
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Table 27(vii)
Lesional Involvement: Site Palatal Mucosa
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK
11 3**
21 1 2 1
25 1
41 1 1 1 1
42 1
89 1
* See Table 27.
** Number of patients.
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Table 27(viii)
Lesional Involvement: Site Upper Alveolar Ridge
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK






* See Table 27.
** Number of patients.
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Table 27(ix)
Lesional Involvement: Site Lower Alveolar Ridge
Clinical Diagnostic Category








* See Table 27.
** Numbers of patients.
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Table 27(x)
Lesional Involvement: Site Retromolar Region
Clinical Diagnostic Category







42 1 1 2
62 1
81 1
* See Table 27.
** Number of patients.
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Table 2 7(xi)
Lesional Involvement: Site Gingivae
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK









* See Table 27.
** Number of patients.
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Table 27(xii)
Lesional Involvement: Site Dorsum of Tongue
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK
11 6** 1 4 1 12
12 3








* See Table 27.




Involvement: Site Lateral Border of Tongue
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK HK













* See Table 27.
** Number of patients.
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Table 27(xiv)
Lesional Involvement: Site Ventral Surface of Tongue
Clinical Diagnostic Category
Appearance* LP INT ILK DLE CL SCC NILK FSK








* See Table 27.
** Number of patients.
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Table 27(xv)
Lesional Involvement: Site Floor of Mouth
Clinical Diagnostic







* See Table 27.
** Number of patients.
Category






Lesional Involvement: Site Pharynx and Fauces
Clinical Diagnostic Category




* See Table 27.
** Number of patients.
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Table 28
Estimated Areas of Keratotic Involvement of Oral Mucosa
Code 123-
No. of Patients 25 67 58 9
Code 1. Lesional involvement equal to or less than one square
centimetre.
2. Lesional involvement greater than one square centimetre
but equal to or less than four square centimetres.
3. Lesional involvement greater than four square
centimetres.
No size recording made.
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h) Concurrent Oral Disease Concurrent oral disease identified during
the clinical examination was recorded (Table 29). It was noted that
recurrent oral ulceration was not seen to affect patients attending
with oral keratoses. Pigmentation was detected in association with
lichen planus in three patients.
i) Concurrent Drug Treatment Medications taken by the 159 patients
with oral keratosis were crosstabulated with the diagnostic
categories and were cumulated with the following groups of drugs.
1. Non steroidal anti-inflammatory drugs (NSAID)
2. Anti-hypertensive drugs
3. Oral hypoglycaemic drugs
4. Psychotropic drugs
5. Other medications.
It was considered useful to adopt this system of drug categorisation
which relates to previous reports and so facilitating comparison of
the data (395). Tables 30-32 illustrate the numbers of patients in
each diagnostic category taking the specified drug or medication. In
Table 32, the lichen planus category was divided in those without
erosion (LP) and those with erosion (ELP).
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Table 29
















Drug History for 159 Patients with Oral Keratoses
Taking* NSAID* A-H* O-H * Psych* Other* Total
IKP Patients
LP 33** 6 10 6 22 49
INT 8 2 2 1 2 5 9
ILK 15 6 2 4 9 26
CL 2 - - - - 3
DLE 3 2 1 1 - 1 4
see 4 1 - - 3 6
Subtotal 65 17 15 2 12 38 107
NIK
NILK 18 5 4 1 1 9 26
FSK 12 2 3 3 8 24
HK - - - - - 2
Subtotal 30 7 7 1 4 17 52
TOTAL 95 24 22 3 16 55 159
* Taking- Total Number of Patients on one or more
Medications
NSAID - Non Steroid Anti-inflammatory Drugs
A-H - Anti-hypertensive Medication
O-H - Oral Hypoglycaemic Medication
Psych - Psychotropic Medication
Other - Other Medications




Taking* NSAID* A -H* O-H* Psych * Other*
IK
LP 67 12 20 12 45
INT 89 22 22 11 22 56
ILK 58 23 8 15 35
CL 66 - - - -
DLE 75 50 25 25 - 25
see 67 17 - - 50
Subtotal 61 16 14 2 11 36
NIK
NILK 69 19 15 4 11 35
FSK 50 8 13 13 33
HK - - - - -
Subtotal 58 13 13 2 8 33
TOTAL 60 15 14 2 10 35
* See Table 30
Note : Some patients were taking more than one
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Similar percentages for the IK and NIK groups were seen for the six
categories of medication. In the IK group, LP had a lower percentage
of patients (67%) than the INT (891), DLE (75%), SCC (67%) and NILK
(69%) categories. The LP category also had fewer numbers taking NSAID
(12%). This was exceeded by INT (22%), I LK (2 3%), DLE (50%), SCC (17%)
and NILK (19%) categories. 15% of all patients with oral keratoses
were taking NSAID. Similarly 14% of these patients were on
hypotensive medication. A higher percentage (11%) of IK patients were
taking psychotropic drugs than NIK (8%) patients. The INT category
had 22% of patients taking psychotropic medication and the ILK (15%)
and FSK (13%) categories exceeded the percentage of lichen planus
(12%) patients on this form of medication.
The "other" medications category included those that did not qualify
for inclusion in the specific categories. Recent history of short
term antibiotic therapy was excluded from this, however long term use,
in one case was included. This patient (no. 146) was in the NILK
category. "Other" medications were taken in high proportions in most
categories. The INT category was the highest (56%) with the SCC and
LP categories showing 50% and 41% respectively. The ILK and NILK
categories had equal percentages of patients using "other" medications
(35%).
17 patients in the LP category had erosive lichen planus (ELP). This
included three patients who had desquamative gingivitis in addition to
lichen planus affecting the buccal mucosa. Table 32 illustrates the




Drug Use in Erosive Lichen Planus
Taking NSAID A-H O-H Psych Other Total
Patients
ELP 10* 5 4 0 1 5 17
% 58 29 24 0 6 24 -
LP 23* 1 6 0 5 16 32
% 71 3 19 0 16 50 -
* Number of Patients.
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Fewer patients with ELP (58%) were taking medication compared to LP
(71%). A greater proportion of those with ELP were taking NSAID (29%)
compared to LP (3%) and a higher percentage (50%) in the LP category
were taking other medications than the ELP category (24%).
Desquamative gingivitis was seen in 17.6% of patients with ELP. This
compares closely to values reported by Potts et al 1987 (395).
Patients nos. 81 and 137 were taking insulin for the control of
diabetes mellitus. They were from the diagnostic categories INT and
LP respectively. Patient no. 81 was taking oral hypoglycaemic
medication (chlorpropamide) in addition to the insulin. Furthermore,
two patients (nos. 23 and 63) from diagnostic categories DLE and NILK
respectively were taking oral hypoglycaemic medication. Apart from
these four patients, no further patients were identified as having
diabetes mellitus.
j) Erosive Oral Keratoses Erosion or ulceration was not restricted to
erosive lichen planus. In addition to the 17 patients presenting with
ELP, patients from the ILK, INT, DLE, SCC and NILK categories showed
oral erosive lesions (Table 35). 50% of DLE had erosion with LP 35%
and INT 22%. There was a similar percentage of patients with erosion
in the ILK and NILK categories (15%). The IK group contained 28% of
patients with erosions and the NIK group 8%. Within the study































k) Malignant Change Six patients with oral malignancy contributed to
the study. Of these patients, four were seen with neoplasia and two
developed neoplasia just prior to the commencement of the study in
1985.
Patient no. 109, female aged 60 years, presented with squamous cell
carcinoma of the lateral border of the tongue. This was excised and
follow up arranged. Within six months of the excision, histologically
proven lichen planus was noted to involve the lateral aspects of the
tongue and both left and right buccal mucosae. There was no
recurrence during the remaining study period.
Patient no. 121, male aged 70 years, was seen as an inpatient in the
Royal Infirmary, Edinburgh. The primary squamous cell carcinoma
involved the left lateral border of tongue and the floor of mouth.
Metastases were suspected and the tissues were investigated
immunologically after radical neck excision. The clinical notes
detailed heavy alcohol and tobacco use along with previous oral
involvement with leukoplakia. The patient did not survive more than
six months after the initial excision.
Patient no. 11, male aged 70 years, had oral leukoplakia involving
left and right buccal mucosa. Histopathology initially indicated an
infiltrated keratosis (IK) and he was categorised as ILK. Moderate
dysplasia was a feature of the initial biopsy. Erosive and
hyperkeratotic areas of the buccal mucosa were persistent clinical
features but erythroplakia was not considered to be present.
Subsequent biopsy of an ulcerated region of the right buccal mucosa
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showed severe dysplasia and monthly review continued (Figure 14) . A
hyperkeratotic lesion involving the right wrist was also biopsied by
the dermatopathologist reported as consistent with lichen planus.
Outwith the department, systemic prednisolone was prescribed for the
patient's oral discomfort. Within six weeks of the second biopsy, an
exophytic squamous cell carcinoma of the right buccal mucosa (3cm x
2cm x 1cm) was excised (Figure 15). Node metastases occurred within
six months and the patient did not survive a year following removal of
the primary carcinoma.
Patient no. 13, female aged 58 years, initially presented with erosive
lichen planus involving the floor of mouth, lower alveolar ridge and
lateral borders of the tongue before the present study was carried
out. A squamous cell carcinoma of the floor of mouth had then
developed and subsequent biopsies revealed lichen planus with mild
dysplasia. The oral mucosa was seen to improve moderately following
the removal of the squamous cell carcinoma. When reviewed as part of
the present study the oral lichen planus continued but there had been
no recurrence of the carcinoma after five years.
Patient no. 68, female aged 58 years, had atrophic lichen planus
involving the left and right buccal mucosae. This tissue became
erosive on occasions and allergy to a chrome cobalt denture, as
assessed by a patch test, considered to be a further complication.
Just prior to the present study squamous cell carcinoma had been
removed from the lateral border of the tongue. Following placement of
a non allergenic type metal partial denture, the lingual and buccal
mucosa was seen to improve markedly. No further complications were
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seen during the remainder of the study period.
Patient no. 116, male aged 63 years, presented with an exophytic
gingival lesion involving the mandibular left canine and premolar
tissues. A similar lesion had previously been removed surgically a
year prior to this study, the histopathology of which showed
pseudoepitheliomatous hyperplasia with areas of deeper infiltrate of
lymphocytes which suggested lichen planus or discoid lupus
erythematosus. When the lesion recurred it was surgically removed,
together with adjacent teeth. The histological appearance was that of
a well differentiated squamous cell carcinoma.
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FIGURE 14. Infiltrated Leukoplakia
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I) Remission During the study there were spontaneous or
therapeutically related remissions of keratoses. This was a
subjective assessment of the benefit of clinical management of these
patients and cannot be positively related to medication or other
treatments used during the study period. Therapeutic measures used in
the treatment of these keratoses were altered when initial regimes
appeared ineffective in controlling the oral keratosis. Surgical
measures were also used to reduce keratoses and routine biopsies
played a significant part in the removal of keratotic mucosa. The
medications used in the treatment of oral lichen planus are recorded
in table 34.
m) Mortality Figures Consistent with the study of this elderly patient
population fatalities were recorded. One patient (no. 11) with
leukoplakia (ILK) and two patients (nos. 13,68) with lichen planus died
with squamous cell carcinoma. Five patients died due to unrelated
causes including gastric carcinoma and hepatic failure. These details
are recorded in Table 35.
n) Oral Symptoms These were recorded and ranged from no symptoms to
tingling sensations with or without spicy or acidic food or a burning
mouth. Seventy eight patients complained of one or more of these
symptoms representing 49% of the study population.
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Table 34
Steroid Medications used in Treatment



















Patient ID Cause of Death Age Diagnostic Category
11 Oral SCC 70 SCC
121 Oral SCC 70 SCC
31 Gastric carcinoma 54 NILK
36 Unknown 68 NILK
57 Unknown 53 LP
61 HIV infection 32 NILK
64 Hepatic failure 67 LP
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o) Treatment This was indicated in 106 patients and included the
adjustment or renewal of any inadequate dental prosthesis, habit
advice, medication or surgical intervention. It was noted that the
steroid treatments were varied during the course of the disease thus
preventing the tabulation of the response to a particular therapy.
Furthermore patients differed in responses to such treatments and in
certain cases medication was refused as the patient was prepared to
tolerate the oral discomfort.
p) Oral Restorations and Prostheses Oral examination included the
inspection of teeth and dental prostheses. In light of reported
amalgam allergy and electrogalvanic potentials in certain instances
(19,24,27, 1 89-196), a note as to whether amalagam restorations were
present was made. Edentulous patients may have had amalgam
restorations in the past but this was not investigated and it remains
unclear as to whether such a previous history would have any bearing
on the disease observed in the present study. The presence of full
dentures was recorded and, of these, seven patients had only a full
upper set. A further two patients had full upper sets with partial
lower dentures. Altogether acrylic dentures were recorded in 45
patients. Two edentulous patients (nos. 59, 155) did not have dentures
or wish dentures.
Amalgam restorations were present in 104 patients and the remaining 10
patients were dentate and amalgam free. These data will be further
examined when patch tests to dental materials are reported. Cold
restorations in the form of crowns or bridges were noted in 11
patients. Amalgam restorations adjacent and relating to sites of oral
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mucosal keratosis were noted in eight patients. While these data are
contributory to the clinical details it is unclear whether the
restorations have been influential in the oral disease detected.
Furthermore a distinctive keratosis was recorded in patient no. 131 on
the left lateral and ventral surface of her tongue in the region
adjacent to two dissimilar gold crowns. A galvanic phenomenon was
suspected and ceramic porcelain crowns were made to replace the two
gold crowns (Figures 16 and 17). Following the replacement of the
crowns there was no clinical change in the tongue lesion after one
year and this was reduced surgically as it was seen to be spreading
anteriorly along the lateral and ventral surface of the tongue. A
further case with patient no. 152 suggested a galvanic phenomena where
a chrome cobalt partial denture was in contact with an amalgam
restored left third molar. The adjacent mucosa improved however,
following biopsy in which the affected mucosa was removed under local
anaesthetic.
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FIGURE 16. Lingual Lichen Planus.
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q) Evaluation of Stress Induced Anxiety . Speilberger's State-Trait
Anxiety Inventory (STAI) was administered to 126 oral keratosis
patients (67 male and 59 female) and compared to data using the same
test on recurrent oral aphthous stomatitis patients (52 male and 37
female) at onset of new ulcers (384). Of those patients with oral
keratosis, 37 (15 males and 22 females) had lichen planus and 89 (52
males and 37 females) had other oral keratoses. The results are
presented in Table 36. There was no significant difference between
the scores for patients with lichen planus,with other forms of oral




Trait and State Anxiety Scores
Diagnostic Category Number A-Trait# A-State#
LP 37* 37.9 + 13.4 41.8 + 9.3
OK 89 36.3 + 12.2 41.8 + 1 1 .5
CMS - 41 .9 + 12.7 42.4 + 13.8
RAS 89 38.5 + 10.0 43.6 + 13.4
* Number of Patients
LP - Lichen Planus.
OK - Oral Keratoses (excluding lichen planus).
GMS - General Medical and Surgical Patients (382,383).
RAS - Recurrent Aphthous Stomatitis Patients.
# Mean score + standard deviation
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r) Cellobiose/Mannitol Sugar Permeability Test Sugar permeability was
evaluated in 27 patients with oral keratoses and 31 patients with
recurrent aphthous stomatitis (RAS). The RAS patients provided a
comparison population for the oral keratoses (OK). The OK included 17
patients with lichen planus, 5 patients with infiltrated leukoplakia
(ILK) and 2 with non infiltrated leukoplakia (NILK). There were also
2 patients with frictional or smoking keratoses (FSK) and one patient
with squamous cell carcinoma (5CC). These details are summarised in
Table 37.
Abnormality was accepted when the cellobiose/mannitol (c/m) ratio was
greater than 0.037 and this accounts for the presentation of the data.
As illustrated in Table 38, a high proportion of the LP and ILK
categories, 65.0% and 60% respectively, have abnormal sugar
absorption. Abnormality does not appear to be a feature of the SCC,
NILK or FSK categories, with none detected as being abnormal. The RAS
group showed 51.9% abnormality. Comparison of the infiltrated and non
infiltrated keratoses revealed obvious differences with 64% of
patients in the LP and ILK categories being abnormal in sugar
absorption and none of the patients in the non-infiltrated keratoses
being abnormal. This would suggest that the infiltrated keratoses
have abnormal gut permeability and this may be contributory to the
oral disease. In almost half of those patients with RAS, abnormality
of sugar permeability is also a feature.
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Table 37












Sugar Permeability Ratios for Oral Keratoses
and Recurrent Oral Aphthous Stomatitis
Category No Ratio % Abnormal
\K_ LP 11 > 0.037 65.0
6 < 0.037
ILK 3 > 0.037 60.0
2 < 0.037
SCC 1 < 0.037 0.0
NIK NILK 2 < 0.037 0.0
FSK 2 < 0.037 0.0
OJ< (IK+NIK) 14 > 0.037 51 .9
13 < 0.037
RAS 15 > 0.037 48.3
16 < 0.037
OK = Oral keratosis patients
RAS = Recurrent Aphthous Stomatitis Patients
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HAEMATOLOGICAL AND BIOCHEMICAL EVALUATION
Mean values for haemoglobin, mean cell volume, white cell count and
erythrocyte sedimentation rates are given in Table 39, and total iron
binding capacity, serum iron, serum folate, serum Vitamin B12 and a
random serum glucose evaluation are given in Table 40.
a) Haemoglobin Four patients (nos.32,33,51,149) had low haemoglobin
levels consistent with anaemia. The aetiology of the iron deficiency
anaemia was menorrhagia and/or dietary inadequacy. The respective
haemoglobin values were 11.9, 6.8, 10.1 and 8.1 g/1. Three of the
patients were female (nos. 32, 33, 149) and showed classical iron
deficiency anaemia with reduced iron levels. Patient no. 32 had only
a reduced haemoglobin; patient no. 33 also had a MCV of 57 fl. and a
microcytic film and patient no. 149 had a MCV of 71 fl. and also
displayed rnicrocytosis. All three women responded to replacement
therapy without detectable effect on their oral condition.
The ILK category had a mean haemoglobin of 15.1 g/1 compared to the
lichen planus category of 14.4g/1 (p<0.066). Patient no. 51, who
suffered from candidal endocrinopathy syndrome, also suffered from
coeliac disease and pernicous anaemia. Despite parenteral Vitamin B12
supplements his haemoglobin remained at 10.1 g/l.
b) Mean Cell Volume Sixty five (40.9%) patients with oral keratoses
showed a raised MCV when compared to normal values for males and
females (Table 41). Two patients (nos.10,153) had macrocytosis
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associated with deficiencies of folate and Vitamin B12 respectively.
Patient no. 66 had a raised MCV of 99 fl. despite iron deficiency. No
pathological causes were established for this raised level. Patient
nos. 33 and 149 showed reduced MCVs of 57 fl. and 71 fl. respectively.
This was consistent with their reduced haemoglobin and anaemia
previously reported. The highest MCV recorded was 111 fl. for patient
no. 155 in the NILK category. High alcohol consumption was recognised
as a contributory factor for this patient.
Significant differences between the diagnostic categories were seen
using Student's T-test. The LP category showed a significantly lower
MCV value than the ILK, NILK, INT and SCC categories (p<0.006) . The
ILK, NILK and INT categories showed significantly higher values than




Mean Haematological Values in Oral Keratoses
IK
Diagnostic Category Hb* MCV** WBC# ESR##
LP 14.4 89.3 6.4 13.0
INT 14.9 92.3 5.7 12.0
ILK 15.1 92.8 6.9 12.0
DLE 13.3 93.5 6.8 27.3
CL 13.0 89.7 7.1 5.0
see 14.7 95.3 5.9 22.7
Subtotal 14.5 90.9 6.5 13.7
NILK 14.7 94.6 6.7 12.4
FSK 14.5 87.9 6.6 14.1
HK 14.3 90.0 6.2 2.0
Subtotal 14.6 91.4 6.6 12.6
TOTAL 14.6 91.1 6.5 13.4
* Haemoglobin (g/l)
** Mean Cell Volume (fl.)
# White Blood Cell Count (xlOOO/ml)
## Erythrocyte Sedimentation Rate (mm/hour)
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Table 40
Mean Biochemical Values in Oral Keratoses
T1BC* Iron Folate B12* * Glucose
LP 63.7 19.5 9.2 503 0.48
INT 59.0 23.8 7.0 382 0.48
ILK 56.2 20.5 7.0 514 0.46
DLE 58.3 19.0 7.4 474 0.56
CL 75.0 38.0 4.7 368 0.46
SCC 63.2 19.8 6.7 499 0.53
Subtotal 61.2 20.4 8.2 492 0.48
K
NILK 60.7 19.5 7.9 380 0.50
FSK 63.5 16.9 8.1 458 0.50
HK 66.5 25.5 7. 1 389 0.48
Subtotal 62.1 18.7 8.0 411 0.49
TOTAL 61.5 19.8 8.1 468 0.48








































* Mean Cell Volume (fl.)
** Number of patients.
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c) Erythrocyte Sedimentation Rate The erythrocyte sedimentation rate
in the first hour was recorded for patients on initial examination.
The mean value for the diagnostic categories ranged from 2mm/hour for
the HK category to 27.3mm/hour for the DLE category. These mean
values for the diagnostic categories are reported in Table 42.
Male and female patients with values greater than 10 and 15mm/hour
respectively were considered to be abnormal and are detailed in Table
42. Female patients within the LP category showed the highest mean
ESR of 30.6mm/hour. The lowest mean ESR was 13.8 mm/hour for male
patients in the ILK category. The highest recorded ESR of 85mm/hour




Abnormal Erythrocyte Sedimentation Rates
MALE FEMALE
Patient ID ESR* Patient ID ESR*
IK
LP 8 35 1 25
21 16 10 33









INT 158 11 81 25
112 22
ILK 47 18 24 24
58 11 125 16
130 15 129 71
143 11 138 29
DLE 23 47
152 33




Abnormal Erythrocyte Sedimentation Rates
MALE FEMALE
Patient ID ESR* Patient ID ESR*
NIK
NILK 35 47 31 17
146 18 36 27
63 25
104 42
FSK 15 13 33 33
50 66 132 19
93 16 148 18
110 11
* Erythrocyte sedimentation rate mm/hour.
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d) Biochemistry 23 patients (14.4%) had iron folate or Vitamin B12
deficiencies, singly or in combination, or were on supplements to
correct these deficiencies (Table 43). Eight were male and 15 female.
12 patients had iron deficiency, 2 having iron deficiency anaemia
(nos.33, 149); 3 were male and 9 were female. Of the 2 with iron
deficiency anaemia one (no.33) had a reduced haemoglobin of 6.8g/1 and
a reduced MCV of 57 and the other (no.149) had a haemoglobin of 8.1 g/1
and a MCV of 71. Investigation by the Haematology Department, Royal
Infirmary, Edinburgh revealed that both were due to dietary
deficiency. A third male patient (no.66) with iron deficiency anaemia
had a raised MCV but no other abnormality to explain his iron
deficiency. The other 2 male patients with iron deficiency
(nos.58, 59) were alcohol abusers. The remaining woman had latent iron
deficiency, either unexplained or associated with menstrual blood
loss.
Three patients were folate deficient and one (no.83) was on folate
supplements. The 3 untreated patients with folate deficiency were
deemed deficient due to dietary causes.
Five patients were Vitamin B12 deficient and 4 (nos. 51 ,64, 97, 150) were
on supplements for previously diagnosed pernicious anaemia. Of the 5
undiagnosed Vitamin B12 deficiencies, 4 were latent and one patient
(no.153) had a raised MCV. Two patients (nos.21,153) were
subsequently diagnosed as having pernicious anaemia. The remaining 3
were undiagnosed despite further investigation, including absorption
studies.
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One (no.51) of the 4 treated for Addisonian pernicious anaemia had
persistent peripheral blood abnormality with a reduced haemoglobin of
10. 1g /I.
Thus only 4 patients (20%) of 19 with previously undiagnosed
deficiency showed evidence of peripheral blood changes and the
remainder would have been unidentified if investigations had been
restricted to routine investigation.
Nonetheless the incidence of deficiencies in this group was not
significantly higher than other reported control groups (384) which




Serum Iron, Folate and Vitamin B12 Abnormalities
















See footnote for abreviations
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Table 13 contd.













* Deficiency with anaemia
## Supplements









e) Blood Glucose Blood glucose levels were evaluated for patients as a
screening method for diabetes. There was no fasting arranged and the
mean values for diagnostic categories are illustrated in Table 40. No
abnormally high levels were found and so no patients were found to be
diabetic.
f) Serum Complement Evaluation During initial examination peripheral
blood was tested for three complement constituents: CH5g, C3 and C4.
The mean values for these complement components are summarised in
Table 44. No significant differences between the diagnostic
categories were detected using the Student's t-test. No significant
differences were detected between the infiltrated and non infiltrated





C H *:rll50 C3** C4#
LP 74.2 1.22 0.36
INT 69.8 1 .09 0.44
ILK 69.0 1.16 0.37
DLE 89.0 1.31 0.33
CL 84.0 0.92 0.15
see 65.3 1 .08 0.30
Subtotal 73.0 1.20 0.36
NILK 74.6 1.14 0.41
FSK 71.0 1.14 0.39
HK 115.0 1 .05 0.37
Subtotal 76.7 1.10 0.40
TOTAL 74.0 1.17 0.37
* CHjq The mean total haemolytic capacity of the patients'
serum against a human normal pool (%HNP)
(normal range 50-150).
** C3 Complement C3 gms/l (Normal range 0.76-1 .60).
# C4 Complement C4 gms/l (Normal range 0.20-0.65).
-218-
g) Autoimmune Evaluation Serum antinuclear factor (ANF) was
determined for 74 patients and the results were recorded on a scale of
0 to 3 depending on the reaction observed. Of the patients tested, 38
showed no reaction, 18 were graded at 1, 13 graded at 2 and 5 graded
at 3. The diagnostic categories and the ANF determinations are
illustrated in Table 45. In the LP category the grades 1, 2 and 3
accounted for 20.6%, 17.6% and 5.9% of patients tested. This compares
with the ILK category where the three grades 1, 2 and 3 accounted for
28.6%, 14.3% and 7.1%. The NILK and FSK categories had a higher
proportion of patients showing positive reactions. Grades 1, 2 and 3
accounted for 33.3%, 22.2%, 11.1% for NILK and 37.5% and 25.0% for
































* Anti nuclear factor grade.
** Number of patients.
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h) Serum Immunoglobulins The main classes of serum immunoglobulins
were evaluated and the mean values for the diagnostic categories are
presented in Table 46. In general, differences were not obvious from
examination of the means obtained for the diagnostic categories.
However the lower values seen in the INT category were significantly
different from certain other categories when using Student's t-test as
follows:
Class P Value
INT < LP IgC 0.008
INT < NILK IgG 0.021
INT < see igG 0.002
INT < FSK IgC 0.000
INT < NILK IgA 0.021
INT < ILK IgA 0.052
INT < LP IgM 0.000
INT < sec IgM 0.007
These lower values seen for the INT category for all classes of
immunoglobulin indicate humoral differences for this subpopulation of
patients with oral keratoses. No significant differences between







LP 11.7 2.2 1 .5
INT 8.8 1.6 0.8
ILK 11.0 2.4 1.4
DLE 10.4 2.0 1.2
CL 11.9 1.5 1.3
see 12.6 2.4 1.7
Subtotal 11.5 2.3 1.5
NILK 11.8 2.7 1.3
FSK 12.2 2.3 1.2
HK 10.6 3.1 1.6
Subtotal 11.5 2.4 1.2




## Grams per litre
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i) Dermatological Tests As illustrated by Tables 47 and 48,
dermatological reaction to the panel of standard test materials was
uncommon. Notably nickel and mercury showed a greater number of
reactions than the other test substances. For LP 131 and 26.31 were
positive for nickel and mercury respectively. For ILK the figures
were 251 and 37.51 respectively. NILK showed 7.11 and 21.41 positive
reaction for nickel and mercury. There was a similar nickel and
mercury sensitivity in the F5K category. The typical positive
response for mercury is illustrated in Figure 18. Although amalgam
restorations were identified adjacent to lichen planus in a number of
instances, these results did not support that the mucosal lesions
resulted from a hypersensitivity reaction. It was unethical to
establish controls for these patch tests but the inclusion of the FSK
category enabled comparisons to be made. There were no significant
differences between this comparison group (FSK) and other categories
for hypersensitivity reaction to the materials tested.
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Table 47
Patch Tests to Dental Materials
Nickel Mercury
0 1 2 3 0 1 2 3 0
IK






1 10 3 2 1 14

































0 - No reaction
1 - Mild erythema and swelling within the disc
2 - Erythema and swelling to margin of disc
3 - Erythema and swelling extending beyond the disc
* Number of patients.
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Table 18
Patch Tests to Dental Materials
Epoxy. Potass. Wood Ale. Form. Acrylic
£12.12.15.121
IK
LP 38 - 38 38 - 38 38 -
INT 4 - 4 - 4 - 31 4 -
ILK 16 16 15 1 16 15 1
DLE 1 1 - 1 - 1 1 -
CL _ _________
SCC 2 2- 2- 2- 2 -
Subtotal 61 - 61 - 60 1 60 1 60 1
NIK
NILK 14 - 13 1 14 - 14 - 14 -
FSK 11 11 11 11 11 -
HK __________
25 24 1 25 - 25 - 25 -
86 85 1 85 1 85 1 85 1
Refer to Table 47 for Code description.
Substance Abreviation
Epoxy. Epoxy resin Wood Ale. Wood Alcohols






FIGURE 18. Positive Cutaneous Reaction to Mercury
FIGURE 19. Amalgam Adjacent to Oral Lichen Planus
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j) Tobacco Habits
The data detailed in Tables 49 to 55 illustrate the breadth of tobacco
habit amongst the study population. Table 49 and 50 shows the tobacco
histories of the patients with oral keratoses. 651 of the patients
had a positive history of tobacco use and 381 of these patients had
stopped the tobacco habit for more than a year during their lives.
Non smokers constituted 35% of the patient population. 38% of
patients in the immune keratosis (IK) group, compared to 42% in the
non immune keratosis (NIK) group, were current smokers.
Table 51 illustrates the distribution of different types of tobacco
use amongst the diagnostic categories. Combinations of cigarette,
cigar and pipe smoking accounted for a small proportion of the
patients.
The distribution of filtered, non filtered and reverse cigarette
smoking was also examined and these data are illustrated in Table 51.
73% of patients used tobacco with a filter and 26% of patients had
used non filtered tobacco products. This non filter category included
those patients who used non filtered cigarettes, cigars or the pipe.
Only one patient, in the FSK category, reverse cigarette smoked.
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Table 49
History of Tobacco Use
Never Smoking Stopped +History# Total
IK
LP 25* 13 17 30 55
INT 3 5 1 6 9
ILK 5 14 6 20 25
DLE - 3 1 4 4
CL 1 1 - 1 2
see - 2 3 5 5
Subtotal 34 38 28 66 100
NILK 9 12 4 16 25
FSK 9 8 6 14 23
HK 1 1 - 1 2
Subtotal 19 21 9 31 50
TOTAL 53 59 38 97 150
* Number of patients.
# Positive History of Tobacco Use
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Table 50
Tobacco Use for Filter, Non Filtered and RCS*
for Past and Present Smokers
Never Filter Non Filter RCS* Total
IK
LP 25** 23 7 - 30
INT 3 5 1 - 6
ILK 5 14 6 - 20
DLE - 3 1 - 4
CL 1 1 - - 1
see - 4 1 - 5
Subtotal 34 50 16 0 66
NILK 9 10 6 16
FSK 9 10 3 1 14
HK 1 1 - - 1
Subtotal 19 21 9 1 31
TOTAL 53 71 25 1 97
* Reverse Cigarette Smoking
** Number of patients.
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Table 51
Tobacco Use for Different Forms and
Combinations of Habit
Cigs+ Cigar+ Cigs+
Cigs* Pipe RCS# Cigar Pipe Pipe Total
IK
NIK
LP 27** 2 - 1 - — 30
INT 5 1 - - - - 6
ILK 15 1 - 1 1 2 20
DLE 4 - - - - - 4
CL 1 - - - - - 1
see 5 - - - - - 5
Subtotal 57 4 - 2 1 2 66
NILK 13 1 1 1 16
FSK 9 1 1 1 2 - 14
HK 1 - - - - - 1
Subtotal 23 2 1 1 3 1 31
TOTAL 80 6 1 3 4 3 97
* Cigarettes
# Reverse Cigarette Smoking
** Number of patients.
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For those patients who had stopped smoking tobacco, the numbers and
the years of cessation are illustrated in Table 52. There are no
obvious differences between the IK and NIK groups for this parameter.
The cigarette, cigar and pipe use for the diagnostic categories is
tabulated (Tables 53 to 55). Significant differences between the
diagnostic categories using Student's t-test were seen as follows:
Parameter* Diagnostic Category P Val
Cigday LP < ILK 0.007
Gramday LP < ILK 0.024
Cigyrs LP < ILK 0.008
Cigall LP < ILK 0.003
Yrsmoke LP < SCC 0.002
Cigday LP < SCC 0.004
Cigyrs LP < SCC 0.000
Cigyrs LP < NILK 0.017
Cigall LP < NILK 0.044
Yrsmoke NILK < SCC 0.009
Cigyrs INT < SCC 0.059
Cigyrs FSK < SCC 0.035
* See glossary of abreviations pXXV
Significant differences appear to exist between the diagnostic
categories LP, ILK, SCC and NILK for different aspects of tobacco use.
The ILK category smoke cigarettes for significantly more years and
this contributed to a significantly higher consumption of cigarette
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tobacco than the lichen planus category (p<0.01 for these two
parameters). In respect of the recognised risk of neoplastic change
with prolonged smoking of cigarettes (179,181) the significantly
raised consumption of cigarettes both on a daily basis and over a
period of years, is significantly higher for the SCC category compared
to the LP category (p<0.001 for these two parameters) . Furthermore,
the parameters of a) mean of years smoking cigarettes (cigyrs) and b)
the mean total number of cigarettes smoked (cigall), suggests that the
smoking patterns of the categories LP, FSK,NILK, ILK and SCC differ







This suggests that tobacco smoke plays a part in the aetiology of non
infiltrated and infiltrated leukoplakia. A dose relationship appears























Mean Cigarette Use for Diagnostic Categories
Number Cig/Day* Years* Cigall*
LP 54 9.9 9.3 81746
INT 8 11.9 13.8 144859
ILK 24 20.3 19.9 217479
DLE 4 17.3 35.8 195913
CL 2 15.0 17.5 191625
see 5 31.0 32.0 389455
mean (97) 14.1 14.8 144011
NILK 25 15.7 17.3 167301
FSK 24 13.9 13.9 124017
HK 2 2.5 5.0 9125
mean (51) 14.3 15.3 14141 1
MEAN 148 14.2 15.0 143132
(Total)
* Cigall is a mean value for the diagnostic category for total
cigarettes consumed. This is calculated by multiplying the
number of cigarettes smoked per day by 365 by the years
smoked.
Cig/Day x 365 x Years = Cigall.
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Table 54
Mean Pipe Tobacco Use for Diagnostic Categories
! K
NIK
Number gm/Week* Years* Gramall*
LP 54 0.26 0.93 2027
INT 8 6.25 1.75 31937
ILK 24 2.40 3.68 12585
DLE 4 - -
CL 2 - -
see 5 - -
mean (97) 1.27 1.59 6935
NILK 25 1 .92 1 .36 4263
FSK 24 5.73 3.14 28569
HK 2 - -
mean (51) 3.55 2.10 1 5002
TOTAL 148 2.03 1 .76 9624
(Total)
* Gramall is a mean value for the diagnostic category for
tobacco used for pipe smoking. This is calculated by
multiplying the grams of tobacco used per week by 52 by the
years smoked.
Gram/week x 52 x years = Gramall.
-235-
Table 55
Mean Cigar Use for Diagnostic Categories
Number Cigar/Week* Years* Garall*
IK
LP 54 0.19 - -
INT 8 - -
ILK 24 2.80 4.24 1 164
DLE 4 - -
CL 2 - -
see 5 - -
mean (97) 0.82 0.29 297
NILK 25 0.04 7.99 4.2
FSK 24 - -
HK 2 - -
mean (51) 0.02 0.86 2
MEAN 148 0.55 0.48 198
(Total)
* Garall is a mean value for the diagnostic category for the
total number of cigars smoked. This is calculated by
multiplying the number of cigars smoked per week by 52 by
the years smoked.
Cigar/week x 52 x years = Garall.
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k) Alcohol Habits
Patient alcoholic beverage consumption was recorded and these data are
presented in Tables 56 to 61. Of the 143 patients contributing to
this information, 62% had used or currently used alcoholic beverages
and 38% were non users. The IK group had 51% past or current users of
alcohol while the NIK group had 67%. Spirits and beer constituted the
highest amounts of alcoholic drinking. Using Student's t-test the
following differences between categories are noted:
Parameter* Diagnostic Category P Value
Nipyrs LP <N I LK 0.038
Nipyrs LP <ILK 0.054
Wineyrs LP <l LK 0.054
Beeryrs NILK <l LK 0.046
Yrsalk FSK <l LK 0.056
Yrsalk FSK <N I LK 0.049
Beeryrs IRK <FSK 0.059
Unwine SSC <l LK 0.043
* See glossary of abreviations p XXV.
Spirit and beer drinking constitute the more commonly used beverages
for the categories of oral keratoses. It is remarkable that both the
SCC and the ILK categories have a mean weekly consumption of spirits
of 30 and 31 units respectively, comparing with 9 and 12 units for the
NILK and LP categories. Furthermore, beer drinking is seen in the
ILK,SCC and NILK categories with weekly consumption 13, 15 and 18
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units respectively. These results do not achieve statistical
significance however a threefold difference between LP and ILK is seen
when the mean weekly unit values for spirits and beer are added.
spirits + beer = total (mean units/week)
LP 12 3 15
NILK 9 18 27
ILK 31 13 44
see 30 13 43
The duration of the use of alcoholic beverages for the categories
LP,NILK and ILK was significantly different with LP having the lowest
mean and ILK the highest mean (p<0.05). These data are similar to the
spirit and beer values recorded above, suggesting that comparable
patterns of tobacco and alcohol use exist between lichen planus, non
infiltrated leukoplakia and infiltrated leukoplakia (see page 232).
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Table 56
Patient Alcohol Use for Diagnostic Categories
Never User Stopped Total
IK
LP 25* 27 1 53
INT 4 4 - 8
ILK 8 14 3 25
DLE 4 - - 4
CL 1 1 - 2
see
•
- 3 2 5
Subtotal 42 49 6 97
NILK 6 17 2 25
FSK 6 13 - 19
HK 1 1 - 2
Subtotal 13 31 2 46
TOTAL 55 80 8 143
* Number of patients.
-239-
Table 57





























LP 11.5 3.3 6151
INT 2.6 8.2 4797
ILK 31.4 9.7 14146
DLE - - -
CL 2.0 17.5 3640
see 29.6 11.6 16307
mean 16.2 5.9 8318
NILK 8.5 11.4 9214
FSK 5.9 8.3 6294
HK - - -
mean 7.0 9.8 7607
TOTAL MEAN 13.3 7.2 8089
* Spiritall is a mean value for the diagnostic category
for total units of spirit consumed. This is calculated by
multiplying the units consumed per week by 52 by the years
of spirit drinking.
Units/week x 52 x years = Spiritall.
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Table 59




LP 2.8 2.6 2058
INT 10.8 4.4 5785
ILK 12.8 2.2 5809
DLE - - -
CL 15.0 17.5 27300
see 15.0 8.0 31200
mean 6.8 3.1 5270
NILK 17.5 7.4 22526
FSK 6.5 9.4 9516
HK 15.0 0.0 -
mean 12.8 7.9 16173
TOTAL MEAN 8.7 4.7 8777
* Beerall is a mean value for the diagnostic category for
the total number of units of beer consumed. This is
calculated by multiplying the units consumed per week by 52
by the years of beer drinking.
Units/week x 52 x years = Beerall.
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Table 60


































* Wineall is a mean value for the diagnostic category for
the total number of units of wine consumed. This is
calculated by multiplying the units consumed per week by 52
by the years of wine drinking.
Units/week x 52 x years = Wineall.
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I) Tobacco and Alcohol habits
Table 61 illustrates the mean total amounts of cigarettes, spirits and
beer for the categories of keratoses. The "TOTAL" seen in the last
column records the mean total value for all the types of alcohol and
tobacco consumed by the respective categories. The SCC category had a
significantly higher consumption than the NILK category (p<0.018) and
ILK had a significantly higher consumption than LP (p<0.004) for this
combination of habits. The highest total value for the SCC category
(437x10^ ) is almost double the values seen in ILK, CL, NILK, DLE,
FSK, and INT (255, 222, 21 3, 196, 183 and 187x10^ respectively). The
mean value for LP (90 x 10 ) is less than half of those values seen in
the categories detailed above, with lower cigarette consumption the
main factor. The mean ages detailed in table 23 suggest that
differences in mean age are not significant in the assessment of the
tobacco and alcohol habits. As described on page 231-232, the
duration of the habit and the number of cigarettes smoked are
significant features distinguishing the LP category from the ILK, NILK
and SCC categories.
Differences between the Infiltrated Keratoses (IK) and the Non
Infiltrated Keratoses (NIK) for the mean values of tobacco, alcohol
and the total for these parameters, do not suggest that these habits
influence the presence or absence of the infiltrate seen in this
keratosis grouping. However the NILK category has a high consumption
of beer rather than spirits and the reverse is seen with the ILK and
SCC categories, where spirits are consumed in very high ammounts and
beer in high amounts (page 238).
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Table 61
Mean Cumulation of Tobacco and Alcohol Consumption
Cigall* Spiritall* Beerall* TOTAL##
IK
LP 81 .7# 6.2 2.1 90.2
INT 144.9 4.8 5.8 187.4
ILK 217.5 14.1 5.8 255.5
DLE 196.0 - - 195.9
CL 191.6 3.6 27.3 222.6
see 339.4 16.3 31.2 437.4
mean 144.0 8.3 5.3 165.7
NILK 167.3 9.2 22.5 212.8
FSK 124.0 6.3 9.5 183.1
HK 9.1 - - 9.1
mean 141.4 7.6 16.2 191.2
TOTAL MEAN 143.3 8.1 8.8 173.9
* Refer to Tables 53,58,59.
# Values x 10^.
## TOTAL refers to the mean cumulated units of tobacco




1. General Histological Assessment
The male and female distribution, and the biopsy sites for the 132
patients from whom biopsy was carried out, are shown on tables 62 and
63. The assessment of the histopathological features of the 132
biopsies was carried out with particular reference to the following
features.
A. Types of keratinization
B. Epithelial thickness
C. Epithelial Dysplasia
D. Epithelial and connective tissue interface
E. Morphological arrangement of inflammatory cell infiltrates
F. Cytological aspects of inflammatory cell infiltrates
G. Blood vessels in the lamina propria
Haematoxylin and eosin stained sections were examined at medium and
high power (xlO and x40 objectives) for these features, a minimum of 5
sections at one level being studied. The histological features for
this part of the study, were assessed independently without knowing
which disease categories the patients had been given. Tables 64-70
are in two forms: a) illustration of the absolute numbers of patients
with the specific histological feature for each diagnostic category
and b) the percentage, of patients in the diagnostic category, with
positive responses for the particular histological feature.
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Table 62
Sex Distribution in the Diagnostic Categories for
132 Patients with Oral Keratoses Evaluated Histologically
Male Female Total
IK
LP 22* 27 49
INT 3 3 6
ILK 16 10 26
DLE 1 3 4
CL 1 1 2
see 3 3 6
Subtotal 46 47 93
NILK 11 13 24
FSK 10 3 13
HK 1 1 2
Subtotal 22 17 39
TOTAL 68 64 132





















Biopsy Sites for 132 Patients with Oral Keratoses
Evaluated Histologically
Site IK NIK Total Percentage
V. border - - -
Commissure 3** 1 4 3.0
U.B.S.* 2 - 2 1.5
L.B.S.* - - -
Buccal 57 21 78 59.0
Buccal 3M 4 - 4 3.0
Palate 2 2 1.5
U.A.R.* - - -
L.A.R.* 1 1 2 1.5
Retromolar - - - -
Gingivae 2 2 4 3.0
Tong. Dors. 6 - 6 4.6
Tong. Lat. 10 5 15 1 1.4
Tong. Vent. 1 - 1 0.8
F.O.M.* 7 6 13 9.9
Fauces 1 - 1 0.8
TOTAL 94 38 132 100.0
Refer to Chapter 2 for the full description of the 16 sites.
Number of patients
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a) Types of Keratinization
The types of keratinization ie. orthokeratosis, parakeratosis,
hyperorthokeratosis, hyperparakeratosis and the presence of a granular
layer are given in table 64a and 64b. The predominent feature of
keratinization was recorded for each biopsy. Hyperorthokeratosis
featured frequently in the INT category, 671, and to a lesser extent
in all other categories. Hyperparakeratosis was seen in 351 of
patients in the FSK category and both biopsies (1001) in the HK
category. Parakeratosis was a more frequent finding in the IK group,
531, compared to 131 for the NIK group. However hyperparakeratosis
was a more frequent feature in the NIK group (441) compared to the IK
group (241). The FSK category contributed substantially to the
numbers of patients in the NIK group with hyperparakeratosis.
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Table 64a
Types of Keratinization in Oral Keratoses
IK
OK' PK HOK HPK GRAN Total
NIK
LP - 30** 6 13 25 49
INT - 1 4 1 4 6
ILK 1 11 8 6 15 26
DLE 1 2 1 - 4 4
CL - 1 - 1 - 2
see - 4 1 1 - 6
Subtotal 2 49 20 22 50 93
NILK 5 4 1 1 4 16 24
FSK - 1 1 1 1 2 13
HK - - - 2 - 2
Subtotal 5 5 12 17 18 39
TOTAL 7 54 32 39 68 132




GRAN - Granular layer present
(See text for explanation)
** Number of Patients.
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Table 64b
Types of Keratinization in Oral Keratoses
(Percentage)
OK* PK HOK HPK GRAN
! K




GRAN - Granular layer present
(See text for explanation).
LP - 61 12 27 51
INT - 17 67 17 67
ILK 4 42 31 23 58
DLE 25 50 25 - 100
CL - 50 - 50 -
see - " 67 17 17 -
Subtotal 2 53 22 24 54
NIK
NILK 21 17 46 17 67
FSK - 8 8 85 15
HK - - - 100 -
Subtotal 13 13 31 44 46
TOTAL 5 41 24 30 52
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b) Epithelial Thickness
Epithelial thickness was assessed subjectively as normal,
hyperplastic, atrophic or with erosion. The range of epithelial
thickness is given in tables 65a and 65b. A number of biopsies showed
variation in thickness and this is reflected in the disparity between
the individual and total numbers.
In the LP category 53% of biopsies were considered to be of normal
thickness and 43% to have atrophy. Erosion only affected 10% of the
LP category. The INT and SCC categories however showed higher
proportions of erosion; 17% and 50% respectively. Erosion or
ulceration was an infrequent observation in the NILK category (4%).
Atrophy occurred in similar proportions for specimens in the LP, ILK,
DLE and SCC categories (approximately 50%). Only in the CL category
was atrophy seen in both specimens (100%). As with erosion, atrophy
was a less frequent finding in the NIK group (13%) compared to the IK
group (45%). Hyperplasia, infrequent in the LP category (14%), was
seen in proportionately more cases for ILK (31%), DLE (25%), CL (50%)
and SCC (67%). The IK group had 24% of specimens with hyperplasia.
In the NIK group, hyperplasia occurred in 54% of cases. Notably the
FSK category had a high value of 77% of cases with hyperplasia. This




Epithelial Thickness in Oral Keratoses
Normal Hyperplasia Atrophy Erosion Number
LP 26* 7 21 5 49
INT 4 1 1 1 6
ILK 12 8 13 2 26
DLE 1 1 2 - 4
CL - 1 2 - 2
see - 4 3 3 6
Subtotal 43 22 42 11 93
NILK 12 9 3 1 24
FSK 2 10 2 - 13
HK - 2 - - 2
Subtotal 14 21 5 1 39
TOTAL 57 43 47 12 132
















Epithelial Thickness in Oral Keratoses
(Percentage)
Normal Hyperplasia Atrophy Erosion
53 14 43 10
67 17 17 17
46 31 50 8
25 25 50 -
- 50 100 -
- 67 50 50












Features of epithelial dysplasia have been described in Chapter 1 .
Epithelial dysplasia is difficult to evaluate objectively so a
subjective assessment was made in which five categories were used.
1. No epithelial dysplasia .
2. Minimal epithelial dysplasia minimal features of cellular
dysplasia present but not enough to achieve the next
category
3. 1/3rd epithelial dysplasia, dysplasia was limited to the
basal one third of the epithelium.
4. 2/3rds epithelial dysplasia, dysplasia was limited to the
basal two thirds of the epithelium.
5. 3/3rds epithelial dysplasia, dysplasia involved the full
thickness of the epithelium.
Difficulties in this evaluation occurred when the epithelium was
atrophic and thus the features of epithelial dysplasia would appear to
affect a greater proportion of the epithelium. Also where the
epithelium contained a thick keratin layer, the part showing dysplasia
would thus appear proportionately smaller. The scoring for this
parameter of epithelial change was designed to include the four
categories of dysplasia, 2 to For Tables 66a and 66b, the data
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have been adapted so that the numbers and percentages for each of the
four categories of dysplasia indicate the number of patients achieving
the stated category of dysplasia.
1. No Epithelial Dysplasia
Epithelial dysplasia could not be identified in the majority of the
sections examined.
2. Minimal Epithelial Dysplasia
Minimal epithelial dysplasia was seen in all diagnostic categories
except HK (Tables 66a,66b). The highest percentage of biopsies
displaying minimal dysplasia (331) was seen in the INT category.
Some specimens in the categories LP, ILK, DLE, NILK and FSK had
evidence of a minimal degree of dysplasia.
3. 1/3rd Epithelial Dysplasia
Dysplasia affecting the basal one third of epithelium was seen in a
high percentage of ILK and CL sections (39% and 50% respectively).
IK showed dysplasia of the basal one third of the epithelium in more
cases than NIK (19% and 5%) respectively.
4. 2/3rds Epithelial Dysplasia
Dysplasia involving the basal two thirds of epithelium was seen in the
LP, ILK, SCC and NILK categories. While the SCC category contained
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the highest proportion (17%), the LP and NILK categories had the
lowest with 4% of sections affected. LP, ILK and NILK showed this
degree of dysplasia.
5. 3/3rds Epithelial Dysplasia
The presence of dysplasia involving the full thickness of the
epithelium was confined to the three patients in the SCC category.
The other three patients with sections not showing 3/3rds epithelial
dysplasia, had presented with squamous cell carcinoma prior to the
study and biopsy during follow-up gave the range of epithelial





Epithelial Dysplasia in Oral Keratoses
None# Minimal 1/3# 2/3# 3/3# Number
LP 33* 9 6 1- 49
INT 4 2 - - - 6
ILK 12 2 10 2 26
DLE 3 1 - - - 4
CL 1 1 2
see 1 1 1 3 6
Subtotal 54 •£=" —* CO U) 93
NILK 18 3 2 1- 24
FSK 12 1 - - - 13
HK 2 _ _ _ _ 2
Subtotal 32 4 2 1 - 39
TOTAL 86 18 20 5 3 132
* Number of Patients
# Refer to text for explanation
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Table 66b
Epithelial Dysplasia in Oral Keratoses
(Percentage)
None* Minimal 1 /3 2/3 3/3
IRK
LP 67 18 12 4 -
INT 67 33 - - -
ILK 46 8 39 8 -
DLE 75 25 - - -
CL 50 - 50 - -
see 17 _ 17 17 50
NIRK
NILK 75 13 8 4
FSK 78 8
HK -
* See text for explanation.
-259-
d) Epithelial and Connective Tissue Interface
The assessment of the epithelial and connective tissue interface
examined three aspects of the histopathology.
1. Liquifactive degeneration
2. Basement membrane thickness
3. Apoptosis
1. Liquifactive Degeneration
Liquifactive degeneration is an appearance produced by oedema in the
basal and parabasal layers of the epithelium. Areas of liquifactive
degeneration were a feature of all diagnostic categories except HK
(Tables 67a and 67b). The LP category contained the highest
percentage (71%) showing liquifactive degeneration while other
categories such as INT, DLE and SCC had this feature in 67%, 50% and
50% of specimens respectively. The ILK category had 27% showing
liquifactive degeneration, representing just over one third of that
seen in the LP category. The NILK and FSK categories had lower
percentages of liquifaction, 4% and 8% respectively and the HK
category had none. There was a large difference in the presence of
liquifactive degeneration between the ILK and NILK categories, 27% and
4% respectively, suggesting that an inflammatory infiltrate was
related.
2. Basement Membrane Thickness
By basement membrane is meant the interface between the epithelium and
-260-
the lamina propria which can be seen as a layer 1-2um thick in normal
mucosa with staining such as the PAS reaction. It is a composite
structure and includes the basal lamina which can only be seen by
electron microscopy. The basement membrane thickness appears greater
when an eosinophilic coagulum appears at the junction of epithelium
and connective tissue. This is often seen in lichen planus and may
also appear in other conditions such as discoid lupus erythematosus.
Increased basement membrane thickness was seen in approximately 25% of
those patients with lichen planus or discoid lupus erythematosus
(Tables 67a and 67b). The ILK category had a lower proportion, 8%,
while the INT category failed to demonstrate any thickening of the
basement membrane. The NILK category similarly had no thickening of
the basement membrane while the FSK category, similar to the ILK
category, had 8%. The SCC category demonstrated a thickened basement
membrane in one patient (17%).
3. Apoptosis
The presence of hyaline (Civatte) bodies occurring in the lower parts
of the epithelium or in the upper parts of the connective tissue is
now considered to result from apoptosis. The presence of apoptosis
was seen commonly in the LP category (71%), with all other categories
in the IK group presenting between 25% and 50% apoptosis (Tables 67a
and 67b). In the NILK and FSK categories lower levels of apoptosis





































* Number of Patients
# TBM = Thickened Basement Membrane
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Table 67b





LP 71 24 71
INT 67 - 50
ILK 27 8 38
DLE 50 25 25
CL - 50
SCC 50 17 50
NIK
NILK 4-21
FSK 8 8 23
HK
# TBM = Thickened Basement Membrane
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e) Morphological Arrangement of Inflammatory cell Infiltrates
The morphological arrangement of the infiltrate was categorised into
four types.
1. A juxta-epithelial infiltrate of inflammatory cells.
2. A band like infiltrate which is a clearly delineated layer
from the lower connective tissue region.
3. Inflammatory infiltrates localised to foci of cells
irregularly occurring in the lamina propria.
4. The presence of inflammatory infiltrates deep in the
connective tissue, often perivascular.
A summary of the results is given in Tables 68a and 68b.
1. Juxta-epithelial Infiltrate
Juxta-epithelial infiltrates occurred in all sections examined from
the LP, INT, DLE and SCC categories (100%). The ILK category also
had a high proportion of specimens with this feature (62%). Juxta-
epithelial infiltrates were also detected in the NILK and FSK
categories, 13% and 8% respectively, although these categories by
definition would not be expected to have a pronounced inflammatory
cell infiltrate.
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2. Band Like Infiltrate
92% of samples showed this in the LP category and it was also seen in
approximately one third of samples in the INT, ILK and DLE categories.
The SCC category had half the samples with this morphological feature
while the FSK category had 8%. The subtotals for IK and NIK groups of
63% and 3% illustrate the major difference between these two groups.
3. Localised Foci of Infiltrate
Localised Infiltrates of cells within the lamina propria were uncommon
in the LP category (25%) when they related to the localised
involvement of the mucosa in reticular and papular lichen planus.
Localised infiltrates were seen more frequently in the INT, ILK, DLE,
CL and SCC categories (83%, 73%, 75%, 50%, 50% respectively). This
contrasted with the localised infiltrates seen in the NILK category
where 29% of samples presented this feature. Also one sample in the
FSK category demonstrated a localised infiltrate.
4. Deep Infiltrates
The presence of an infiltrate deep in the connective tissue was
infrequent in the LP and INT categories (8% and 0%). Other
infiltrated keratoses had higher proportions of deep infiltrates
identified, notably DLE (75%) where this is one of the diagnostic
features of the condition. The ILK, CL and SCC categories had
approximately half the samples presenting with deep infiltrates while
the NILK category had this feature in 13% of samples. The presence of
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deep infiltrates of lymphocytes is a feature occurring more frequently
in the IK group than the NIK group, 25% and 8% respectively.
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Table 68a
Morphological Arrangement of Inflammatory
Cell Infiltrates in Oral Keratoses
Juxta. # Bandlike# Local. # Deep# Number
IK
LP 49* 45 12 4 49
INT 6 2 5 - 6
ILK 16 8 19 12 26
DLE 4 1 3 3 4
CL 1 - 1 1 2
see 6 3 3 3 6
Subtotal 82 59 43 23 93
NILK 3 . 7 3 24
FSK 1 1 1 - 13
HK - - - - 2
Subtotal 4 1 8 3 39
TOTAL 86 60 51 26 132
* Number of Patients
# Refer to text for explanation of headings
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Table 68b
Morphological Arrangement of Inflammatory
Cell Infiltrates in Oral Keratoses
(Percentage)
Juxta. # Bandlike# Local. # Deep#
IK
LP 100* 92 25 8
INT 100 33 83 -
ILK 62 31 73 46
DLE 100 25 75 75
CL 50 - 50 50
see 100 50 50 50
Subtotal 88 63 46 25
NILK 13 . 29 13
FSK 8 8 8 -
HK - - - -
Subtotal 10 3 21 8
TOTAL 65 46 39 20
# Refer to text for explanation of headings
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f) Cytological Aspects of Inflammatory Cell Infiltrates.
The sections were examined for different cellular types that
constituted the infiltrates detected. The principle cells detected by
histopathological criteria were lymphocytes, plasma cells, macrophages
and polymorphonoclear leukocytes. This identification relied on the
morphological appearance and staining of the cells using haematoxylin
and eosin. Tables 69a and 69b illustrate the range of infiltrates
observed in the 132 sections examined.
1. Lymphocytes
Lymphocytes were the most frequently identified cells constituting the
infiltrates for the infiltrated and non infiltrated keratoses. In the
NILK category one third of the sections revealed lymphocytes (33%)
although it must be remembered that by definition NILK lesions
contained very few,if any, inflammatory cells.
2. Plasma Cells
No plasma cells were observed in the DLE, FSK and HK categories and
were present in only 4% of LP lesions. Plasma cells were present in
83% of the SCC category while the CL and ILK categories had 50% and
23% respectively.
3. Macrophages
Macrophages were seen to be similar to lymphocytes in their
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distribution amongst the diagnostic categories. IK and NIK had 96%
and 231 of sections with macrophages detected respectively.
4. Polymorphonuclear Leukocytes
Polymorphonuclear leukocytes (PMNL) were detected in many diagnostic
categories but always in small percentages. The SCC category had 331
of sections showing PMNL which may be a reflection of the fact that
501 of this category displayed erosion thus permitting superimposed
infection.
Lymphocytes and macrophages were the predominant cells in the
infiltrates. The presence of PMNL and plasma cells was a much less
frequent finding. However the CL, SCC and ILK categories had higher
numbers of plasma cells and PMNL cells than other categories. A lower
number of plasma cells were found in the INT and LP categories where
171 and 41 of sections showed this feature.
g) Blood Vessels in the Lamina Propria
The final histopathological feature examined was the presence of
dilated or increased numbers of blood vessels. It was unclear at the
start of the examination what contribution this feature would provide
in the overall histopathological evaluation. During preliminary
assessments it was thought that the presence of dilated or increased
numbers of blood vessels should not be overlooked as increased
vascularity was thought to occur. It is difficult to detect an
absolute increase in the number of blood vessels as previously
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physiologically colapsed vessels may dilate and become visible. A
subjective assessment as to whether the vascularity was increased or
not was attempted and the results shown in Table 70. The category
with the least vascularity was thought to be FSK (8%), contrasting
with the other categories which varied between 25% to 50%.
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Table 69a
Cell Types in Inflammatory Infiltrates of Oral Keratoses
Lymph** Macro# PMNL## Plasma cells
LP 49* 48 2 2
INT 6 6 1 1
ILK 24 23 1 6
DLE 4 4 - -
CL 2 2 1 1
see 6 6 2 5
Subtotal 91 89 7 2
N1LK 8 7 2
FSK 2 2 - -
HK - - - -
Subtotal 10 9 - 2
TOTAL 101 98 7 4
* Number of Patients
** Lymph - Lymphocytes
# Macro - Macrophages
## PMNL - Polymorphonuclear Leukocytes
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Table 69b




Lymph** Macro# PMNL## Plasma cells
LP 100 98 4 4
INT 100 100 17 17
ILK 92 88 4 23
DLE 100 100 - -
CL 100 100 50 50
see 100 100 33 83
Subtotal 98 96 8 2
NILK 33 29 . 8
FSK 15 15 - -
HK - - - -
Subtotal 26 23 - 5
TOTAL 77 74 5 3
** Lymph - Lymphocytes
# Macro - Macrophages
## PMNL - Polymorphonuclear leukocytes
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Table 70
Sections Detected with Increased vascularity


















Immunocytochemistry was used for investigation of the subsets of
immunocytes present in the biopsies when the biopsies were of
sufficient size to allow both histolopathology and immunocytochemical
analysis. 28 patients provided biopsies for this investigation and 2
of these patients provided biopsies on two separate occasions,
providing 30 sets of stained sections (Table 71). The purpose of this
study was to compare the quantity of different immunocytes present in
both the epithelium and the lamina propria for the diagnostic
categories.
The means of computer units of detected area for the diagnostic
categories for the different phenotypes examined are illustrated in
Tables 73-75.
a) Evaluation of Different Phenotypes
Comparison of the mean values seen for T1, T4, T8 and B1 phoenotypes and
for T8 phenotypes identified in the epithelium is illustrated in
Tables 72 and 73. The mean value in lichen planus for T1 is 33408,
thus exceeding the values for ILK (30058), INT (23420) and NILK
(16893). The purpose of this comparison was to identify quantifiable
differences in infiltrate between the combined leukoplakia categories.
It is noteworthy that T4 in LP, INT and ILK were between 10858 and
13310. In comparison, the value in NILK was 6711 which represents an
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approximate reduction of 50% of this phenotype (Table 72). Also the
FSK category had a similar level of T4 phenotype to the LP, INT and
ILK categories. Low values (5800 and 7389) were also recorded for DLE
and CL categories for the T4 phenotype. The T8 value in the INT
category exceeded that of the T1 value (27850 and 23420 respectively).
It is not clear what contributed to this value, however the mean
values for the cases were diverse, as illustrated by the standard
error of the mean (Table 72).
In the FSK category, the B1 phenotype evaluation had the lowest value
(572) of all categories (Table 73). The B1 phenotype was higher in
the ILK than LP categories (3119 and 2463 respectively). In
leukoplakia the INT category had the lowest B1 phenotype ( 1532) while
ILK had double at 3119. The identification of T8 phenotypes in the
epithelium showed no specific trend. The LP, INT, NILK and FSK
categories showed similar values for Epithelial T3 phenotype ( 1988,
1 705, 2040 and 2182 respectively), i LK had a very much reduced




Patients Contributing to the
Immunocytochemical Study of Oral Keratoses
Male Female Total
IK
LP 7 6 13
INT 2 1 3
ILK 2 3 5
DLE - 1 1
CL 2 - 2
NILK 2 2 4
FSK 1 1 2
TOTAL 15 14 30
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Mean Total Detected Area for the Diagnostic
Categories and the Idiotypes Investigated
No. T1 SEM* T4 SEM* T8 SEM*
LP 13 33408# 6813 13310 2812 25933 4518
INT 3 23420 5591 10858 4113 27850 10523
ILK 5 30058 3525 11718 3905 1 8260 4257
DLE 1 14120 - 5800 - 10040 -
CL 2 25427 5281 7389 1936 1 1983 4483
NILK 4 1 6893 2768 6711 1791 14073 1590
FSK 2 21975 8442 12435 5576 17406 12706
OK
TOTAL30 29992 4348 11130 1538 21095 2561
* SEM - Standard Error of the Mean
# Computer units of mean detected area.
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Table 73
Mean Total Detected Area for the Diagnostic
Categories and the Idiotypes Investigated
No. B1 SEM* EpT8* * SEM* Cont# SE
LP 13 2463## 638 1988 424 70 20
INT 3 1532 629 1705 595 59 10
ILK 5 3119 1411 516 31 137 66
DLE 1 1248 - 7259 - 109 -
CL 2 1893 1356 3325 2480 41 6
NIK
NILK 4 2620 1 505 2040 782 90 21
FSK 2 572 52 2182 1217 90 47
OK
TOTAL30 2296 415 2092 363 84 14
* SEM - Standard Error of the Mean
** Ep T8 describes the T8 phenotypes detected in the
epithelium of the section
# Cont - Control Sections
## Computer units of mean detected area.
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A broad disease comparison between lichen planus and the combined
disease categories of leukoplakia was possible (Table 75). For the
phenotypes T1, T4, T8 and Epithelial T8, a ratio between 1.5 and 1.3
to 1 was seen in each case, except for B1 where a ratio of 1:1 was
present.
The values for the phenotypes T1,T4,T8,B1 and T8 Epith for LP, ILK,
INT and NILK are shown (Table 76). NILK had a value approximately
half that seen in LP for the phenotypes T1 and T4. The ILK and INT
categories showed intermediate values between LP and NILK for these
phenotypes. The INT category displayed the highest value for the T8
phenotype (27330) and NILK the lowest (14073). The B1 phenotype was
similar in LP and NILK (2463 and 2620 respectively). INT had half the
values of B1 compared to ILK ( 1532 and 3119 respectivley) . ILK showed
the lowest value for Epithelial T3 phenotype (516) and the other
categories had similar values. The low T4 value in NILK, the high T3
value in INT and the low Epithelial T8 value in ILK were not found to
be relevant diagnostic indicators for these categories.
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Table 74
Comparison Between Lichen Planus and Leukoplakia
LP Leukoplakia# Ratio
T1 33408* 21915 1.5 to 1
T4 13310 10113 1.3 to 1
T8 25933 19831 1.3 to 1
B1 2463 2556 1.0 to 1
Ep T8 1988 1385 1.4 to 1
* Mean values of detected areas.
# Leukoplakia = categories ILK + INT + NILK
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Table 75
Comparison Between Lichen Planus and the
Respective Categories of Leukoplakia (ILK, INT, NILK)
Diagnostic Category
Phenotype LP ILK INT NILK
T1 33408* 30058 23420 16893
T4 13310 11718 10858 671 1
T8 25933 18260 27850 14073
B1 2463 3119 1532 2620
Ep T8 1988 516 1705 2040
* Mean values of detected areas.
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b) Ratios for T4/T8 Phenotypes
Ratios for T4/T8 phenotypes are illustrated in Table 77. The highest
value of 0.71 for the T4/T8 ratio was seen in the FSK category. The
lowest ratio was 0.39 for the INT category. In descending order ILK
0.64, CL 0.62, DLE 0.58, LP 0.51 and NILK 0.48 values were obtained.
It was unclear why the FSK category showed the highest ratio and INT
the lowest for this parameter. The values for T4 for categories INT
and FSK were 1 0858 and 12435 respectively. Accepting the large
variation in these values in the individual specimens, as suggested by
the standard error of the mean, the relatively high level of T8 in the
INT category was responsible for the T4/T8 ratio of 0.39. The NILK
category, with a low value of 6711 for the T4 phenotype compared to
the approximate value of 12000 for LP, INT, ILK and FSK, would suggest
that relative reductions of T4 and T8 phenotypes was an important
consideration for the NILK category.
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Table 76












Three major aspects of in vitro cellular immunology of peripheral
blood lymphocytes were investigated for oral keratoses; viz Lymphocyte
transformation, T-cell mediated supression and Macrophage supression.
In addition, an initial assessment of lesional cells was attempted
using simple extraction techniques to obtain immunocytes from the
keratotic lesions. Materials and methods used for these studies are
given in chapter 3 and the controls were obtained within the dental
hospital from age, sex and tobacco use matched adults without disease.
a) Lymphocyte Transformation
The mean lymphocyte transformation values obtained for patients and
controls are illustrated in Table 77. Both patient and control
lymphocytes obtained from peripheral blood showed stimulation with
mitogens PHA, PVVM and ConA but there were no significant differences.
A difference between patients and controls for unstimulated
lymphocytes (p<0.013) was found and could be of biological
significance. These data may suggest greater spontaneous
transformation of patient lymphocytes over those of controls.
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Table 77
Lymphocyte Transformation in Patients and Controls
According to Diagnostic Categories of Oral Keratoses
(Mean Values)*
Diagnostic
Category Cells 0 No . PHA No,. PWM No . ConA No.
LP P 179 8 7039 8 625 5 3516 8
C 142 5746 504 4106
DLE P 11 5 2 3628 2 369 2 733 2
C 60 6146 417 1289
see P 249 3 5343 3 742 4 3456 4
C 139 5466 631 3828
INT P 96 3 5008 3 610 3 4332 3
C 73 5323 671 5427
ILK P 111 3 3376 4 710 3 567 2
C 71 5067 596 2041
NILK P 186 4 561 8 3 2553 4 562 2
c 132 8156 1821 955
OK## p 164** 23 5430 24 1000 21 2794 21
TOTAL c 114** 5868 808 3477
S.D. omitted for clarity as data are not statistically significant
* Counts per minute (cpm).
**
p < 0.013.
No. Number of pairs in the paired t-test.
## Oral Keratoses - total contributing to the paired tests.
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b) T-Cell Mediated Suppression
T-cell suppression in co-culture lymphocyte transformation tests did
not provide evidence of raised or lowered T-cell suppression in
patients or controls (Table 78). Similar mean values in co-cultures
for T-cell mitogens PHA and ConA suggests that no significant
differences in the ability of T-cells to respond to such mitogens
exist between control and patient populations of peripheral blood
lymphocytes. Results in later tables (Tables 80 and 81) confirm that
T-cell mediated suppression was not significantly raised in patients
or controls even when the influence of macrophage suppression was
eliminated.
The production of immunoglobulins from co-cultures of T and B-cells
was assessed using the ELISA technique described in chapter 4. The
evaluation of the immunoglobulins G, A and M, as a product of T-cell
suppression, was not possible due to insurmountable problems
encountered with the computer software.
c) Macrophage Mediated Suppression
The contribution of macrophage suppression in lymphocyte
transformation was examined by eliminating the effect of macrophages
using Indomethacin and Vitamin E (Table 79). The effect of
eliminating macrophage suppression generally showed enhancement of the
lymphocyte transformation. However in the LP category, the
spontaneous Lymphocyte transformation was significantly higher
(p<0.034) if macrophage suppression was not eliminated, suggesting
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that increased spontaneous lymphocyte transformation is present in
lichen planus. Although similar differences between spontaneous
lymphocyte transformation values, with and without macrophage
suppression were obtained in the DLE and SCC categories, too few









No. PHA No. PWM No. ConA No.










No. Number of pairs in the paired t-test.
* Mean value counts per minute (cpm).
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Table 79
Macrophage Suppression of Lymphocyte Transformation
for the Diagnostic Categories of Oral Keratoses
(Expressed as Mean counts per minute)
Diagnostic
Category Cells 0_ No. PHA No. PVVM No. ConA No.
LP P-# 196* 7 10998 9 523 8 3516 8
P+## 110* 12876 581 5709
OLE P- 115 2 3628 2 369 2 733 2
P+ 56 5436 267 588
see P- 334 2 5343 4 742 4 3456 4
P+ 94 5964 907 4465
INT P- 96 3 5008 3 610 3 4332 3
P+ 306 5925 735 5155
ILK P- 93 4 3376 4 710 3 567 2
P+ 85 5914 1556 619
NILK P- 150 2 1455 1 715 2 372 1
P+ 149 1570 419 433
OK P- 159 24 6919 25 921 24 3692 22
TOTAL P+ 143 22 8198 24 746 24 3939 21
No. Number of pairs in the paired t-test.
# Patient cells.
## Patient cells: macrophage suppression eliminated with




The effect of eliminating macrophage suppression was further assessed
using co-culture tests of patient and control lymphocytes (Table 80).
These data suggest that no significant differences exist between the
patient and control peripheral blood lymphocytes. Furthermore,
comparison of Tables 78 and 80 would indicate maintainance of
lymphocyte transformation values for both patient and controls,
regardless of the macrophage function.
Macrophage suppression was assessed in autologous patient and control
cultures for lymphocyte transformation (Table 80). Again, as for
Tables 78 and 80, enhancement of lymphocyte transformation was seen
when the effect of macrophage suppression was eliminated using
Indomethacin and Vitamin E. Unstimulated patient and control
lymphocytes in co-culture underwent enhancement, consistent with the
allogeneic effect of non-specific activation of B-cells by factors
from T-cells. This effect was also seen in mixed co-culture tests for
spontaneous lymphocyte transformation in Tables 78 and 80. A similar
increase in lymphocyte transformation between patient, control and co-
culture tests for PHA, PYVM and ConA was seen. The percentage increase
ranges between 10 and 20%.
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Table 80
Co-Culture Lymphocyte Transformation for Patients and Control
































No. Number of pairs in the paired t-test.
* Macrophage suppression eliminated by Indomethacin and
Vitamin E.
** Mean value counts per minute (cpm).
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Table. 81
Macrophage Suppression for Autologous Patient, Control
and Co-Culture for Lymphocyte Transformation
Diagnostic
Category Cells 0 No. PHA No. PWM No. ConA No
OK P - 161* 20 6852 23 605 22 2896 20
P + 131 8418 751 4092
P value NS <0.014 NS NS
OK C - 116 20 5236 23 551 19 2787 19
C + 143 6016 646 3032
P value NS NS <0.038 NS
OK PC - 674 19 5885 17 502 19 2908 1 7
PC + 809 6892 596 3202
P value NS <0.022 NS NS
No. Number of pairs in the paired t-test
NS Not significant.
Patient and control cells
+ Patient and control cells with Macrophage suppression
eliminated by Indomethacin and Vitamin E.
* Mean value counts per minute (cpm).
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d) Functional Tests of Lesional Lymphocytes
The lesional lymphocytes from oral keratoses were only minimally
responsive to mitogenic stimulation (Table 82). The oral keratoses
tested, included nine patients of whom three were LP, two ILK, three
SCC and one patient belonged to the NILK category. The numbers of
patients indicated in Tables 82-86 varied depending upon the pairs
contributing to the paired t-tests.
There was no difference in spontaneous lymphocyte transformation
between peripheral blood and lesional cells. Stimulated lymphocytes
transformation was always higher for peripheral blood than for
lesional cellsbut the differences were only significant for PHA and
ConA stimulated cultures (p<0.01 and p<0.05 respectively).
Lesional lymphocytes in each of the diagnostic categories examined
(LP, ILK, SCC and NILK) were hypo-responsive to mitogenic stimulation
(Table 83). Furthermore, lesional lymphocyte transformation was not




Lymphocyte Transformation for Peripheral Blood
and Lesional Lymphocytes in Oral Keratoses
(expressed in mean value counts per minute)
0 No. PHA No. PWM No. ConA No.
PB* 108 7 6353 8 659 6 3359 7
5EM 26.2 1890.5 188.0 1409.7
Lesional 1 05 7 1 56 8 131 6 536 7
5EM 43.2 33.3 43.8 387.4
Significance NS # NS ##
No. Number of pairs in the paired t-test.
* Peripheral blood lymphocytes.
SEM Standard error of the mean.
# p < 0.01.
## p < 0.05.
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Table 83
Lesional Lymphocyte Transformation for Four
Diagnostic Categories of Oral Keratoses
0_ PHA PWM ConA
LP 34 (2)* 205 (1) 39 (2) 70 (2)
SEM 14 - 5 31
ILK 49 (2) 71 (2) 46 (2)
SEM 19 25 12
SCC 223 (2) 212 (2) 213 (2) 239 (2)
SEM 85 94 82 88
NILK 229 (1) 303 (1) 224 (1) 264 (1)
SEM -
SEM Standard error of the mean.
* Number of pairs in the paired t-test.
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Table 84
Lymphocyte Transformation for Lesional Cells
with and without Macrophage Suppression in Lichen Planus
(expressed in mean value counts per minute)
Cells 0 No. PHA No. PWM No. ConA No.
Lesional- 33.6 2 204.6 1 39.3 2 69.6
SEM 14.6 - 5.3 31.6
Lesional+ 44.0 2 45. 6 1 61 .5 2 92.0
SEM 6.0 - 6.1 23.3
Significance NS NS # NS
No. Number of pairs in the paired t-test.
Patient cells
+ Patient cells with macrophage suppression
eliminated by Indomethacin and Vitamin E.
# p < 0.02.
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Table 85
Lymphocyte Transformation for Lesional Cells with and
without Macrophage Suppression in Infiltrated Leukoplakia (ILK)
(expressed in mean value counts per minute)
No. ConA No.Cells 0_ No. PHA No. PWM
Lesional- 49.0 2 71.0 1 46.3
SEM 19.3 25.3 12.0
Lesional+ 72.8 2 94.0 1 59.0
SEM 45.1 68.3 28.0
Signifi cance NS NS NS
No. Number of pairs in the paired t-test.
Patient cells
+ Patient cells with macrophage suppression
eliminated by Indomethacin and Vitamin E.
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Table 86
Lymphocyte Transformation for Lesional Cells with and
without Macrophage Suppression in Squamous Cell Carcinoma (SCC)
(expressed in mean value counts per minute)
Cells 0 No. PHA No. PWM No. ConA No.
Lesional- 223.3 2 212.0 2 213.3 2 239.3 2
SEM 84.6 94.3 82.0 88.0
Lesional+ 145.5 2 145.0 2 190.3 2 164.8 2
SEM 30.8 31.0 92.6 63.8
Signifi cance NS NS NS NS
No. Number of pairs in the paired t--test
Patient cells
+ Patient cells with macrophage suppression
eliminated by Indomethacin and Vitamin E.
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Co-cultures were set up to examine the influence of lesional
lymphocytes on peripheral blood lymphocytes (Table 87).
The suppressor capacity of the lesional lymphocytes was assessed by
comparing the separate transformation values for cultures of lesional
and peripheral blood lymphocytes, with the co-cultures of these cells.
The mean transformation value for the peripheral blood lymphocytes and
the lesional cells was used as a reference point and was called the
expected value. The value obtained for the co-culture of peripheral
blood lymphocytes and the lesional cells was called the actual value.
If the actual value was greater than the expected value, the
combination of the cells in the co-culture was suggestive of
immunological enhancement. Similarily, if the actual value of the co-
culture was lower than the expected mean value, then immunological
suppression was interpreted. The actual value could be calculated as
a percentage of the expected value and these data are shown in Table
88.
It is seen that immunological suppression is the predominant response
of the co-cultures with the combination of oral keratoses (OK)
producing the greatest value of 632% with ConA stimulation. It is
further seen that the SCC category produced a higher pecentage of
suppression with PHA stimulation than other categories, suggesting
that the lesional immunocytes exert a strong suppressive influence on
the peripheral blood lymphocytes in co-culture. It may be relevant
that what is seen as minimal lesional immunological enhancement in ILK
with PHA, contrasts with the strong immunological suppression seen in
the SCC category with the same mitogenic influence.
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Table 87
Co-Cultures Between Lesional and Peripheral Blood
Lymphocytes in Oral Keratosis and its Diagnostic Categories
(expressed in mean value counts per minute)
Diagnostic
Category Cells 0_ No. PHA No . PWM No. ConA N
LP L 34 2 155 2 39 2 995 3
L/PB - - - - - - - -
PB 81 2 11705 2 723 2 6849 3
ILK L 46 3 62 3 58 1 23 1
L/PB 72 2 2908 3 340 2 206 2
PB 98 3 4017 3 1460 1 836 1
SCC L 308 1 202 3 213 2 239 2
L/PB 199 1 783 2 266 2 339 2
PB 86 1 6754 3 370 2 882 2
NILK L 229 1 303 1 224 1 264 1
L/PB 209 1 798 1 189 1 244 1
PB 221 1 1455 1 310 1 373 1
L 106 7 156 9 131 6 536 7
L/PB - - 1847 7 280 5 266 5
PB 109 7 6353 9 659 6 3359 7
No. Number of pairs in the paired t-test.
L Lesional lymphocytes.
L/PB Co-culture of lesional and peripheral blood lymphocytes.
PB Peripheral blood lymphocytes.
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Table 88
T-Cell Suppression of Lymphocyte Transformation
by Lesional Lymphocytes in Oral Keratoses
Category PH A PWM ConA
LP -
ILK (30%)* 123% 109%
see 344 % 10% 66%
NILK 10% (14%) 31%
Combined Oral 76% 41 % 632%
Keratoses (OK)
Values are approximate as paired t-tests for L/PB co-cultures
were fewer than autologous cell cultures (see Table 87).
The values in brackets indicate immunological enhancement in the
co-cultures. Refer to text for explanation.
* ^suppression(enhancement) = actual counts per minute(cpm) x 100
expected counts per minute(cpm)
where actual cpm = cpm of co-culture and





Oral keratoses present clinically and pathologically with a broad
range of features. The literature review shows the importance of
obtaining a specific diagnosis of an individual keratosis whenever
possible, as diagnosis generally determines management and the risk of
malignant change varies between different keratoses. Diagnosis
remains partly subjective and no strict objective criteria have
emerged which can determine diagnosis or confidently predict the
development of malignant change. The diagnosis of both leukoplakia
and lichen planus is often straight forward when both clinical and
histological examinations have been completed. The histological
features of lichen planus are not as variable as those of leukoplakia
and the pathologist is limited by strict histological criteria when
diagnosing lichen planus. Although a review of the literature
suggests that distinction between these two conditions is generally
clear cut, the present study shows that some patients present with
lesions which are not easy to diagnose. This is particularly
difficult when a patient presents with features of both conditions or
a change is seen within a specific lesion over the course of time.
During the course of the work involved in the present study, it became
apparent that it might be helpful to distinguish those lesions which
had an inflammatory infiltrate (whether in a particular pattern as in
lichen planus or in a more heterogeneous pattern as in leukoplakia)
from those lesions in which an inflammatory infiltrate was absent.
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A different classification of keratoses from that generally in current
use was adopted, but the classification could easily be compared with
those used in previous studies. While it may be preferable in an
ideal study to have similar numbers of patients in all diagnostic
categories for comparison, a prospective study over three years of
patients with keratoses presenting in a hospital did not allow such
and opportunity.
Some of the findings in the present study were consistent with those
previously reported. For example the higher incidence of lichen
planus in females contrasting with that of males in leukoplakia, the
high frequency of smoking in leukoplakia and the combination of
tobacco and alcohol use in squamous cell carcinoma.
No obvious differences could be detected in the haematological and
biochemical results from patients in the different diagnostic
categories which could be of value in establishing a diagnosis. A
comparable proportion of oral keratosis (OK) patients (14.4%) were
found to have a similar range of deficiencies compared to the patients
reported in the study by Wray et al (1975) where 130 RAS patients





Total deficient 23 (14.4%) 23 (17.7%)
Study Total 159 130
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The diagnostic categories of lichen planus and non-infiltrated
leukoplakia had a higher proportion of patients presenting
deficiencies, 22.5% and 19.2% respectively, than the RAS group (241)
suggesting haematological screening may be of value for these
categories.
Nutritional deficiencies were found in a few patients with oral
keratoses, but whether these deficiencies are the cause rather than
the result of the disease has not been established, nor has it been
determined whether the deficiency is dietary or not. As part of a
larger study of patients with oral mucosal disease, a few patients
with oral keratoses were investigated for gut permeability. No
abnormalities were found in the non-infiltrated leukoplakia group
while more than half of the patients with infiltrated leukoplakia were
determined to have abnormal permeability. The significance of this
finding is unclear at present.
The intermediate keratosis category was introduced in the
classification because a group of lesions did not have the criteria
either for inclusion into lichen planus and the infiltrated keratoses,
or for inclusion into the non-infiltrated keratoses. These lesions
were termed intermediate because of the likelihood that they
represented an intermediate state of disease. It was surprising
therefore that the intermediate category had significantly lower serum
immunoglobulin levels than the lichen planus, infiltrated leukoplakia
and non-infiltrated leukoplakia categories suggesting that systemic
immunoglobulin changes may be related to the intermediate categories
only. Dermatological patch testing suggested that patients with
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infiltrated lesions (particularly infiltrated leukoplakia) had a
greater sensitivity to nickel and mercury than those with non
infiltrated leukoplakia, but this was not matched by differences in
the lymphocyte transformation. A relationship between mercury and
nickel sensitivity and the presence of amlagam restorations adjacent
to lesions of lichen planus could not be established.
In the present study, possible lichenoid drug reactions were not
distinguished within the lichen planus category and it was expected
that this category might show an increased use of drugs when compared
with the other categories where no relationships with drug histories
have been shown. It was found however that there was no obvious
difference in the frequency of patients taking drugs between any of
the diagnostic categories. In addition, although the overall
incidence of drug taking was higher in the non-erosive than in the
erosive lichen planus patients, there was a distinct increase in the
number of patients using non-steroidal anti-inflammatory drugs in the
patients with erosive lesions. The use of non-steroidal anti¬
inflammatory drugs by patients with erosive lichen planus compares
closely to those values for patients with erosive lichen planus
reported by Potts et al (1987)(395).
The associated presence of autoimmunity was monitored by measuring
ANF levels which were found to be raised in patients in all disease
categories which included more than three patients. It was concluded
that the presence of ANF did not help in the diagnosis of the known
autoimmune disease discoid lupus erythematosus when presenting as an
oral keratosis.
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The literature review details the characteristic histological features
of keratoses such as lichen planus and discoid lupus erythematosus,
the diagnosis of which may be entirely based on histology. This
contrasts with other keratoses such as frictional keratosis and
leukoplakia where the histological features alone are insufficient for
a definitive diagnosis. There are however some patients with lesions
which histologically do not conform to the strict criteria for the
diagnosis of lichen planus but which clinically do conform. For
management, it is preferable to regard them as having infiltrated
keratoses and if the clinical criteria are sufficiently pronounced
they should be managed as lichen planus. One of the purposes of
the histological study was to attempt to assess which criteria of
lichen planus were most helpful in diagnosis and which criteria were
less helpful in that they are also commonly present in other
keratoses.
Keratinisation may be ortho or para and, if the variation in thickness
of the keratin is ignored, Table 64b shows that parakeratin is the
"dominant" type in lichen planus and frictional and smoking keratosis
with intermediate and non-infiltrated leukoplakia showing orthokeratin
as the "dominant" type. In the other keratoses the frequencies were
more balanced. The presence or absence of a granular layer was not
found to be helpful. Epithelial thickness was not found to be helpful
in diagnosis, although atrophy featured more commonly in the
infiltrated than in the non-infiltrated keratoses. Liquefactive
degeneration was rarely seen in non-infiltrated leukoplakia but this
was not surprising in that it is generally regarded as being
associated with inflammatory oedema. For that reason it was commonly
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seen in infiltrated keratoses. A thickened basement membrane, while
not commonly seen, was almost entirely a feature of lichen planus and
discoid lupus erythematosus. The frequency of apoptosis was similar
to that of liquefactive degeneration, reflecting increased cell
turnover. The most consistent histological feature of lichen planus
was the almost universal presence of a juxta-epithelial, band-like
infiltrate with no associated infiltrates in the deeper connective
tissue. In lichen planus this infiltrate was almost exclusively
composed of lymphocytes and macrophages. This contrasts with other
types of infiltrated keratoses where the juxta-epithelial infiltrate
was sometimes band-like, with a tendency for infiltrates in the deeper
connective tissue also, the infiltrates having a much more variable
composition with plasma cells and polymorphs also present (Tables 67
and 68). Dysplasia was detected in approximately 50% of infiltrated
leukoplakia biopsies and in 30% of lichen planus biopsies. The
presence of dysplasia in keratotic lesions is thought to be of value
in predicting malignant change, but the presence of dysplasia in
lichen planus appears to be related to the inflammatory infiltrate and
not a predictor of malignant change. As explained earlier, the
intermediate category was introduced for those cases which, for one
reason or another, did not conform with the criteria required for
diagnosis of the other categories. When the histological features of
patients with intermediate diagnoses were assessed, the results
suggested that intermediate was a valid category linking non-
infiltrated leukoplakia with infiltrated leukoplakia in that the type
of keratinisation and the nature of the infiltrates resembled
infiltrated leukoplakia while the basement membrane and frequency of
dysplasia resembled non-infiltrated leukoplakia.
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The 30 sections stained for mononuclear cells provided a comparison of
immunological infiltrates between oral keratoses. Previous studies by
Ishii (1987), Migliorati et al (1 986) and Takeuchi et al ( 1988) have
been restricted to lichen planus or leukoplakia (349, 360, 397).
Antigen presentation by monocytes and Langherhans cells is suggested
in lichen planus and altered T4/T8 ratios are associated with
epithelial dysplasia (349,360).
In the present study, B1 phenotype lymphocytes were found in the
connective tissue infiltrate both in lichen planus and a combined
leukoplakia group consisting of infiltrated leukoplakia, intermediate
and non infiltrated leukoplakia. This monoclonal antibody detects
both B cells and plasma cells. Plasma cells are very infrequently
seen histologically in lichen planus and therefore B1 staining in
lichen planus suggests that B cells may be resident in the lichen
planus infiltrate but are not maturing into plasma cells. This is
consistent with the reported predominate of cell mediated activity
related to T cells in lichen planus.
Quantifiable differences in the non-B cell population of lymphocytes
were observed between diagnostic categories (Tables 72-74). The non-
infiltrated leukoplakia category showed lower values of connective
tissue infiltrate for T1, T4 and T8 phenotypes than the frictional and
smoking keratosis category. This comparison may suggest that an
immunological hyporesponsive state exists for the non- infiltrated
leukoplakia category. Furthermore, ten patients with leukoplakia of
the floor of mouth were identified within the non-infiltrated
leukoplakia category (Table 27xv).
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The assessment of T8 infiltrate in the epithelium was seen to be
similar for lichen planus, intermediate leukoplakia, non-infiltrated
leukoplakia and the frictional and smoking keratosis category, with
much higher values in discoid lupus erythematosus and candidal
leukoplakia categories and lower values in the infiltrated leukoplakia
category (Table 73). The T4/T8 ratio reflects the numerical
relationship of helper to suppressor lymphocytes in a lesion. As the
proportion of T4 lymphocytes in the intermediate category is similar
to that in the lichen planus and infiltrated leukoplakia categories,
the increase of T3 phenotype is largely responsible for the low T4/T8
ratio of 0.39 in the intermediate category suggesting that more
suppressor/cytotoxic activity is involved in intermediate leukoplakia
compared to lichen planus or infiltrated leukoplakia (table 76).
The cellular immunological tests were unhelpful in providing
diagnostic indicators for the categories of oral keratoses. The data
were presented in a basic form of mean counts per minute and although
calculation of the stimulation index from the data was possible, this
was not thought appropriate (388). The biological significance of the
difference between spontaneous patient and control lymphocyte
transformation (p<0.013) is unclear (Table 77). Recent evidence that
soluble serum interleukin 2 receptor is associated with disease
activity of atopic eczema may, however, be useful in explaining this
difference in lymphocyte transformation (398). The reduced lymphocyte
transformation in peripheral blood lymphocytes in lichen planus with
elimination of macrophage suppression is not of biological
significance (Table 79). These data suggest that the basic lymphocyte
proliferative responses remain intact for all categories of oral
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keratoses and that macrophage suppression does not account for a
significant effect on the proliferation of peripheral blood
lymphoctyes under T and B cell mitogen stimulation. It is recognised
that lymphocyte transformation provides a 'rough' estimation of the
cellular immune functions.
Data illustrated in Table 81 do, however, suggest that in both
autologous and mixed patient and control cultures, significantly
greater effects of macrophage suppression may indeed be a feature of
patient lymphocytes when compared to control lymphocytes (p<0.014 and
p<0.022 respectively). Again, activation of macrophages via soluble
cytokines or interleukin 2 can be speculated (398) .
In an attempt to identify cellular immune information on the
inflammatory infiltrates of oral keratoses, biopsies were used to
extract available immunocytes. The technique was hindered by the
limited amount of infiltrate and size of biopsy possible. Where
lesional cells were extracted and separated from lesional tissue
debris by using the ficoll-hypaque separation technique, the cells
appeared unresponsive to mitogenic stimulation (Tables 83-86). This
aspect was further investigated by utilising co-culture experiments
and thereby obtaining an indication of the suppressor effect that the
lesional cells retain. It was also anticipated that, following the
harsh extraction process, the cellular capacities may be reduced.
Furthermore, histopathological sections of the tissue processed for
lesional immunocytes showed that not all lymphocytes had been
extracted. The data therefore should be regarded with these
observations in mind.
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Large amounts of tissue were obtained from squamous cell carcinomas
and the lesional immunocytes extracted appear to have a strong
suppressive capacity (Table 88). The values for oral keratoses
collectively appear strongly influenced by the squamous cell carcinoma
category response. It would therefore appear that strong suppressive
capacities are present in the lesional cells extracted from squamous
cell carcinoma. This initial study will require further data to
confirm these results.
Summarising the main aspects of this thesis, a number of observations
can be made. Some of these observations confirm what was already
generally accepted, while others have not been described previously
but require further investigation for confirmation. A number of the
observations answer the questions listed at the end of the Literature
Review (page 97) outlining the objective of the present study. The
following observations confirm previous findings which are generally
accepted :-
1. Oral keratoses present a broad spectrum of clinical and
pathological features.
2. The clinical presentations of the different categories of oral
keratoses were not specific to each category.
3. Tobacco and alcohol are positively associated with categories
infiltrated leukoplakia, discoid lupus erythematosus, candidal
leukoplakia, squamous cell carcinoma and non infiltrated
leukoplakia. Patients with lichen planus smoke less
tobacco and drink significantly less alcohol than certain other
categories including infiltrated leukoplakia, non infiltrated
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leukoplakia and squamous cell carcinoma.
4. Quantitative differences are detectable in the immunocyte
infiltrates in the different diagnostic categories of oral
keratosis.
The following observations have either not been reported previously or
provide further evidence to support results which are not generally
accepted: -
1. Haematological deficiencies were not related to particular types of
oral keratoses with the exception of lichen planus and non-
infiltrated leukoplakia.
2. Drugs are frequently taken by patients in all categories of oral
keratoses. The use of non-steroidal anti-inflammatory drugs may be
related to erosive forms of lichen planus rather than to non-
erosive forms.
3. Quantitative differences in both alcohol consumption and tobacco
smoking between the diagnostic categories exist
4. Abnormal intestinal permeability to sugars was found in patients
with infiltrated keratoses but not in those with non-infiltrated
keratoses.
5. Serum immunoglobulin levels are similar for all categories of oral
keratoses except for patients in the intermediate leukoplakia
category of oral keratosis whose serum immunoglobulin levels were
reduced.
6. While basic cellular immunological tests have been unhelpful, as of
yet, in determining major functional abnormalities in oral
keratoses, the squamous cell carcinoma category presented lesional
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immunocytes which had strong suppressive capacities.
The hypothesis that the cellular infiltrate, present or absent from
the oral keratosis, is important in determining the malignant
potential of the lesion, cannot be rejected on the evidence of the
results presented. While it was not possible to relate malignant
change with the cellular infiltrates preceeding the malignancy, the
T4/T8 ratios (Table 76) suggest polarisation between the categories of
leukoplakia. The T4/T8 ratios and the tobacco and alcohol history may
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